EMBO Molecular Medicine is on Bluesky!
➡️ bsky.app/profile/emboreports.org
See you there!
EMBO Molecular Medicine
EMBO Molecular Medicine is an open-access peer-reviewed medical journal covering research in molecular medicine. More on Wikipedia
-
EMBO Mol. Medicine reposted
EMBO Mol. Medicine
@EmboMolMed
-
EMBO Mol. Medicine reposted
EMBO Mol. Medicine
@EmboMolMed
EMBO Molecular Medicine is on Bluesky!
@embomolmed.org
➡️ bsky.app/profile/emboreports.org
See you there! -
EMBO Mol. Medicine reposted
EMBO Mol. Medicine
@EmboMolMed
EMBO Mol. Med. shares news and updates on the alternative platform now. We'd love to stay connected!
Find us there: bsky.app/profile/embomolmed.org -
EMBO Mol. Medicine
@EmboMolMed
EMBO Molecular Medicine is on Bluesky!
➡️ bsky.app/profile/emboreports.org
See you there! -
EMBO Mol. Medicine
@EmboMolMed
EMBO Mol. Med. shares news and updates on the alternative platform now. We'd love to stay connected!
Find us there: bsky.app/profile/embomolmed.org -
EMBO Mol. Medicine
@EmboMolMed
EMBO Molecular Medicine is on Bluesky!
@embomolmed.org
➡️ bsky.app/profile/emboreports.org
See you there! -
EMBO Mol. Medicine reposted
Matthew S. Alexander
@Matt_Muscle_Guy
Excited to share this new collaborative @EmboMolMed work from my lab @ChildrensAL & @jdowling007 labs. Work highlights efforts to generate a new animal model for X-linked myopathy with excessive autophagy (XMEA) and perform corrective drug screening. 1/n idp.springer.com/authorize?response_type=cookie&client_id…
-
EMBO Mol. Medicine reposted
Intestinal Cell News
@Intestinal_Cell
🧬 Dr. Abdel-Majid Khatib's team at @BRIC_Bordeaux explored the therapeutic potential of targeting proapelin cleavage sites in metastatic #crc by introducing apelin-dm, a variant resulting from alteration in proapelin cleavage sites.
@EmboMolMed | idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine
@EmboMolMed
Repression of #apelin Furin cleavage sites provides antimetastatic strategy in #colorectalcancer
By B. Demoures, G. Siegfried, AM Khatib & colleagues @Inserm
➡️doi.org/10.1038/s44321-025-00196-5 -
EMBO Mol. Medicine
@EmboMolMed
Portimine A #toxin causes #skininflammation through ZAKα-dependent #nlrp1 inflammasome activation
By P. Brehmer, F. Roca, F. Zhong, J. Common, E. Meunier, P. Hess & colleagues
🗞️doi.org/10.1038/s44321-025-00197-4 -
EMBO Mol. Medicine
@EmboMolMed
➡️Read this review by A. Bleckmann & colleagues that provides a comparison of in vivo, ex vivo, and in vitro models for studying #tumor - #microbiome interactions in early-onset #colorectalcancer
🗞️doi.org/10.1038/s44321-025-00198-3 -
EMBO Mol. Medicine
@EmboMolMed
📢New issue online!
The cover highlights the study by M Breßer, K D Siemens, R Schneider et al. on the role of reactive resident #macrophages in surgery-induced #gutinflammation & resulting enteric #neurodegeneration.
Image by R. Schneider & colleagues
📰www.embopress.org/journal/17574684 -
EMBO Mol. Medicine reposted
EMBO Reports
@emboreports
Are you attending the #embometabolicdiseases meeting in beautiful Torremolinos? So is our editor Deniz Senyilmaz Tiebe! Talk to her if you are looking for a home for your paper or about scientific publishing. @EMBOevents @EMBOPress
-
EMBO Mol. Medicine reposted
Hatoon
@Hatoon_Bkeerah
Very excited to share our recent research exploring the role of #fabp4 in modulating #sarscov2
Thank you to all my colleagues @gshlab, to @ghotamis and all our collaborators.
#metabolism #virology #infectiousdisease
EMBO Mol. Medicine
@EmboMolMed
#fabp4 as a therapeutic host target controlling #sarscov2 infection
By H. Baazim, A. Ozkul, @ghotamis & colleagues @AnkaraUni and @broadinstitute
➡️doi.org/10.1038/s44321-024-00188-x -
EMBO Mol. Medicine
@EmboMolMed
Online today ➡️#microbialmetabolites tune #amygdala neuronal hyperexcitability and #anxiety -linked behaviors.
By W. Yu, Y. Xiao, S. Pettersson, H.S. Je & colleagues @dukenus
🗞️doi.org/10.1038/s44321-024-00179-y -
EMBO Mol. Medicine
@EmboMolMed
Exploiting #metabolicvulnerability in #glioblastoma using a brain-penetrant drug with a safe profile
By @audrey_burban, @AndreasBikfalvi, @Thomas_Daubon, @SharanekAhmad & colleagues @Inserm & Bordeaux University
➡️doi.org/10.1038/s44321-025-00195-6 -
EMBO Mol. Medicine
@EmboMolMed
An AI-assisted morphoproteomic approach is a supportive tool in #esophagitis -related #precisionmedicine
By S. Mattern, S. Singer & colleagues at Tübingen University
➡️doi.org/10.1038/s44321-025-00194-7 -
EMBO Mol. Medicine
@EmboMolMed
📢Review by K. Nadeau & colleagues at Harvard T. H. Chan School of Public Health 👉 #exposomics: a review of methodologies, applications, & future directions in #molecularmedicine
doi.org/10.1038/s44321-025-00191-w -
EMBO Mol. Medicine
@EmboMolMed
Review by M. Moll & D. Baumjohann @UniklinikBonn
➡️Boosting human immunology: harnessing the potential of immune organoids.
🗞️doi.org/10.1038/s44321-025-00193-8 -
EMBO Mol. Medicine
@EmboMolMed
"Improving the odds of survival: transgenerational effects of infections"
👉Read the review by V. Spanou, T. Andriopoulou, E. Giamarellos-Bourboulis & M. Neteai at University of Athens & @radboudumc
🗞️doi.org/10.1038/s44321-025-00192-9 -
EMBO Mol. Medicine
@EmboMolMed
#fabp4 as a therapeutic host target controlling #sarscov2 infection
By H. Baazim, A. Ozkul, @ghotamis & colleagues @AnkaraUni and @broadinstitute
➡️doi.org/10.1038/s44321-024-00188-x -
EMBO Mol. Medicine
@EmboMolMed
Do not miss the review by K. Cook and colleagues @KLCookLab @wakeforestmed that discusses the role of #gutmicrobiota in #breastcancer therapeutic outcomes!
🗞️doi.org/10.1038/s44321-024-00185-0 -
EMBO Mol. Medicine reposted
Immune Regulation News
@Immune_News
🔬 Drs. Florian Kühnel lead @MHH_life researchers in demonstrated that membrane-associated T cell engagers expressing oncolytic #viruses are powerful T cell activating tools suitable for local #immunotherapy of a broad range of tumors.
🔓 @EmboMolMed | idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine reposted
Nico Franzmeier
@nfranzme
Happy to share @davinabiel newest in @EmboMolMed showing stronger Aβ-dependent p-tau increases in women, potentially driven by elevated sTREM2-related microglial activation and stronger effects of ApoE4 carriership in women
Many thanks also to @matbrendel! doi.org/10.1038/s44321-024-00190-3 -
EMBO Mol. Medicine
@EmboMolMed
January issue now online!
👉www.embopress.org/journal/17574684
The cover highlights the study by E Bayam, B Yalcin, JD Godin et al. that demonstrates a causal link between variants in #wdr47 gene & a #neurodevelopmentalsyndrome in humans & mice.
Scientific image by E. Bayam & E. Brivio -
EMBO Mol. Medicine
@EmboMolMed
Female sex is linked to a stronger association between #strem2 and CSF #ptau in #alzheimersdisease
By D. Biel, M. Brendel, N. Franzmeier & colleagues @LMU_Muenchen
➡️doi.org/10.1038/s44321-024-00190-3 -
EMBO Mol. Medicine
@EmboMolMed
Online today 👉 #oncolyticviruses expressing MATEs facilitate target-independent #tcell activation in tumors.
By M. Peter, F. Kühnel & colleagues at Hannover Medical School
🗞️doi.org/10.1038/s44321-024-00187-y -
EMBO Mol. Medicine
@EmboMolMed
📢Don’t miss this Perspective by C. Buchholz, M. Funk & colleagues on #cartcell -associated secondary malignancies:
"CAR T-cell-associated secondary malignancies challenge current pharmacovigilance concepts"
👉doi.org/10.1038/s44321-024-00183-2 -
EMBO Mol. Medicine
@EmboMolMed
Macrophage-induced #enteric #neurodegeneration leads to motility impairment during #gutinflammation
By M. Breßer, K. D. Siemens, R. Schneider & colleagues @UniklinikBonn
➡️doi.org/10.1038/s44321-024-00189-w -
EMBO Mol. Medicine
@EmboMolMed
A therapeutic regimen using neoantigen-specific #tcr #tcells for HLA-A*2402-positive solid tumors.
By Y. Bei, B. Liu, R. Li & colleagues at Nanjing University
👉doi.org/10.1038/s44321-024-00184-1 -
EMBO Mol. Medicine
@EmboMolMed
First paper of 2025!💫
#plexind1 is a driver and a therapeutic target in advanced #prostatecancer
By J. Wei, J. Wang, B. J. Wu & colleagues at Washington State University and @DanaFarber
🗞️doi.org/10.1038/s44321-024-00186-z -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
We are packing our bags for San Diego and looking forward to great talks and community at #cellbio24! Be sure to visit the EMBO booth (#625) in the exhibit hall, and check out our featured events in the program. @ASCBiology
www.ascb.org/cellbio2024/program/ -
EMBO Mol. Medicine reposted
MedUni Wien
@MedUni_Wien
Researchers at #medunivienna lay the foundation for the first treatment option that addresses the mechanism of scarring #alopecia 👉🏻 #jakinhibitors can reactivate #hairgrowth. More about the new findings! ➡️ www.meduniwien.ac.at/web/en/about-us/news/2024/news-in-de…
#cancertherapy @EmboMolMed -
EMBO Mol. Medicine
@EmboMolMed
Our last 2024 issue is out!
➡️www.embopress.org/journal/17574684
The beautiful cover highlights the study by K Strobl, @sibilia_maria, T Bauer & al that highlights JAK-STAT1 as therapeutic target for #egfr deficiency-associated #scarringalopecia.
Illustration by authors @CCR_SibiliaLab -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
We are pleased to partner with and sponsor @EACRnews for the upcoming EACR-AstraZeneca Circulating Nucleic Acids virtual conference (28-29 Jan). Our @EmboMolMed editor Jingyi Hou will attend!
Details & registration: eacr.org/conference/circulatingnucleicacids2025 -
EMBO Mol. Medicine reposted
Pablo Pelegrin
@PelegrinPablo
We found that the inflammasome adaptor protein ASC promotes amyloid deposition in cryopyrin-associated periodic syndromes @EmboMolMed www.embopress.org/doi/full/10.1038/s44321-024-00176-1 @UMU @IMIB_RMurcia
-
EMBO Mol. Medicine
@EmboMolMed
The #inflammasome adaptor protein ASC promotes #amyloid deposition in cryopyrin-associated periodic syndromes.
C. Alarcon-Vila, J. Martinez-Garcia, @PelegrinPablo & colleagues @UMU
🗞️doi.org/10.1038/s44321-024-00176-1 -
EMBO Mol. Medicine
@EmboMolMed
#bmp9 mediates fibroproliferation in #fibrodysplasia ossificans progressiva through #tgfbeta signaling.
#raredisease
By C. Zhao, M. Ikeya & colleagues @KyotoU_News
🗞️doi.org/10.1038/s44321-024-00174-3
Also online today ➡️ related N&V by Qiwen Li & Quan Yuan🗞️doi.org/10.1038/s44321-024-00180-5 -
EMBO Mol. Medicine
@EmboMolMed
Bi-allelic variants in WDR47 cause a complex neurodevelopmental syndrome 👉
doi.org/10.1038/s44321-024-00178-z
by E. Bayam, B. Yalcin, J. Godin & colleagues @IGBMC
#corpuscallosum #dysgenesis #microcephaly -
EMBO Mol. Medicine
@EmboMolMed
Don’t miss the review by PC Yang and colleagues on the role of #airpollution, particularly #fineparticulatematter PM2.5, in #lungcarcinogenesis
➡️doi.org/10.1038/s44321-024-00175-2
By C-Y Chen, K-Y Huang, T-H Wang, P-C Yang & colleagues @NTU_TW -
EMBO Mol. Medicine
@EmboMolMed
Pathogenic PDE12 variants impair mitochondrial RNA processing causing neonatal #mitochondrialdisease.
🗞️doi.org/10.1038/s44321-024-00172-5
By @LindseyVanHaute & colleagues @mito_gene @taylorlabncl
Read related highlight by C. Yu, @MarcoTigano & E. Seifert ➡️ doi.org/10.1038/s44321-024-00171-6 -
EMBO Mol. Medicine reposted
Minczuk Lab
@mito_gene
Excited to share our latest study led by @LindseyVanHaute out in @EmboMolMed. Pathogenic variants in PDE12 disrupt mitochondrial RNA processing lead to neonatal mitochondrial disease. Great collaboration with @taylorlabncl et al. Congrats! @MBU_postdocs
www.embopress.org/doi/full/10.1038/s44321-024-00172-5 -
EMBO Mol. Medicine
@EmboMolMed
👉doi.org/10.1038/s44321-024-00159-2
Salmonella discovery offers new hope for bowel cancer therapies www.birmingham.ac.uk/news/2024/salmonella-discovery-offer… -
EMBO Mol. Medicine
@EmboMolMed
Melanin-like #nanoparticles slow cyst growth in #adpkd by dual inhibition of #oxidativestress & #creb
By Y Sun, L Zhang & colleagues at Tianjin Medical University
➡️doi.org/10.1038/s44321-024-00167-2
Read also related N&V by L Cassina & A Boletta @Boletta_Lab
➡️doi.org/10.1038/s44321-024-00173-4 -
EMBO Mol. Medicine reposted
UofG MVLS
@UofGMVLS
The team, led by @UofGlasgow researcher Dr Kendle Maslowsi, studied the response of T cells to a specially engineered safe form of Salmonella in mice with colorectal cancer.
The full study is published in @EmboMolMed
➡️ www.embopress.org/doi/full/10.1038/s44321-024-00159-2
Cancer Research UK in Scotland
@CRUKScotland
Fighting cancer with Salmonella could be a step closer after research, funded by us, discovered how the bacteria suppresses the immune system as well as tumour growth. The team @CRUK_SI led by Dr Kendle Maslowsi identified how a safe form of Salmonella could be engineered to allow our immune system to attack the cancer alongside the bacteria. You can find their research paper here 👉cruk.ink/4exBPlS
-
EMBO Mol. Medicine
@EmboMolMed
Online today! #salmonella #cancertherapy metabolically disrupts tumours at the collateral cost of T cell immunity.
By A. Copland, K. Maslowski & colleagues @MaslowskiLab @UofGlasgow
➡️doi.org/10.1038/s44321-024-00159-2 -
EMBO Mol. Medicine reposted
Faculty of Science of Charles University
@science_charles
Genetic disorder #algs affects newborns' livers. @JanMasekLab and colleagues uncovered how immature #hepatocytes & #tregs contribute to pericellular #fibrosis in ALGS.
Read more in @EmboMolMed!
🔗www.embopress.org/doi/full/10.1038/s44321-024-00145-8
(TŽ) -
EMBO Mol. Medicine
@EmboMolMed
Diagnosis and prognosis prediction of #gastriccancer by high-performance serum #lipidome fingerprints.
Z-R. Cai, W. Wang, D. Chen, H-J. Chen, Y. Hu, H-I. Piao, R-H. Hu, H-Q. Ju & colleagues
➡️doi.org/10.1038/s44321-024-00169-0 -
EMBO Mol. Medicine
@EmboMolMed
APOE from #astrocytes restores #alzheimers Aβ-pathology and DAM-like responses in APOE deficient #microglia.
By P. Preman, M. Fiers, B. De Strooper & colleagues @CBD_VIB
🗞️doi.org/10.1038/s44321-024-00162-7 -
EMBO Mol. Medicine
@EmboMolMed
JAK-STAT1 as therapeutic target for #egfr deficiency-associated inflammation and #scarringalopecia.
By K. Strobl, @sibilia_maria, T. Bauer & colleagues @cancerCCR
🗞️doi.org/10.1038/s44321-024-00166-3
👉Read related N&V by J. Durgin & S. Wong: doi.org/10.1038/s44321-024-00170-7 -
EMBO Mol. Medicine
@EmboMolMed
Our November issue is online!
➡️www.embopress.org/toc/17574684/16/11
This month's cover highlights the article by T Ackermann et al showing that incorporation of selenium in selenoproteins is important for #tnbc to form colonies & lung mets.
Scientific illustration by S. Tardito @cancerCCR -
EMBO Mol. Medicine reposted
Mammary Cell News
@MammaryCell
🧬 Using a genome-wide #crispr-Cas9 screen, scientists investigated escape mechanisms of NOTCH-driven #tnbc treated with a gamma-secretase inhibitor and identified SOX2 as a target of resistance to Notch inhibition.
@EmboMolMed | idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine
@EmboMolMed
In this N&V ➡️ doi.org/10.1038/s44321-024-00154-7, R. Meehan & S. Pennings discuss the recent work from Frasca et al that shows that neural precursor cells rescue symptoms of #rettsyndrome by activation of the #interferon γ pathway.
Related research article ➡️doi.org/10.1038/s44321-024-00144-9 -
EMBO Mol. Medicine
@EmboMolMed
Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas
👉doi.org/10.1038/s44321-024-00157-4
#pancreaticcancer
By J. Chen, C. Stockmann & colleagues @Unispital_USZ -
EMBO Mol. Medicine
@EmboMolMed
Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in #triplenegativebreastcancer
By M. Fournier, J. Javary, F. Radtke & colleagues @EPFL_en
doi.org/10.1038/s44321-024-00161-8 -
EMBO Mol. Medicine reposted
Hepatic Cell News
@hepaticcellnews
In this @EmboMolMed article, scientists identified luteolin as a potential drug, which showcasing robust efficacy in detoxifying the DEHP by facilitating the expulsion of DEHP in both mouse primary #hepatocytes and livers. 🔎 💊
idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine
@EmboMolMed
#luteolin detoxifies DEHP and prevents #liver injury by degrading Uroc1 protein in mice
By H. Wang, S. Chen & colleagues at Pharmaceutical University, Nanjing
👉doi.org/10.1038/s44321-024-00160-9
Read also related N&V by F. Cappelli & A. Mengozzi @Unipisa
👉doi.org/10.1038/s44321-024-00158-3 -
EMBO Mol. Medicine
@EmboMolMed
Don’t miss the review by E. Barazzone, M. Diard, I. Hug, L. Larsson & E. Slack on the potential and challenges of engineering the #gutmicrobiota for medical intervention
@ETH_en @BRC_CH
🗞️doi.org/10.1038/s44321-024-00149-4 -
EMBO Mol. Medicine
@EmboMolMed
Ependymal cell lineage reprogramming as a potential therapeutic intervention for #hydrocephalus
By K. Kaplani, S. Taraviras & colleagues @stemcellslab @upatras
👉doi.org/10.1038/s44321-024-00156-5 -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
We're hiring!
We're looking for a scientific editor to join the open-access, peer-reviewed journal, Life Science Alliance (www.life-science-alliance.org). If you'd like to come and work in Heidelberg & are passionate about academic publishing, apply today: www.jobs.ac.uk/job/DKE564/scientific-editor -
EMBO Mol. Medicine
@EmboMolMed
Are you attending #cytokines2024 in Seoul?
So is our editor Zeljko Durdevic! Reach out and talk to him about your research
👉cytokines2024.org
@EMBOPress -
EMBO Mol. Medicine
@EmboMolMed
📢 N&V from @AngeliFriedmann & @AncelyF highlighting 2 recent studies reporting examples of alterations in #lipidmetabolism that can promote targetable vulnerabilities for #breastcancer.
👉doi.org/10.1038/s44321-024-00150-x
Related articles:
doi.org/10.1038/s44321-024-00090-6
doi.org/10.1038/s44321-024-00142-x -
EMBO Mol. Medicine
@EmboMolMed
#breastcancer secretes anti-ferroptotic MUFAs and depends on selenoprotein synthesis for metastasis.
By T. Ackermann, S. Tardito & colleagues @UofGlasgow
#ferroptosis
📰doi.org/10.1038/s44321-024-00142-x -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Join our team - @LSAjournal has an exciting opportunity for a scientific editor based in Heidelberg, Germany! Prior editorial experience will be an advantage, but is not a prerequisite -- apply for this position by Nov. 15!
www.nature.com/naturecareers/job/12831125/scientific-edit… -
EMBO Mol. Medicine reposted
Endothelial Cell News
@endothelialnews
This week in @EmboMolMed!
Researchers developed a novel therapeutic approach for the treatment of cerebral cavernous malformation through targeting the polycomb repressive complex 1 protein CBX7.
📖 Read the article here: idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine
@EmboMolMed
Read online today! Transient #cartcells with specificity to oncofetal glycosaminoglycans in #solidtumors 👉doi.org/10.1038/s44321-024-00153-8
By N. Khazamipour, M. Daugaard & colleagues @VanProstateCtr -
EMBO Mol. Medicine
@EmboMolMed
Our October issue is out!
The cover highlights the work by Z Guo, Q Zhao, X He & al. (doi.org/10.1038/s44321-024-00140-zshowing) showing that the liver protects neuron viability & electrocortical activity in #postcardiacarrest brain injury. Image by the authors.
New issue: www.embopress.org/toc/17574684/16/10 -
EMBO Mol. Medicine
@EmboMolMed
Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models.
#rettsyndrome
By A. Esposito, F. C. Guarnieri, M. Palmieri & colleagues @SanRaffaeleMI
🗞️doi.org/10.1038/s44321-024-00151-w -
EMBO Mol. Medicine
@EmboMolMed
Online today! Epigenetic regulation by polycomb repressive complex 1 promotes #cerebralcavernousmalformations
By V.C. Pham, C. J. Rödel, M. Pagani, S. Abdelilah-Seyfried & colleagues @IFOMresearch @unipotsdam
👉doi.org/10.1038/s44321-024-00152-9 -
EMBO Mol. Medicine reposted
Maria Sibilia
@sibilia_maria
Congratulations to Luana from my group @CCR_SibiliaLab, @cancerCCR for winning the poster prize at the 46th @HCR_Symposium on
#cancer Signalling & #metabolism in beautiful Mont Sainte Odile, sponsored by @EmboMolMed. -
EMBO Mol. Medicine
@EmboMolMed
Online today ➡️Targeting #usp11 regulation by a novel lithium-organic coordination compound improves #neuropathologies and cognitive functions in #alzheimer transgenic mice.
by Yi Guo, Song Li, Jun Tan & colleagues at Guizhou Medical University
🗞️doi.org/10.1038/s44321-024-00146-7 -
EMBO Mol. Medicine
@EmboMolMed
Congratulations Emanuela Bocchi for winning the EMBO Mol. Med. poster award at the 3rd Epithelial Mesenchymal Interactions in Lung Development and Fibrosis Fusion conference!✨
#fusionlung24 -
EMBO Mol. Medicine reposted
José Pedro Friedmann Angeli
@AngeliFriedmann
😊
Here is @AncelyF 🎉 #newsviews on two recent studies by the groups of #saveriotardito and @andMORand published in @EmboMolMed
Troubling bonds: lipid unsaturation promotes selenium dependency and sensitivity to ferroptosis | EMBO Molecular Medicine www.embopress.org/doi/full/10.1038/s44321-024-00150-x -
EMBO Mol. Medicine reposted
Hepatic Cell News
@hepaticcellnews
🐭 Scientists showed that Jag1Ndr/Ndr mice recapitulated Alagille syndrome-like #fibrosis and revealed immature #hepatocytes and paradoxically low intrahepatic T cell infiltration despite #cholestasis.
📖 @EmboMolMed | idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine reposted
Daniel Klimmeck
@DanielKlimmeck
🍾Celebrating the four poster prize winners #eesmetastasis
>Elisabetta D’Avanzo @UniFAU (@embojournal)
>Alexandra Benó @HcemmSzeged (@EmboMolMed)
>Chiara Spadazzi IRCCS, Italy (@MetastasisRS)
>@anke_vandekeere @VIB (@MetastasisRS)
Exciting science & splendid presentations! 👏💪🏅 -
EMBO Mol. Medicine reposted
Fusion Conferences
@Fusion_Conf
What an amazing evening it was at the Gala last night, filled with wonderful conversations and a celebration of everyone’s achievements! 🌟
A huge congratulations to our Poster, Short Talk and Q&A Engagement winners. 🌟
#fusionlung24
@Delanghelab @ana_saganta @Tatalab_Duke @hnarasim23 @anaivonneva @BrownfieldLab @EmboMolMed -
EMBO Mol. Medicine reposted
Daniel V. Oliveira
@dfvoliveira
Check out the new paper from our lab that is now out @EmboMolMed
A very nice collaboration that I was lucky to be a part involving development biologists, hepatologists and immunologist. For more about the paper check the nice recap 👇
Jan Mašek
@JanMasekLab
🧵1/8 Excited to share our latest research published in EMBO Molecular Medicine! We explored the specific, pericellular fibrosis in Alagille syndrome (ALGS). #fibrosis #algs #liverdisease #embo
doi.org/10.1038/s44321-024-00145-8 -
EMBO Mol. Medicine
@EmboMolMed
Pre-clinical development of AP4B1 #genereplacementtherapy for hereditary spastic paraplegia type 47.
By J. P. Wiseman, M. Azzouz & colleagues @sheffielduni
👉doi.org/10.1038/s44321-024-00148-5 -
EMBO Mol. Medicine
@EmboMolMed
Jag1 insufficiency alters #liverfibrosis via #tcell and #hepatocyte differentiation defects.
#alagillesyndrome
By J. Mašek, @EmmaRAndersson & colleagues @karolinskainst
👉doi.org/10.1038/s44321-024-00145-8 -
EMBO Mol. Medicine
@EmboMolMed
Online today! A new class of capsid-targeting inhibitors that specifically block #hiv1 nuclear import.
By A. Boulay, N. J. Arhel & colleagues @IRIM_life
🗞️doi.org/10.1038/s44321-024-00143-w -
EMBO Mol. Medicine
@EmboMolMed
Congratulations to @LeonardoMatta for winning the @EMBOMolMed poster award! 👏
@BarteltLab
#helmholtzdiabetes2024
Helmholtz Diabetes Center (HDC)
@helmholtz_diabc
30 posters were presented during the Diabetes Conference, showcasing cutting-edge research on wasting metabolism! 🎉
Congratulations to @LeonardoMatta for winning the #posterprize, sponsored by @EMBO. 🏆
Thank you to all the participants for their inspiring contributions! 🙏 -
EMBO Mol. Medicine
@EmboMolMed
RIG-I is an intracellular checkpoint that limits #cd8tcell antitumour immunity.
By X. Duan, J. Hu, Y. Zhang, HW. Sun, XY. Li, L. Lu & colleagues at Zhuhai People’s Hospital
#cancerimmunotherapy
🗞️doi.org/10.1038/s44321-024-00136-9 -
EMBO Mol. Medicine
@EmboMolMed
#neuralprecursorcells rescue symptoms of #rettsyndrome by activation of the Interferon γ pathway
By A. Frasca, F. Miramondi, N. Landsberger & colleagues @SanRaffaelespa @LaStatale
👉doi.org/10.1038/s44321-024-00144-9 -
EMBO Mol. Medicine
@EmboMolMed
Liver protects neuron viability and electrocortical activity in post- #cardiacarrest #braininjury
By Z. Guo, Q. Zhao, X. He and colleagues at Guangzhou, China
👉doi.org/10.1038/s44321-024-00140-z -
EMBO Mol. Medicine
@EmboMolMed
Another #malaria paper online today! 👉Infection length and host environment influence on Plasmodium falciparum dry season reservoir.
By C. Andrade, M. Carrasquilla, S. Portugal & colleagues @mpiib_berlin @uniklinik_hd
🗞️doi.org/10.1038/s44321-024-00127-w -
EMBO Mol. Medicine
@EmboMolMed
📢Read the review online today by D. Moita & M. Prudêncio @ULisboa_ that discusses challenges in developing #malaria #vaccines and recent developments in whole-sporozoite vaccines using genetically engineered parasites
📰doi.org/10.1038/s44321-024-00131-0 -
EMBO Mol. Medicine
@EmboMolMed
#crispr -enabled point-of-care genotyping for #apol1genetic risk assessment.
By R. Greensmith, L.V. Riella, M.M. Kaminski & colleagues @MDC_Berlin @ChariteBerlin @harvardmed
#kidneydisease
➡️doi.org/10.1038/s44321-024-00126-x -
EMBO Mol. Medicine
@EmboMolMed
Do not miss! 👉An intrinsic mechanism of metabolic tuning promotes cardiac resilience to stress 🫀
By M. Sorge, @berteroale, M. Brancaccio & colleagues @unito
🗞️doi.org/10.1038/s44321-024-00132-z -
EMBO Mol. Medicine reposted
Immunology of Infectious Disease News
@infdisease_news
Céline Van Dender and team from @InflamResCen showed that hepatic HNF4α activity is decreased during #sepsis, causing PPARα downregulation, metabolic problems, and a disturbed IL6-mediated acute phase response.
🖨️ @EmboMolMed | 🔗 idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine reposted
Alessandro Bertero
@berteroale
What happens when cardiac #metabolism goes off balance? Our new paper @EmboMolMed uncovers how Melusin, a muscle #chaperone protein, fine-tunes heart metabolism, boosting #cardiac #resilience against #pressureoverload and #doxorubicin toxicity. 1/3
www.embopress.org/doi/full/10.1038/s44321-024-00132-z.. -
EMBO Mol. Medicine reposted
rlevato
@RicLevato
Happy to share that our review on Engineering Human Mammary tissue via #organoids and #bioprinting, lead by Maj-Britt Buchholz @Dream3DLab @IamAnneRios, is now online #openaccess at @EmboMolMed
📰 www.embopress.org/doi/full/10.1038/s44321-024-00112-3
@prinsesmaximac @VET_UniUtrecht @UMCU_Intl @RMUtrecht -
EMBO Mol. Medicine reposted
Mammary Cell News
@MammaryCell
Dr. Maj-Britt Buchholz and collaborators propose methods to validate breast function and highlight preclinical applications for improved understanding and targeting 🎯 of #breastcancer in this recent @EmboMolMed review.
📖 Give it a read: idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine reposted
Medicines for Malaria Venture (MMV)
@MedsforMalaria
@ANU_Research & @HumboldtUni scientists have developed a Trojan horse method to trick #malaria parasites into ingesting a fatal dose of drugs by exploiting their need for cholesterol, offering insights into drug resistance & development: idp.springer.com/authorize?response_type=cookie&client_id…
-
EMBO Mol. Medicine reposted
Science Advancement and Outreach
@SAOscience
📚 A new #review on engineering human #breast tissue using #organoids and #bioprinting by Maj-Britt Buchholz, @RicLevato, & team was published recently in @EmboMolMed.
The authors outline their application in health and disease research. Check it out!
www.embopress.org/doi/full/10.1038/s44321-024-00112-3 -
EMBO Mol. Medicine reposted
Oroboros Instruments
@OroborosI
In a recent #o2kpublication, Lorito et al reveal a new vulnerability in aggressive triple-negative breast cancer: wiki.oroboros.at/index.php/Lorito_2024_EMBO_Mol_Med
#lipidmetabolism #ferroptosis #tnbc #breastcancer #highresolutionrespirometry #o2knetwork
@EmboMolMed -
EMBO Mol. Medicine
@EmboMolMed
Our September issue is online!
This month's cover highlights the article by J. M. Sattler, F. Frischknecht and colleagues @FrischknechtLab on vaccination against #malaria
Scientific illustration by Marco Binder @TheBinderLab
🗞️www.embopress.org/toc/17574684/16/9 -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
It's not too late to join the “Scientific integrity: how to publish reproducible results” online workshop on 09-10 October! Sign up now: lab-management.embo.org/dates/sci-integrity
@EMBOPress @EMBO @embojournal
EMBO Lab Leadership
@LifeSciLearn
🆕Learn more about #researchintegrity in a friendly + interactive setting. Sign up for "Scientific integrity: how to publish reproducible results": lab-management.embo.org/dates/sci-integrity Ieva Gailite @embojournal provides insights + offers a unique angle from @EMBOPress #editor's point of view
-
EMBO Mol. Medicine reposted
Lindsay Wu
@LindsayWu_UNSW
Grateful for this lovely writeup of our work on chemo induced infertility in @EmboMolMed! Many thanks to @norahspears @AgnesStefansd and Adomas Liugaila
Can we manipulate the ovary’s own metabolism to protect it from chemotherapy-induced damage? www.embopress.org/doi/full/10.1038/s44321-024-00124-z -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
🆕Learn more about #researchintegrity in a friendly + interactive setting. Sign up for "Scientific integrity: how to publish reproducible results": lab-management.embo.org/dates/sci-integrity Ieva Gailite @embojournal provides insights + offers a unique angle from @EMBOPress #editor's point of view
-
EMBO Mol. Medicine
@EmboMolMed
Our August issue is online !
The cover highlights the article by I. Hawwari, L. Rossnagel, B. Franklin et al. & illustrates a novel intercellular communication mechanism between #platelets & #monocytes 👉doi.org/10.1038/s44321-024-00093-3
Scientific illustration by Salie Maasewerd @IIIBonn -
EMBO Mol. Medicine
@EmboMolMed
Online today! Comprehensive molecular characterization of #collectingductcarcinoma for therapeutic vulnerability.
By P. Guan, J. Chen, C. Mo, T. Fukawa, X. Yao, B. T. Teh, J. Tan & colleagues @astar_gis & Sun Yat-sen University Cancer Center China
🗞️doi.org/10.1038/s44321-024-00102-5 -
EMBO Mol. Medicine reposted
Luisa Chocarro de Erauso
@LuisaChocarro
Finally out!🎉Very excited to share that we have just published part of my PhD research! We have identified PD-1/LAG-3 molecular mechanism of co-signaling, and tripled survival in mouse models of lung cancer refractory to immunotherapies, reverting PD-1/LAG-3-mediated resistance.
EMBO Mol. Medicine
@EmboMolMed
📢PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key #immunotherapy targets.
#tcells #lungcancer
By L. Chocarro, E. Blanco, D. Escors & colleagues @navarrabiomed @idisnanavarra
➡️doi.org/10.1038/s44321-024-00098-y -
EMBO Mol. Medicine
@EmboMolMed
🦟Experimental #vaccination by single dose sporozoite injection of blood-stage attenuated #malaria parasites🦟
By J. Sattler, F. Frischknecht & colleagues @FrischknechtLab
➡️doi.org/10.1038/s44321-024-00101-6 -
EMBO Mol. Medicine
@EmboMolMed
The #mondoa -dependent TXNIP/GDF15 axis predicts #oxaliplatin response in #colorectalcancer.
By J. Deng, T. Pan, R. Beatson, T. Ng & colleagues @QMUL @KingsCollegeLon @ucl
👉doi.org/10.1038/s44321-024-00105-2 -
EMBO Mol. Medicine
@EmboMolMed
Inhibition of GSK3α,β rescues cognitive phenotypes in a preclinical #mousemodel of #ctnnb1 syndrome.
#neurodevelopmentaldisorder
By J. Alexander, M. Jacob & colleagues @TuftsGSBS
🗞️doi.org/10.1038/s44321-024-00110-5 -
EMBO Mol. Medicine reposted
Freddy Frischknecht
@FrischknechtLab
Finally out @EmboMolMed: our study exploring a new way of experimental #vaccination for #malaria using attenuated #parasites and featuring antibodies, CD4 + CD8 T cells, interferon + interleukins. Soon we'll be immunologists; high time to start surfing: www.embopress.org/doi/full/10.1038/s44321-024-00101-6
-
EMBO Mol. Medicine
@EmboMolMed
Therapeutic targeting #errγ suppresses metastasis via #extracellularmatrix remodeling in #smallcelllungcancer.
By H. Wang, H. Sun, J. Huang, X. Lu, W. Feng, J. Wang & colleagues at Guangzhou, China
➡️doi.org/10.1038/s44321-024-00108-z -
EMBO Mol. Medicine reposted
Navarrabiomed
@navarrabiomed
👩🔬Researchers from the #oncoimmunology Unit of @Navarrabiomed have identified one of the major mechanisms of resistance to PD-1/PD-L1 blockade #immunotherapy
📰 Published by @EmboMolMed doi.org/10.1038/s44321-024-00098-y
Open thread!👇
navarrabiomed.es/en/actualidad/noticias/navarrabiomed-ide… -
EMBO Mol. Medicine
@EmboMolMed
📢The ASC #inflammasome adapter governs SAA-derived protein aggregation in inflammatory #amyloidosis
By M. Losa, @AdrianoAguzzi & colleagues @Unispital_USZ
👉doi.org/10.1038/s44321-024-00107-0
Read also related News & Views by S. Maasewerd & B. Franklin @UniBonn
👉doi.org/10.1038/s44321-024-00109-y -
EMBO Mol. Medicine
@EmboMolMed
The RhoB p.S73F mutation leads to #cerebralpalsy through dysregulation of #lipidhomeostasis.
By X. Wu, R. Liu, L. Lai, Y. Song, Z. Li at Jilin University, Changchun
➡️doi.org/10.1038/s44321-024-00113-2 -
EMBO Mol. Medicine
@EmboMolMed
#dantrolene corrects cellular disease features of #darierdisease and may be a novel treatment.
By M. Hunt, N. Wang, E. Bachar-Wikstrom, J. Wikstrom & colleagues @karolinskainst
🗞️doi.org/10.1038/s44321-024-00104-3 -
EMBO Mol. Medicine reposted
Institut Cochin
@InstitutCochin
New #publication in @EmboMolMed, scientists @InstitutCochin (Iryna Pirozhkova's group) & @GustaveRoussy describe DiPRO1 protein as a new potential therapeutic target in pediatric #mesenchymal #cancers
institutcochin.fr/en/news/new-therapeutic-target-pediatri…
@CNRSbiologie @Inserm @CNRS_Villejuif @univ_paris_cite -
EMBO Mol. Medicine
@EmboMolMed
📢PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key #immunotherapy targets.
#tcells #lungcancer
By L. Chocarro, E. Blanco, D. Escors & colleagues @navarrabiomed @idisnanavarra
➡️doi.org/10.1038/s44321-024-00098-y -
EMBO Mol. Medicine
@EmboMolMed
LILRB1-HLA-G axis defines a checkpoint driving #naturalkillercell exhaustion in #tuberculosis
By Y. Pang, G.F. Gao, C.H. Liu & colleagues at Chinese Academy of Sciences, China
🗞️doi.org/10.1038/s44321-024-00106-1 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Our academic editor @YehuMoran is attending #evol2024 in Montreal from 26-30 July. If you’re attending, please join him July 27th from 12:45-13:45 as he introduces our journals’ portfolio expansion in #ecology and #evolution. @sse_evolution @systbiol @eseb_org @ASNAmNat @Evol_mtg
-
EMBO Mol. Medicine
@EmboMolMed
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells.
#myoblasts #rhabdomyosarcoma #ewingsarcoma
👉doi.org/10.1038/s44321-024-00097-z
by J. Rich, B. Geoerger, I. Pirozhkova & colleagues @GustaveRoussy @InstitutCochin -
EMBO Mol. Medicine
@EmboMolMed
Immune-enhancing #neutrophils reprogrammed by subclinical low-dose #endotoxin in #cancertreatment
By Y. Zhang, L. Li & colleagues @virginia_tech @VT_Biology
➡️doi.org/10.1038/s44321-024-00100-7 -
EMBO Mol. Medicine
@EmboMolMed
In vitro and in vivo inhibition of the host TRPC4 channel attenuates #zikavirus infection
By X. Chen, Y. Yan, Z. Liu, S. Yang, A. Obukhov, R. Cao, W. Zhong & colleagues at Beijing Institute of Pharmacology and Toxicology & @IUMedSchool
🗞️doi.org/10.1038/s44321-024-00103-4 -
EMBO Mol. Medicine
@EmboMolMed
Our July issue is online ☀️
www.embopress.org/toc/17574684/16/7
This month's beautiful cover highlights the article by B Jeremiasse, @IamAnneRios & al @prinsesmaximac
👉multispectral confocal microscopy visualization of live #neuroblastoma #organoids
Scientific image by R L van Ineveld -
EMBO Mol. Medicine reposted
EMBO Reports
@emboreports
Our @EMBO director Fiona Watt giving the @ISSCR Achievement Award Lecture at #isscr2024 in Hamburg.
Congratulations also from @EMBOpress! -
EMBO Mol. Medicine reposted
EMBO Reports
@emboreports
Hi #isscr2024!
Are you looking for nice a home for your paper? Talk to our editor Achim Breiling attending the meeting. Also get in touch if you have other #publishing related questions.
Moreover, check out the @EMBOpress #stemcell article collection:
www.embopress.org/page/collections/stem_cells-2024 -
EMBO Mol. Medicine
@EmboMolMed
Online today! #platelet transcription factors license the pro-inflammatory #cytokine response of human #monocytes
By I. Hawwari, L. Rossnagel, B. Franklin & colleagues @bernardo647 @UniBonn
👉doi.org/10.1038/s44321-024-00093-3 -
EMBO Mol. Medicine
@EmboMolMed
Pharmacological Gq inhibition induces strong pulmonary vasorelaxation & reverses #pulmonaryhypertension
By A. Seidinger, D. Wenzel & colleagues at Bochum University
🗞️doi.org/10.1038/s44321-024-00096-0
👉Read also: news.rub.de/english/press-releases/2024-07-08-medicine-ac… -
EMBO Mol. Medicine reposted
Swarnali Acharyya
@SwarnaliAchary5
We are delighted to share our new study on FLT1 activation and PARP inhibitor resistance in breast cancer. This study was led by Yifan Tai, an exceptional Masters student from Columbia Univ. Biotech Program. Congratulations to all the co-authors and collaborators!
EMBO Mol. Medicine
@EmboMolMed
Online this week! FLT1 activation in cancer cells promotes #parpinhibitor resistance in #breastcancer
By Yifan Tai, Anup Biswas, @SwarnaliAchary5 & colleagues @ColumbiaMed
🗞️doi.org/10.1038/s44321-024-00094-2 -
EMBO Mol. Medicine
@EmboMolMed
📢Another #breastcancer paper this week in @EmboMolMed!
🗞️doi.org/10.1038/s44321-024-00090-6
by N. Lorito, A. Subbiani, @andMORand & colleagues @UNI_FIRENZE
👉"FADS1/2 control #lipidmetabolism and #ferroptosis susceptibility in #tnbc" -
EMBO Mol. Medicine
@EmboMolMed
Online this week! FLT1 activation in cancer cells promotes #parpinhibitor resistance in #breastcancer
By Yifan Tai, Anup Biswas, @SwarnaliAchary5 & colleagues @ColumbiaMed
🗞️doi.org/10.1038/s44321-024-00094-2 -
EMBO Mol. Medicine reposted
Daniel Klimmeck
@DanielKlimmeck
📢One week to submit an abstract for our second #eesmetastasis meeting Sept 30 to Oct 3, 2024; co-organized by @TurajlicLab, @BatlleLab, @Johanna_A_Joyce & @LabMassague.
📩Submit abstract by 8 July
➡️s.embl.org/ees24-10
#cancer #metastasis #oncology
@EMBLEvents @EMBO -
EMBO Mol. Medicine reposted
Mammary Cell News
@MammaryCell
We're thrilled to share the latest paper from
Dr. Morandi's lab (@andMORand)! 🥼
Congratulations to the team, including Nicla Lorito, @AngelaSubbiani, @AlfredoSmirigl1, @LuigiIppolito9 , and @AAvgustinova. 👏
🔗 idp.springer.com/authorize?response_type=cookie&client_id… | @EmboMolMed
Andrea Morandi
@andMORand
🚨 Super excited to see our last effort finally out in @EmboMolMed 🤩
🔬We reveal a new vulnerability in aggressive triple-negative breast cancer. Targeting enzymes FADS1/2 and inducing ferroptosis could offer new treatments
www.embopress.org/doi/full/10.1038/s44321-024-00090-6
a brief 🧵: -
EMBO Mol. Medicine reposted
Andrea Morandi
@andMORand
🚨 Super excited to see our last effort finally out in @EmboMolMed 🤩
🔬We reveal a new vulnerability in aggressive triple-negative breast cancer. Targeting enzymes FADS1/2 and inducing ferroptosis could offer new treatments
www.embopress.org/doi/full/10.1038/s44321-024-00090-6
a brief 🧵: -
EMBO Mol. Medicine
@EmboMolMed
Congratulations Giulia @GiuliaFracassi_ for winning the @EmboMolMed poster prize! 👏
Fondazione Pezcoller
@pezcoller
The recipient of @embojournal Molecular Medicine poster prize is:
Fracassi Giulia @GiuliaFracassi_
@CIBIO_UniTrento @UniTrento -
EMBO Mol. Medicine reposted
Fondazione Pezcoller
@pezcoller
#pezcoller24 Symposium
Take a lap around the poster exhibition and vote for the best poster within today 25/06 14:30!
The best poster will receive the @EmboMolMed poster prize!
EMBO Mol. Medicine
@EmboMolMed
@EmboMolMEd senior editor Lise Roth is attending #pezcoller24 Symposium in beautiful Trento!
Get in touch and talk to her about your research! -
EMBO Mol. Medicine reposted
WEHI (Walter and Eliza Hall Institute)
@WEHI_research
New automated ways of detecting #necroptosis can improve understanding & diagnosis of #inflammatorydisease.
Great research by Prof James Murphy (@pseudokinase), Dr @aysha_h_alani, Dr @AndreSamson15, Shene Chiou and team, published in @EmboMolMed.
👇
www.wehi.edu.au/news/robots-help-put-brakes-on-inflammato… -
EMBO Mol. Medicine
@EmboMolMed
@EmboMolMEd senior editor Lise Roth is attending #pezcoller24 Symposium in beautiful Trento!
Get in touch and talk to her about your research! -
EMBO Mol. Medicine
@EmboMolMed
Online today! Minimally-invasive implantable device enhances #braincancer suppression
By X. Cao, B. Xu and colleagues at Sun Yat-sen University
doi.org/10.1038/s44321-024-00091-5 -
EMBO Mol. Medicine reposted
eMedEvents
@eMedEvents
🔬 Exciting new research on breast cancer treatment!
➡️Read more: emed.news/targeting-dusp6-to-prevent-breast-cancer-recurr…
🧬 Scientists have discovered that targeting the DUSP6 protein can help prevent cancer recurrence.
Credit: @EmboMolMed
#cancerresearch #breastcancer #oncology #cancer #meded #emednews -
EMBO Mol. Medicine
@EmboMolMed
Mutation analysis in individual #circulatingtumorcells depicts intratumor heterogeneity in #melanoma.
By M Sementsov, C. Gebhardt, K. Pantel, L. Keller & colleagues
🗞️doi.org/10.1038/s44321-024-00082-6 -
EMBO Mol. Medicine
@EmboMolMed
Systemic immune challenge exacerbates #neurodegeneration in a model of neurological #lysosomaldisease.
By O. Mandolfo, B. Bigger & colleagues @EdinburghUni @OfficialUoM
👉doi.org/10.1038/s44321-024-00092-4 -
EMBO Mol. Medicine reposted
Comprehensive Cancer Center Niedersachsen
@cccn_news
This was the 4. German #pancreaticcancer Research Meeting - An @EKFStiftung Symposium by @kfo_5002 and #cccn. Congratulations to @krenz_bastian from @Uni_WUE for the @Krebshilfe_Bonn best talk award & Thomas L. Ekstrom from @RBCTStuttgart for the @EmboMolMed best poster award 🎉
-
EMBO Mol. Medicine
@EmboMolMed
#dusp6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ #breastcancer
By M. Momeny, J. Westermarck & colleagues @westermarcklab @BioscienceTurku
doi.org/10.1038/s44321-024-00088-0 -
EMBO Mol. Medicine reposted
Mammary Cell News
@MammaryCell
Scientists from the @westermarcklab present #transcriptional 🧬 profiling of HER2+ #breastcancer cells transitioning from dormant drug tolerant cells to re-proliferating cells under continuous HER2 inhibitor therapy. | @BioscienceTurku
🔗 @EmboMolMed | idp.springer.com/transit?redirect_uri=https%3A%2F%2Flink.… -
EMBO Mol. Medicine reposted
Dr. Sarah Hedtrich
@HedtrichLab
Our paper describing the development of the very first small molecule inhibitor of TSLP is out in @EmboMolMed : idp.springer.com/authorize?response_type=cookie&client_id…
TSLP is a key driver of atopic diseases & and our highly effective anti-TSLP compound can pave the way to novel anti-inflammatory treatments. -
EMBO Mol. Medicine reposted
Biomedical Picture of the Day BPoD
@BPoD_s
Live-imaging of #organoids of healthy- & tumour-derived patient tissue to screen for tumour-distinguishing targets for real-time #fluorescenceguidedsurgery. Still & research by Bernadette Jeremiasse et al @IamAnneRios lab @prinsesmaximac in @EmboMolMed. On bpod.org.uk/archive/2024/6/14
-
EMBO Mol. Medicine
@EmboMolMed
Online today! ➡️ Disrupting #tslp –TSLP receptor interactions via putative small molecule inhibitors yields a novel & efficient treatment option for #atopicdiseases.
By P.P. Adhikary, B. Page, S. Hedtrich & colleagues @HedtrichLab @UBC @ChariteBerlin
🗞️doi.org/10.1038/s44321-024-00085-3 -
EMBO Mol. Medicine
@EmboMolMed
Our June issue is online! ✨
👉www.embopress.org/toc/17574684/16/6
📰Articles on #polysialicacid in #braininjury, #systemiccandidiasis, #encephalopathy, #yellowfevervaccine, #ccrcc, #polycystickidneydisease, #colorectalcancer, #hemophilia (our cover), & more! -
EMBO Mol. Medicine reposted
Centro de Biología Molecular Severo Ochoa
@CBM_CSIC_UAM
Today we've welcomed Zeljko Durdevic, Scientific Editor at @EmboMolMed, with a full agenda: seminar on 'Publishing in @EMBO journals', networking lunch with PhDs and postdocs, and 1:1 meetings with our PIs. Thanks, Zelkjo, and @FormentiniLaura and @MigManzanares for hosting!
-
EMBO Mol. Medicine
@EmboMolMed
N&V by C. Yang & M. Blander 👉 Seeing is believing: a breakthrough to visualize necrosomes in the tissue
🗞️doi.org/10.1038/s44321-024-00086-2
Related article by J. Murphy, A. Samson & collaborators
🗞️doi.org/10.1038/s44321-024-00074-6 -
EMBO Mol. Medicine
@EmboMolMed
Harnessing #cholesterol uptake of #malaria parasites for therapeutic applications
By M. Fraser, B. Curtis, M. McLeod, A. Maier & colleagues @ANUmedia
🗞️doi.org/10.1038/s44321-024-00087-1 -
EMBO Mol. Medicine reposted
Pancreatic Cell News
@PancreaticCell
Here's a new review to kick off your week 📚
🥼 Scientists from @astar_research summarize the roles of PDX1, MAFA, and PAX6 in determining #betacell function and #diabetes development. | @EmboMolMed
🔗 idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine reposted
Centro de Biología Molecular Severo Ochoa
@CBM_CSIC_UAM
La semana que viene recibiremos la visita de Zeljko Durdevic, Scientific Editor en la revista @EmboMolMed. Aprenderemos de su charla sobre el proceso de publicación en EMBO, y nuestros investigadores podrán charlar con él en la comida o en reuniones 1:1.
@EMBO @embojournal -
EMBO Mol. Medicine reposted
Biomedical Picture of the Day BPoD
@BPoD_s
Reduced expression of #gene called Insig1 in #kidney proximal tubule cells associated with renal #fibrosis in #chronickidneydisease – potential novel treatment target. Image & resarch by Shumin Li et al Nanjing Medical University, China in @EmboMolMed. On bpod.org.uk/archive/2024/6/6
-
EMBO Mol. Medicine
@EmboMolMed
Aggregation-resistant #alphasynuclein tetramers are reduced in the blood of #parkinsons patients 🧠
By L. de Boni, T. Bartels & colleagues @UKDRI
🗞️doi.org/10.1038/s44321-024-00083-5 -
EMBO Mol. Medicine reposted
Dream3D Lab
@Dream3DLab
Fantastic to see this new organoid screening application showcasing the power of multispectral imaging technology out now in @EmboMolMed
EMBO Mol. Medicine
@EmboMolMed
📢Online today 👉A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery
#fluorescenceguidedsurgery #liveorganoids
By B. Jeremiasse, @IamAnneRios & colleagues @prinsesmaximac
🗞️doi.org/10.1038/s44321-024-00084-4 -
EMBO Mol. Medicine
@EmboMolMed
📢Online today 👉A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery
#fluorescenceguidedsurgery #liveorganoids
By B. Jeremiasse, @IamAnneRios & colleagues @prinsesmaximac
🗞️doi.org/10.1038/s44321-024-00084-4 -
EMBO Mol. Medicine
@EmboMolMed
Tubular insulin-induced gene 1 deficiency promotes NAD+ consumption and exacerbates #kidneyfibrosis
👉doi.org/10.1038/s44321-024-00081-7
By S. Li, S. Huang, X. Yu & colleagues at Children’s Hospital of Nanjing Medical University
#chronickidneydisease #insig1 -
EMBO Mol. Medicine reposted
Biomedical Picture of the Day BPoD
@BPoD_s
#immunohistochemical methods to detect markers of #necroptosis (cell death => #inflammation) – could identify Pts for targeted therapy. Image & research by Shene Chiou & @aysha_h_alani et al @AndreSamson15 @pseudokinase @WEHI_research in @EmboMolMed. On bpod.org.uk/archive/2024/5/28
-
EMBO Mol. Medicine
@EmboMolMed
#neuraminidase inhibition promotes the collective migration of neurons & recovery of #brainfunction
By M Matsumoto, K Sawamoto et al. at Nagoya City University @SEIRIKEN1977
👉doi.org/10.1038/s44321-024-00073-7
News & Views by J Becker & F Szele @UniofOxford
👉doi.org/10.1038/s44321-024-00075-5 -
EMBO Mol. Medicine
@EmboMolMed
Also online today 👉Diabetes drugs activate neuroprotective pathways in models of #neonatalhypoxicischemicencephalopathy.
#glp1
By L. Poupon-Bejuit, @amy_geard, A. Rahim & colleagues @School_Pharmacy @UCLLifeSciences
🗞️doi.org/10.1038/s44321-024-00079-1 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Immunogenicity & efficacy of CNA25 as a potential whole-cell #vaccine against #systemiccandidiasis
By S. R. Sahu, A. Dutta, N. Acharya at Institute of Life Sciences, Bhubaneswar, India
#innateimmunity #candidaalbicans
🗞️doi.org/10.1038/s44321-024-00080-8 -
EMBO Mol. Medicine reposted
Ahad Rahim
@ProfAhadRahim
New study in @EmboMolMed investigating mechanisms of how #peptide #glp1 receptor agonists trigger neuroprotection in models of neonatal hypoxic-ischemic encephalopathy 🎉www.embopress.org/doi/full/10.1038/s44321-024-00079-1 @amy_geard @DrCThornton @actionmedres @UCLLifeSciences @School_Pharmacy #repurposing
-
EMBO Mol. Medicine
@EmboMolMed
Read 👉An immunohistochemical atlas of necroptotic pathway expression.
By S. Chiou, @aysha_h_alani, @pseudokinase, @AndreSamson15 & colleagues @UniMelb @WEHI_research
🗞️doi.org/10.1038/s44321-024-00074-6 -
EMBO Mol. Medicine
@EmboMolMed
New #vaccine platform: A broadly applicable protein-polymer adjuvant system for #antiviralvaccine.
By C. Wang, Y. Geng, J. Lovell, H. Jin, L. Zhao & colleagues
👉doi.org/10.1038/s44321-024-00076-4 -
EMBO Mol. Medicine
@EmboMolMed
Our May issue is online!
➡️www.embopress.org/toc/17574684/16/5
This month's cover highlights the article by F. Bian, T. Kalin & colleagues @CincyChildrens @uarizona on the role of FOXF1 in tumor #vesselnormalization and #lungcancer progression.
🗞️doi.org/10.1038/s44321-024-00064-8 -
EMBO Mol. Medicine
@EmboMolMed
Online today! #electrontransportchain capacity expands #yellowfevervaccine immunogenicity.
By D. Mok, E. E. Ooi, J. Low & colleagues @dukenus
🗞️doi.org/10.1038/s44321-024-00065-7 -
EMBO Mol. Medicine
@EmboMolMed
📢PML restrains p53 activity & cellular #senescence in #ccrcc
By M. Simoni, R. Bernardi & colleagues @BernardiLab @SanRaffaeleMI
🗞️doi.org/10.1038/s44321-024-00077-3 -
EMBO Mol. Medicine
@EmboMolMed
#highfatdiet ameliorates mitochondrial #cardiomyopathy in #chchd10 mutant mice.
By N. Southwell, H. Kawamata & colleagues @WeillCornell
➡️doi.org/10.1038/s44321-024-00067-5
Read also related News & Views by H.P. Lin & D. Narendra @NIH_NINDS
➡️doi.org/10.1038/s44321-024-00070-w -
EMBO Mol. Medicine reposted
Muscle Cell News
@musclecellnews
Metabolic therapy can be effective in mitochondrial cardiomyopathies associated with proteotoxic stress, report @WCM_BMRI researchers.
📖 Full story in @EmboMolMed: idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine reposted
Intestinal Cell News
@Intestinal_Cell
By ❌ negatively tuning IFNγ-stimulated immune 🧬 genes’ transcription, scientists reported that CBX3 participated in modulating colon inflammatory response and #colorectalcancer chemo-resistance.
😎 Check it out in @EmboMolMed!
link.springer.com/article/10.1038/s44321-024-00066-6 -
EMBO Mol. Medicine reposted
INEM NECKER
@NeckerInem
🔬 New insights into IFNγ and colorectal cancer! Study in @EmboMolMed shows CBX3's crucial role in immune response & treatment potential. 🧬
🚀 Could reshape approaches to colitis & cancer therapy!
🔗www.embopress.org/doi/full/10.1038/s44321-024-00066-6 -
EMBO Mol. Medicine
@EmboMolMed
CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate #coloninflammation and #colorectalcancer chemosensitivity.
By Y. Xiang, L. Arbibe, Y. Chang & colleagues @NeckerInem
🗞️doi.org/10.1038/s44321-024-00066-6 -
EMBO Mol. Medicine reposted
Alessandra Boletta
@Boletta_Lab
🎉 Excited to see our work now published @EmboMolMed
Inhibition of Asparagine Synthetase Retards PKD progression. ASNS in PKD drives glutamine utilization.
Work started by Christine Podrini, completed by @Sara_Cler Thanks to collaborators @FrezzaLab @bachi_lab @dalessandrolab
EMBO Mol. Medicine
@EmboMolMed
➡️Inhibition of #asparaginesynthetase effectively retards #polycystickidneydisease progression.
By S. Clerici, C. Podrini, A. Boletta & colleagues @Boletta_Lab
🗞️doi.org/10.1038/s44321-024-00071-9 -
EMBO Mol. Medicine
@EmboMolMed
➡️Inhibition of #asparaginesynthetase effectively retards #polycystickidneydisease progression.
By S. Clerici, C. Podrini, A. Boletta & colleagues @Boletta_Lab
🗞️doi.org/10.1038/s44321-024-00071-9 -
EMBO Mol. Medicine
@EmboMolMed
Online today! GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct #hemophiliaa mice.
By M. Milani, A. Cantore & colleagues @SanRaffaeleMI
#genetherapy
👉doi.org/10.1038/s44321-024-00072-8 -
EMBO Mol. Medicine
@EmboMolMed
TLR3 activation enhances #abscopaleffect of radiotherapy in #hepatocellularcarcinoma by promoting tumor #ferroptosis.
By L. Qiu, H. Ji, K. Wang, Z. Cai, X. Liu & colleagues at University Fuzhou
🗞️doi.org/10.1038/s44321-024-00068-4 -
EMBO Mol. Medicine
@EmboMolMed
Platinum-induced upregulation of #itga6 promotes #chemoresistance and spreading in #ovariancancer.
By A. Gambelli, A. Nespolo, M. Sonego, G. Baldassarre & colleagues @CroAviano
🗞️doi.org/10.1038/s44321-024-00069-3 -
EMBO Mol. Medicine reposted
EMBO Reports
@emboreports
Are you attending #eesmechanobiology? So is our editor Deniz Senyilmaz Tiebe. Talk to her if you are looking for a home for your paper or about scientific publishing.
-
EMBO Mol. Medicine reposted
Inês Sequeira
@InesSequeira7
Last chance to register to the @LSCN_UK 7th Annual Symposium with an incredible line up of speakers + selected talks + meet the @CellStemCell @EmboMolMed and @natBME Editors + Crick Orchestra 🎶. Free registration for members! #lscn2024
London Stem Cell Network
@LSCN_UK
📢🚨The final agenda of #lscn2024 7th Annual Symposium is now LIVE! Go and have a look! We have an incredible lineup of invited and abstract-selected speakers + "Meet the Editor" Lunchtime Session!
lscn.co.uk/symposia/7th-lscn-annual-symposium/
Book your ticket today: www.eventbrite.co.uk/e/7th-annual-lscn-symposium-tickets-… -
EMBO Mol. Medicine reposted
NAVBO
@vascularbiology
#navbo Member Publication Alert
Shear stress control of vascular leaks and atheromas through Tie2 activation by VE-PTP sequestration
Donald McDonald & Dietmar Vestweber groups @EmboMolMed 2023
www.embopress.org/doi/full/10.15252/emmm.202216128 -
EMBO Mol. Medicine
@EmboMolMed
If you missed it 👇
"An Immunotherapy to Overcome Resistant Leukemia"
www.news.uzh.ch/en/articles/media/2024/CAR-T-Cell-Resista…
Read article: www.embopress.org/doi/full/10.1038/s44321-024-00024-2 -
EMBO Mol. Medicine
@EmboMolMed
Our April issue is online!
The cover highlights the article by E. Partiot, B. Gorda, R. Gaudin et al. on organotypic culture of #humanbrain explants as #preclinicalmodel of AI-driven antiviral studies.
Graphic design: M-J Partiot, photo credit: Istock
🗞️www.embopress.org/toc/17574684/16/4 -
EMBO Mol. Medicine reposted
Annemarthe Van der Veen
@VanderveenLab
Thanks to our seven journal editors from @ScienceMagazine @NatRevImmunol @emboreports @iScience_CP @ReviewCommons @NatImmunol @NatureMicrobiol @DMM_Journal @Co_Biologists for a lively panel discussion on the ins and outs of scientific publishing!#embosignaling2024
-
EMBO Mol. Medicine
@EmboMolMed
📢#foxf1 promotes tumor vessel normalization and prevents #lungcancer progression through FZD4.
By F. Bian, C. Goda, G. Wang, T. Kalin & colleagues @CincyChildrens @uarizona
🗞️doi.org/10.1038/s44321-024-00064-8 -
EMBO Mol. Medicine reposted
UA College of Medicine - Phoenix
@uazmedphx
Dr. Tanya Kalin and her fellow researchers recently had their findings published in EMBO Molecular Medicine.
Read about her recent studies here: phoenixmed.arizona.edu/newsroom/news/nanoparticle-deliver…
#uazmedphx #medicalschool #therapies #lungcancer -
EMBO Mol. Medicine
@EmboMolMed
A missense mutation in human INSC causes #peripheralneuropathy
By J-Y Yeh, Y-C. Lee, C-C. Chan & colleagues at University School of Medicine and National Taiwan University,Taipei
🗞️doi.org/10.1038/s44321-024-00062-w -
EMBO Mol. Medicine reposted
AnnemiekeAartsma-Rus
@oligogirl
#apaperaday From home because I am a bit under the weather (disclaimer) and Yuzu wanted to explore the mobile rather than pose. Today's pick is from Galli et al on cell-mediated exon skipping in a mouse model from @EmboMolMed DOI: 10.1038/s44321-024-00031-3
-
EMBO Mol. Medicine reposted
NAVBO
@vascularbiology
#navbo Member Publication Alert
Shear stress control of vascular leaks and atheromas through Tie2 activation by VE-PTP sequestration
Donald McDonald & Dietmar Vestweber groups @EmboMolMed 2023
www.embopress.org/doi/full/10.15252/emmm.202216128 -
EMBO Mol. Medicine
@EmboMolMed
Online today ➡️ Genome-wide #crisprscreens identify #pkmyt1 as a therapeutic target in #pancreaticductaladenocarcinoma.
By S. Wang, L. Wang, Y. Wang at Chinese Academy of Sciences
🗞️doi.org/10.1038/s44321-024-00060-y -
EMBO Mol. Medicine
@EmboMolMed
Oxidized #glutathione reverts #carbapenemresistance in blaNDM-1-carrying Escherichia coli.
By D. Ye, J. Shen, X. Xia at University Beijing China
➡️doi.org/10.1038/s44321-024-00061-x -
EMBO Mol. Medicine
@EmboMolMed
#immunopet imaging of #trop2 in patients with solid tumours.
By W. Huang, Y. Zhang, M. Cao, J. Liu, F. Xie, W. Wei & colleagues at School of Medicine Shanghai & Fudan University Shanghai
🗞️doi.org/10.1038/s44321-024-00059-5 -
EMBO Mol. Medicine reposted
Leyre Urigüen
@leyreuriguen
New collaborative paper in @EmboMolMed with @Carlos_Costas and team in @unicomplutense @CIBER_SAM @biobizkaia @Neuropsychophar 🧠🔬👇🏻
Carlos Costas Insua
@Carlos_Costas
"It is my pleasure to share our latest study on novel CB1R-interacting partners, now published in @EmboMolMed. You can freely access the article here: www.embopress.org/doi/full/10.1038/s44321-024-00054-w"
@unicomplutense @BBM_UCM -
EMBO Mol. Medicine reposted
Biologie - UNIGE
@Biologie_UNIGE
Congratulations @CentrioleLab for your latest publication in collaboration with Hopital #jules-#gonin in @EmboMolMed : Fine-tuning FAM161A gene augmentation therapy to restore retinal function www.embopress.org/doi/full/10.1038/s44321-024-00053-x @MoCel_Geneva @sciences_UNIGE
-
EMBO Mol. Medicine reposted
Hao Yin
@HaoYin20
Tie2
⏫VE-PTP endocytosis
⏬#vascularpermeability
AND this occurs at the flow downstream in an individual #endothelialcell
EC VE-PTP KO or AKB‐9785 (VE-PTP inhibitor) ⏬Apoe-/-🐭#atherosclerosis
Donald McDonald & Dietmar Vestweber labs @EmboMolMed 2023
www.embopress.org/doi/full/10.15252/emmm.202216128 -
EMBO Mol. Medicine
@EmboMolMed
Online today! A replication competent #plasmodiumfalciparum parasite completely attenuated by dual gene deletion
By D. Goswami, H. Patel, S. Kappe & colleagues @seattlechildren
➡️doi.org/10.1038/s44321-024-00057-7
Related News & Views by D. Moita & M. Prudencio
➡️doi.org/10.1038/s44321-024-00056-8 -
EMBO Mol. Medicine
@EmboMolMed
Basal–epithelial subpopulations underlie and predict #chemotherapyresistance in #triplenegativebreastcancer
M. Inayatullah, V. Tiwari & colleagues @LabTiwari @SyddanskUni
🗞️doi.org/10.1038/s44321-024-00050-0 -
EMBO Mol. Medicine
@EmboMolMed
Fine-tuning FAM161A gene augmentation therapy to restore #retinalfunction
By Y. Arsenijevic, N. Chang, C. Kostic & colleagues at Université of Lausanne
👉doi.org/10.1038/s44321-024-00053-x -
EMBO Mol. Medicine
@EmboMolMed
Our March issue is online! 🌺
This month's cover by @DrawImpacts highlights the article by @TheBoettcherLab that shows that TP53 mutations in #aml confer resistance to #cartcell therapy
➡️www.embopress.org/toc/17574684/16/3 -
EMBO Mol. Medicine reposted
Boettcher Lab
@TheBoettcherLab
!!! PAPER OUT in @EmboMolMed !!!
#tp53-mutant #aml is notoriously hard to treat. Immunotherapies might be a promising therapeutic option. Ever wondered what the impact of the #tp53-mutational status on #cartcell efficacy in AML is? doi.org/10.1038/s44321-024-00024-2 A 🧵1/n -
EMBO Mol. Medicine reposted
Sara Campinoti
@Sara_Campinoti
Do you need one more reason to register for #lscn2024?! You got it: don't miss the chance to ask your questions to @NaturePortfolio @natBME, @EmboMolMed and @CellPressNews @CellStemCell editors at the Lunchtime Session! 🤯
#stemcell #tissueengineering #organoid #ipscs
London Stem Cell Network
@LSCN_UK
During #lscn2024 lunch break, we will host a "Meet the Editor" roundtable discussion! We are honoured to have @ValeCaprettini Associate Editor @natBME, Christine Weber Senior Editor @CellStemCell and Lise Roth Senior Editor @EmboMolMed as panellists! Get your questions ready!🙋♀️🙋
-
EMBO Mol. Medicine reposted
ArckLab
@ArckLab
Microchimeric cells and chimeric extracellular vesicles are increasingly recognized as modulators of health and disease risk in mother and fetus. See our new review @EmboMolMed deciphering their role within the ‘communicatome’ of pregnancy. DOI: 10.1038/s44321-024-00045-x
-
EMBO Mol. Medicine reposted
London Stem Cell Network
@LSCN_UK
During #lscn2024 lunch break, we will host a "Meet the Editor" roundtable discussion! We are honoured to have @ValeCaprettini Associate Editor @natBME, Christine Weber Senior Editor @CellStemCell and Lise Roth Senior Editor @EmboMolMed as panellists! Get your questions ready!🙋♀️🙋
-
EMBO Mol. Medicine reposted
Joseph Therriault
@JosephTherr
Our new head-to-head comparison of the Janssen and Alzpath plasma p-tau217 assays is now published in @EmboMolMed
Congratulations to @andrealessa on her first paper as a senior author!
www.sciencedirect.com/science/article/pii/S2352396424000811 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Abstract deadline is March 20th for the virtual @KeystoneSymp #ai in Biomedicine. Our @EmboMolMed editor Lise Roth looks forward to the science and discussion.
For details: www.keystonesymposia.org/conferences/conference-listing/m…
#ksaibiomed24 #drugdiscovery #bioengineering -
EMBO Mol. Medicine
@EmboMolMed
Online today! A novel strategy to generate #immunocytokines with activity-on-demand using small molecule inhibitors.
By G. Rotta, D. Neri, S. Dakhel Plaza & colleagues @ETH_en
🗞️doi.org/10.1038/s44321-024-00034-0
Read also related News & Views by D. Müller 👇
doi.org/10.1038/s44321-024-00047-9 -
EMBO Mol. Medicine
@EmboMolMed
Online today ➡️Cell-mediated #exonskipping normalizes #dystrophin expression & muscle function in a new mouse model of #duchennemusculardystrophy
By F. Galli, G. Cossu & colleagues @OfficialUoM
🗞️doi.org/10.1038/s44321-024-00031-3 -
EMBO Mol. Medicine reposted
CRCM - Cancer Research Centre of Marseille
@crcm_marseille
📢 Publication Alert 📢
Researchers from the @translateitcrcm department of @crcm_marseille have published a study in @EmboMolMed on the role of #stressgranules in tumors that are driven by the oncogene Kras.
www.embopress.org/doi/full/10.1038/s44321-024-00032-2
A short thread ➡️ 1/5 -
EMBO Mol. Medicine reposted
CNRS Biologie
@CNRSbiologie
#resultatscientifique🔎 | Santé du foie : effets carcinogènes de l’hormone FGF19 et d’un de ses analogues thérapeutiques
🤝 @CNRS @CNRS_OccitaniE @umontpellier @IGMM_Montpel
✍️ @DamsGREGOIRE
📕 @EmboMolMed | link.springer.com/article/10.1038/s44321-023-00021-x
www.insb.cnrs.fr/fr/cnrsinfo/sante-du-foie-effets-carcino… -
EMBO Mol. Medicine
@EmboMolMed
Today is #rarediseaseday -> read #raredisease papers published in @EMBOMolmed 👇
🗞️www.embopress.org/doi/full/10.1038/s44321-024-00035-z
🗞️www.embopress.org/doi/full/10.15252/emmm.202217159
🗞️www.embopress.org/doi/full/10.15252/emmm.202216775
🗞️www.embopress.org/doi/full/10.15252/emmm.202217033
🗞️www.embopress.org/doi/full/10.15252/emmm.202317833 -
EMBO Mol. Medicine
@EmboMolMed
Improved #genetherapy for #spinalmuscularatrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor.
By Q. Xie, X. Chen, J. Xie & colleagues 👇
doi.org/10.1038/s44321-024-00037-x
Highlighted by M. Zwartkruis & E. JN. Groen 👇
doi.org/10.1038/s44321-024-00036-y -
EMBO Mol. Medicine
@EmboMolMed
C. Schneider & G. Schneider discuss the study by Iovanna & colleagues on targeting #nupr1 -dependent #stressgranules formation to induce #syntheticlethality in #pancreaticcancer
➡️doi.org/10.1038/s44321-024-00040-2
➡️Full research article: doi.org/10.1038/s44321-024-00032-2 -
EMBO Mol. Medicine
@EmboMolMed
B cell lineage reconstitution underlies #cartcell therapeutic efficacy in patients with refractory #myastheniagravis
By D-S Tian, C Qin, M-H Dong, W Wang & colleagues at Wuhan University & @UK_Muenster
👉doi.org/10.1038/s44321-024-00043-z -
EMBO Mol. Medicine reposted
中央研究院 Academia Sinica
@AcadSinica
🔬Dr. Mou Yun @IBMS_AcadSinica and his research team introduce bacteria as a foreign species to the TME and explore combinatorial treatment strategies to alter DSP for tumor eradication. This study has been published in @EmboMolMed 🩻 www.sinica.edu.tw/en/News_Content/36/2268 #chemotherapy #tumor
-
EMBO Mol. Medicine
@EmboMolMed
Targeting PI3K/Akt/mTOR signaling in rodent models of #pmp22 gene-dosage diseases.
By D. Krauter, M.W. Sereda & colleagues @mpi_nat
#peripheralneuropathies
🗞️doi.org/10.1038/s44321-023-00019-5 -
EMBO Mol. Medicine reposted
Cell Therapy News
@celltherapynews
📢 New in @EmboMolMed!
Researchers led by Drs. Steffen Boettcher (@TheBoettcherLab) and Markus Manz at @UZH_en demonstrate that the Wnt pathway is a promising CAR T cell therapy-enhancing approach for TP53-deficient #aml/#mds.
Read more: link.springer.com/article/10.1038/s44321-024-00024-2 -
EMBO Mol. Medicine reposted
Karolinska Institutet
@karolinskainst
A KI study in @EmboMolMed links high levels of reactive oxygen species caused by rare NOX4 gene variants to the development of psoriatic #arthritis mutilans (PAM), offering a potential therapeutic target. #psoriasis doi.org/10.1038/s44321-024-00035-z
-
EMBO Mol. Medicine
@EmboMolMed
Rare coding variants in #nox4link high ROS levels to #psoriaticarthritismutilans (PAM)
By S. Wang, M. Ståhle, I. Tapias-Paez & colleagues @karolinskainst
👉doi.org/10.1038/s44321-024-00035-z -
EMBO Mol. Medicine reposted
vipendra kumar singh
@vipendra89
Excited to share my new finding exploring a novel role of mGluR7 in regulating protein synthesis and correcting behavioural phenotypes in Fragile X syndrome. Published in @EmboMolMed. This research is Funded by @FRAXAresearch
,
@NIMHgov
and
@NINDSfunding .
Nien-Pei Tsai (Tsai Lab) @ UIUC
@TsaiNien
Super excited to share our latest study led by our fantastic postdoc @vipendra89 who discovered a new role of mGluR7 and its impact on fragile X syndrome www.embopress.org/doi/full/10.1038/s44321-024-00038-w
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Looking forward to the kick-off of #embocardiobiology in a few hours on the @EMBL campus in Heidelberg! If you are attending, look out for @EmboMolMed senior editor Lise Roth to discuss your latest work. @EMBLEvents
-
EMBO Mol. Medicine
@EmboMolMed
Online today! Lowering mutant #huntingtin by small molecules relieves #huntingtonsdisease symptoms & progression
By A. Bahat, R. Dikstein & colleague @WeizmannScience
🗞️doi.org/10.1038/s44321-023-00020-y -
EMBO Mol. Medicine
@EmboMolMed
#mglur7 allosteric modulator AMN082 corrects protein synthesis & pathological phenotypes in #fragilexsyndrome
By V. Kumar, N-P. Tsai & colleagues @UofIllinois
➡️doi.org/10.1038/s44321-024-00038-w -
EMBO Mol. Medicine
@EmboMolMed
Online today ➡️ Inhibition of #sftsv replication in humanized mice by a subcutaneously administered anti-PD1 nanobody.
By M. Ji, J. Hu, Z. Wu & colleagues at University Yinchuan & Nanjing University
🗞️doi.org/10.1038/s44321-024-00026-0 -
EMBO Mol. Medicine
@EmboMolMed
Targeting NUPR1-dependent #stressgranules formation to induce #syntheticlethality in KrasG12D-driven tumors.
#pancreaticcancer
By P. Santofimia-Castaño, J. Iovanna & colleagues @Inserm
🗞️doi.org/10.1038/s44321-024-00032-2 -
EMBO Mol. Medicine
@EmboMolMed
Our February issue is online! ✨
This month's cover highlights the article by K. Che, J. Wei & al. that shows the dual role of #il33 in anti-tumor activity based on #macrophages reprogramming @TeamSciStories
👉www.embopress.org/toc/17574684/16/2 -
EMBO Mol. Medicine reposted
Yi-Hao Chan Lab
@yihaoo
We showed previously that virus-specific Th1 are drivers of arthralgia during arthritogenic alphavirus infections (science.org/doi/10.1126/scitranslmed.aal1333…), (frontiersin.org/journals/immunology/articles/10.3389/fimm……) Now, we have more insights into the activation and maintenance of these pathogenic T cells!
EMBO Mol. Medicine
@EmboMolMed
Online today! Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during #chikungunya
By F-M Lum, Y-H Chan, L FP Ng & colleagues @idlabs_astar
👉doi.org/10.1038/s44321-024-00028-y -
EMBO Mol. Medicine
@EmboMolMed
📢Targeting the mevalonate or Wnt pathways to overcome #cartcell resistance in TP53-mutant #acutemyeloidleukemia cells.
By J. Mueller, R. Schimmer, M. Manz, S. Boettcher & colleagues @TheBoettcherLab @UZH_en @Unispital_USZ
🗞️doi.org/10.1038/s44321-024-00024-2 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Identification & validation of serum metabolite #biomarkers for #endometrialcancer diagnosis.
By W. Liu, J. Ma, W. Di, K. Qian, X. Yin & colleagues at University Shanghai
➡️doi.org/10.1038/s44321-024-00033-1 -
EMBO Mol. Medicine reposted
Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM
@agingdoc1
Exerkines and cardiometabolic benefits of exercise: from bench to clinic @EmboMolMed
www.embopress.org/doi/full/10.1038/s44321-024-00027-z -
EMBO Mol. Medicine
@EmboMolMed
Online today! Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during #chikungunya
By F-M Lum, Y-H Chan, L FP Ng & colleagues @idlabs_astar
👉doi.org/10.1038/s44321-024-00028-y -
EMBO Mol. Medicine
@EmboMolMed
📢New review online! #exerkines & cardiometabolic benefits of exercise: from bench to clinic 🏃♀️🏃♂️
By Aimin Xu & colleagues at University of Hong Kong
🗞️doi.org/10.1038/s44321-024-00027-z -
EMBO Mol. Medicine
@EmboMolMed
#systemiclupuserythematosus serum induces altered #gobletcell differentiation & leakiness in human #intestinalorganoids
By I. V. Hensel, M. Resnik-Docampo & colleagues at BioMed X
👉doi.org/10.1038/s44321-024-00023-3 -
EMBO Mol. Medicine reposted
Hematopoiesis News
@Hema_News
🔍 Check out this new @EmboMolMed study to learn more about the complex underlying mechanisms of #cerebralmalaria.
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉 Infected #erythrocytes & plasma proteomics reveal a specific protein signature of severe #malaria
By G. Bertin, C. Kamaliddin & colleagues
➡️🗞️doi.org/10.1038/s44321-023-00010-0 -
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉 Infected #erythrocytes & plasma proteomics reveal a specific protein signature of severe #malaria
By G. Bertin, C. Kamaliddin & colleagues
➡️🗞️doi.org/10.1038/s44321-023-00010-0 -
EMBO Mol. Medicine
@EmboMolMed
Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in #diabeticretinopathy
By X Chen, Y Wang, J-N Wang, Q-H Liu & colleagues at Nanjing Medical University
🗞️doi.org/10.1038/s44321-024-00025-1 -
EMBO Mol. Medicine reposted
DrNicoleCampbell.bsky.social
@nk_campbell
It's been a big month for IFNe! Just published in @EmboMolMed is new research characterising regulation of NK cell responses by IFNe in the uterus, and its role in protecting against Chlamydia infections! @CiiiD_Hudson @Hudson_Research
EMBO Mol. Medicine
@EmboMolMed
Read online! #interferonepsilon is a novel regulator of #nkcell responses in the uterus
By J. Mayall, J. Horvat, @pjhpauljh, @HansbroResearch & colleagues @CentenaryInst @UTS_Science @Hudson_Research
🗞️➡️doi.org/10.1038/s44321-023-00018-6 -
EMBO Mol. Medicine
@EmboMolMed
Read online! #interferonepsilon is a novel regulator of #nkcell responses in the uterus
By J. Mayall, J. Horvat, @pjhpauljh, @HansbroResearch & colleagues @CentenaryInst @UTS_Science @Hudson_Research
🗞️➡️doi.org/10.1038/s44321-023-00018-6 -
EMBO Mol. Medicine reposted
Hao Yin
@HaoYin20
Fbn1 C1041G/+ #marfan🐭->
⏫Versican (but not Aggrecan) accumulation in #smoothmusclecell->
⏫Akt-iNOS-#nitricoxide->
SMC Degeneration #aorticaneurysm
Can this cascade be generalized to other #aortopathy?😁
#aortaed
@EmboMolMed 2024 @JorgeOller4
www.embopress.org/doi/full/10.1038/s44321-023-00009-7 -
EMBO Mol. Medicine
@EmboMolMed
Macrophages reprogramming improves #il33 immunotherapy in peritoneal metastasis of #gastriccancer
By K. Che, J. Wei & colleagues at Nanjing University
doi.org/10.1038/s44321-023-00012-y -
EMBO Mol. Medicine reposted
Josep Carreras Leukaemia Research Institute (IJC)
@CarrerasIJC
🥳 Huge achievement by Oscar Molina @omolinacampoy and the whole @Menendez_Lab, making it to the cover of @EmboMolMed with their latest research on Chromosome Instability in paediatric #leukaemia
Congratulations!!
Want to read the report? 👇
www.carrerasresearch.org/en/news/chromosome-instability-r…
Menendez Lab
@Menendez_Lab
Oscar Molina did it again. He publishes , he gets the cover ☺️ Congrats Oscar and the whole team @Menendez_lab @CarrerasIJC and collaborators who have participated #pediatricleukemia !!! Thanks to @ContraCancerEs @unoentrecienmil @fcarreras
-
EMBO Mol. Medicine
@EmboMolMed
📢 Review on the different roles of #necroptosis, including both cell death & extra-necroptotic functions, in the context of #metabolicdiseases
By X. Wu, L. Nagy & J. Gautheron @Inserm
🗞️doi.org/10.1038/s44321-023-00011-z -
EMBO Mol. Medicine
@EmboMolMed
#fgf19 and its analog #aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis
By @Fugates, @GuillaumeDESAN1, @DamsGREGOIRE & colleagues @CNRS
👉doi.org/10.1038/s44321-023-00021-x -
EMBO Mol. Medicine
@EmboMolMed
Our first 2024 issue is out! 💫
This month's cover highlights the article by @omolinacampoy @Menendez_Lab on #chromosomeinstability in aneuploid #acutelymphoblasticleukemia
🗞️Fully #openaccess: www.embopress.org/toc/17574684/16/1 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Deadlines are approaching for @KeystoneSymp #cardiovascular #epigenetics and #generegulation, this April in Hannover @EmboMolMed editor Lise Roth will attend!
Details: www.keystonesymposia.org/conferences/conference-listing/m…
#kscardioepi24 #cardiomyopathy #transcriptomics #cardiomyocytes -
EMBO Mol. Medicine reposted
Biomedical Picture of the Day BPoD
@BPoD_s
Clearing #senescent #schwanncells improves #nerve regeneration. Image & research by Andrés Fuentes‐Flores et al @umayor_ in @EmboMolMed. oN bpod.org.uk/archive/2024/1/14 where you'll find the article link & vast archive documenting over a decade of discoveries & technical advances!
-
EMBO Mol. Medicine reposted
Biomedical Picture of the Day BPoD
@BPoD_s
Accumulation of versican underlies the usually lethal #aorticdisease that's associated with genetic disorder #marfansyndrome. Image & research by María Jesús Ruiz-Rodríguez et al @CampaneroLab Redondo lab @CIBER_CV @CNIC_CARDIO in @EmboMolMed. On bpod.org.uk/archive/2024/1/15
-
EMBO Mol. Medicine reposted
UZH Medical Virology
@UZH_Virology
Check out @IrinaGlas and Shannon David's insights in @EmboMolMed's News & Views. They discuss existing strategies for reducing aerosol transmission and review Styles et al's study on using propylene glycol to inactivate respiratory viruses.
www.embopress.org/doi/full/10.15252/emmm.202318710 -
EMBO Mol. Medicine reposted
Laura Torella
@laura_torella
👉Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1 | EMBO Molecular Medicine www.embopress.org/doi/full/10.1038/s44321-023-00008-8
#crisprcas9nickase #metabolicliverdisease #invivo #dsbrepair #aavintegration #ph1 @EmboMolMed @CIMA_unav -
EMBO Mol. Medicine reposted
Surendra Kumar Prajapat
@skprajapat09
I am thrilled to share our latest publication, which reveals the upregulation of adaptive ER stress and autophagy pathway by Phenothiazine drugs, exhibiting remarkable neuroprotective effects in JEV infection. @unescorcb,@EmboMolMed, @DBTIndia
www.embopress.org/doi/full/10.1038/s44321-023-00014-w -
EMBO Mol. Medicine reposted
Kathryn A Jacobs
@kjacobs7192
Check out this nice news and views describing our recent paper in embo mol medicine! www.embopress.org/doi/full/10.1038/s44321-023-00005-x #autophagy #icb #tecs #melanoma
@AgostinisLab @EmboMolMed -
EMBO Mol. Medicine
@EmboMolMed
MYSM1 acts as a novel co-activator of #erα to confer antiestrogen resistance in #breastcancer
By R. Luan, Q. Zhang, Y. Zhao & colleagues at China Medical University, Shenyang
🗞️embopress.org/doi/full/10.1038/s44321-023-00003-z -
EMBO Mol. Medicine
@EmboMolMed
read article 🗞️embopress.org/doi/full/10.1038/s44321-023-00006-w
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉 #chromosomalinstability in aneuploid #acutelymphoblasticleukemia associates with disease progression
By O. Molina, P. Menendez & colleagues @Menendez_Lab @CarrerasIJC
Read 🗞️doi.org/10.1038/s44321-023-00006-w -
EMBO Mol. Medicine
@EmboMolMed
correct link👉embopress.org/doi/full/10.1038/s44321-023-00004-y
EMBO Mol. Medicine
@EmboMolMed
Highly secreted tryptophanyl #trnasynthetase 1 as a potential theranostic target for hypercytokinemic severe #sepsis
By YT Kim, JW Huh, M Jin & colleagues, Gachon University, Republic of Korea
🗞️doi.org/10.1038/s44321-023-00004-y -
EMBO Mol. Medicine reposted
omolina
@omolinacampoy
So happy to have our paper finally published in @EmboMolMed on chromosome instability in aneuploid subtypes of B-ALL! Many thanks to the colleagues in @Menendez_Lab and all our awesome collaborators 🥳🥂
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉 #chromosomalinstability in aneuploid #acutelymphoblasticleukemia associates with disease progression
By O. Molina, P. Menendez & colleagues @Menendez_Lab @CarrerasIJC
Read 🗞️doi.org/10.1038/s44321-023-00006-w -
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉 #chromosomalinstability in aneuploid #acutelymphoblasticleukemia associates with disease progression
By O. Molina, P. Menendez & colleagues @Menendez_Lab @CarrerasIJC
Read 🗞️doi.org/10.1038/s44321-023-00006-w -
EMBO Mol. Medicine
@EmboMolMed
Highly secreted tryptophanyl #trnasynthetase 1 as a potential theranostic target for hypercytokinemic severe #sepsis
By YT Kim, JW Huh, M Jin & colleagues, Gachon University, Republic of Korea
🗞️doi.org/10.1038/s44321-023-00004-y -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
A festive surprise to discover @EmboMolMed and @MolSystBiol ornaments decorating the @MPI_MolGen Christmas tree! 🧬🎄
-
EMBO Mol. Medicine
@EmboMolMed
Our December issue is online!💫
This month's beautiful cover highlights the article by Vignesh Ramesh, Paolo Ceppi & colleagues on #propionate capacity to reinforce epithelial identity & to reduce #lungcarcinoma aggressiveness
➡️www.embopress.org/toc/17574684/2023/15/12 -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
.@EMBOpress scientific editors help develop and deliver scientific skills training on #researchintegrity, writing & presenting research and #peerreview. 2024 course dates are now available: lab-management.embo.org/dates @emboreports @embojournal @MolSystBiol @EmboMolMed @EMBO
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
On the last day of #cellbio2023, the EMBO Press team are available to discuss your work and how to get published in an EMBO Press journal. Find us at the @EMBO booth (433) and tell us about your research!
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Hey #cellbio23! Meet the @EMBOPress editors today from 1-2pm at booth #433.
-
EMBO Mol. Medicine reposted
Organoid News
@organoidscience
🎇 New in @EmboMolMed!
@ChiaraLago_ & colleagues from the @LucaTiberi_lab and beyond present a protocol that enables efficient generation, expansion, and #biobanking of pediatric brain cancer #organoids.
Full study: 📗 idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine
@EmboMolMed
Patient- and xenograft-derived #organoids recapitulate #pediatricbraintumor features and patient treatments.
By M. Kool, E. Miele & @LucaTiberi_lab @ArmeniseHarvard
👉doi.org/10.15252/emmm.202318199 -
EMBO Mol. Medicine
@EmboMolMed
📢Disabling #autophagy can enhance immune response in #melanoma
🗞️doi.org/10.15252/emmm.202318028
prez.ly/jzCc -
EMBO Mol. Medicine
@EmboMolMed
Read online today ➡️ Tumor endothelial cell #autophagy is a key vascular-immune checkpoint in #melanoma
By J. Verhoeven, @kjacobs7192, M. Agrawal, @AgostinisLab & colleagues @vib_ccb @KU_Leuven
🗞️ #openaccess: doi.org/10.15252/emmm.202318028 -
EMBO Mol. Medicine reposted
Johan Van Weyenbergh
@johanvawe
Nice to see this comprehensive 'mouse to man' effort out: "Tumor endothelial cell #autophagy is a key vascular‐immune checkpoint in #melanoma" ...and to have played a tiny role by employing #ncounter Pancancer profiling @nanostringtech @EmboMolMed www.embopress.org/doi/full/10.15252/emmm.202318028
-
EMBO Mol. Medicine reposted
Kathryn A Jacobs
@kjacobs7192
Very excited to share our new paper with @AgostinisLab in @EmboMolMed on autophagy in tumor vessels ! www.embopress.org/doi/epdf/10.15252/emmm.202318028
-
EMBO Mol. Medicine reposted
Intestinal Cell News
@Intestinal_Cell
Scientists reported the identification of columbamine which enhanced macrophage-mediated efferocytosis and attenuated intestinal inflammation in a murine colitis model. @EmboMolMed
📌 idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine
@EmboMolMed
Online today! ➡️Enhancement of #efferocytosis through biased FPR2 signaling attenuates intestinal #inflammation
By MY Wu, YJ Ge, EJ Wang, RD Ye, JH Lu & colleagues at Institute of Chinese Medical Sciences
Read🗞️doi.org/10.15252/emmm.202317815 -
EMBO Mol. Medicine
@EmboMolMed
Brock-led immunotherapy research shows potential to extend healthy lifespan of humans | brocku.ca/brock-news/2023/11/brock-led-immunotherapy-rese… #brocku
-
EMBO Mol. Medicine
@EmboMolMed
The Centre for Genomic Regulation www.crg.eu/en/news/double-strike-strategy-slows-growth-dr…
👉Read article: doi.org/10.15252/emmm.202318459 -
EMBO Mol. Medicine
@EmboMolMed
HMBA ameliorates #obesity by MYH9- and ACTG1-dependent regulation of hypothalamic #neuropeptides.
By S. Park, S. Oh, N. Kim and E-K Kim at DGIST, Korea
Read 🗞️ #openaccess: doi.org/10.15252/emmm.202318024 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Our journal editors welcome #cellbio23 attendees to the @EMBO booth for daily manuscript consultations from 1-2pm. Less than 2 weeks to go!
@embojournal @MolSystBiol @emboreports @EmboMolMed @LSAjournal
EMBO
@EMBO
Cell Bio 2023 is just around the corner. #cellbio2023 focuses on cell biology as the fundamental basis of biology as well as on emerging interdisciplinary topics.
www.ascb.org/cellbio2023/ -
EMBO Mol. Medicine reposted
IPVS - International Papillomavirus Society
@IPVSociety
Laëtitia Douguet & colleagues at @PasteurVirology developed an immuno-oncotherapy against #hpv-induced tumors based on a lentiviral vector. A single shot into mice resulted in complete tumor eradication & was effective against lung metastases
➡️link.springer.com/10.15252/emmm.202317723
@EmboMolMed -
EMBO Mol. Medicine
@EmboMolMed
#immunotherapy targeting isoDGR-protein damage extends lifespan in a mouse model of protein #deamidation
P. Kalailingam, S.K. Sze & colleagues @NTUsg @BrockUniversity
🗞️doi.org/10.15252/emmm.202318526 -
EMBO Mol. Medicine
@EmboMolMed
Online today 👉 #propyleneglycol inactivates respiratory viruses and prevents airborne transmission
By C. Styles, @RachelSEdgar & colleagues
🗞️doi.org/10.15252/emmm.202317932
Read also related News & Views by I. Glas & S. David
🗞️doi.org/10.15252/emmm.202318710 -
EMBO Mol. Medicine
@EmboMolMed
In anticipation of the 20th BioMalPar, don't miss interview #openaccess: doi.org/10.15252/emmm.202318727
Freddy Frischknecht
@FrischknechtLab
Get ready for 20th BioMalPar #emblmalaria in Heidelberg.
-
EMBO Mol. Medicine reposted
Rachel Edgar 💙
@RachelSEdgar
We’re excited to share our work showing the widely used, non-toxic molecule propylene glycol prevents infection by many different human viruses including SARS-CoV-2 and influenza A virus, published today @EmboMolMed. A thread 1/3 doi.org/10.15252/emmm.202317932
-
EMBO Mol. Medicine
@EmboMolMed
Online today ! Commentary by L. Renia and L. Ng @ASTARsg 👉 Acquired immunity against #sarscov2 infection and vaccination.
🗞️doi.org/10.15252/emmm.202216345 -
EMBO Mol. Medicine
@EmboMolMed
#lkb1 -SIK2 loss drives #uvealmelanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
By S. Proteau, T. Strub, @BertolottoLab, & colleagues @Univ_CotedAzur @Inserm
➡️Read 🗞️#openaccess: doi.org/10.15252/emmm.202317719 -
EMBO Mol. Medicine reposted
Cell Therapy News
@celltherapynews
By identifying PAX6 as a critical regulator of beta cell function, survival, and identity, researchers demonstrate that PAX6 gene transfer might overcome the major barriers to islet transplantation. @EmboMolMed
📑 idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine reposted
Mammary Cell News
@MammaryCell
The following @EmboMolMed study reveals that inhibiting both BRD4 and LOXL2 shows promise as a novel therapeutic approach for the treatment of #tnbc.
Discover more here:
📑 idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine reposted
Pancreatic Cell News
@PancreaticCell
🥼 Scientists identified PAX6 as a critical regulator of beta cell survival.
Under #diabetic conditions, dampened #insulin and incretin signalings and reduced beta cell 🧫 survival were alleviated by PAX6 overexpression.
@EmboMolMed | bitly.ws/ZTFN -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess ➡️Interactions between BRD4S, LOXL2, & MED1 drive #cellcycle transcription in #triplenegativebreastcancer.
By @Lpascual90, @SandraPeiro, @SaraSdelci & colleagues @CRGenomica @VHIO
🗞️doi.org/10.15252/emmm.202318459 -
EMBO Mol. Medicine
@EmboMolMed
Real-time analysis of the cancer genome and fragmentome from plasma and urine #cellfreedna using #nanopore sequencing.
By N. Moldovan, @FlorentMouliere & colleagues @amsterdamumc
👉Read #openaccess: doi.org/10.15252/emmm.202217282 -
EMBO Mol. Medicine reposted
sara sdelci
@SaraSdelci
How cool is it to witness the success of wonderful people? The best part of being a PI 🤩
Congratulations to 👉AMAZING @Lpascual90 👈and all co-authors 👏🎉🍾
Thanks to @marillemaudit for representing our work so beautifully!
@CRGenomica
@ERC_Research
@CienciaGob
@EmboMolMed
Sdelci Lab
@SdelciL
We are very happy to share with you the last paper of the Sdelci Lab published in @EmboMolMed where we decipher a new molecular mechanism for triple-negative breast cancer proliferation www.embopress.org/doi/full/10.15252/emmm.202318459. Follow us in this threat!🧵
-
EMBO Mol. Medicine reposted
Florent Mouliere
@FlorentMouliere
Have you ever wanted to get shallow WGS data back in 24 hours from #cfdna plasma or urine sampling? Is there any very long molecules of tumor-derived #cfdna in #liquidbiopsy? Glad to share our work just published in @EMBOMolMed. doi.org/10.15252/emmm.202217282
-
EMBO Mol. Medicine
@EmboMolMed
📢Our November issue is online!
This month's cover highlights the article by @holger_gerhardt & colleagues @KU_Leuven @vib_ccb that reports the generation of zebrafish avatars to study the interplay between #glioblastoma tumor cells & #macrophages
➡️www.embopress.org/toc/17574684/2023/15/11 -
EMBO Mol. Medicine reposted
Laura Pascual
@Lpascual90
Extremely happy to share our work published in @EmboMolMed: Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer. Thank you very much @SaraSdelci, @SdelciL, @SandraPeiro and all the co-authors.
-
EMBO Mol. Medicine reposted
CIBIO - UniTrento
@CIBIO_UniTrento
📢Stefano Biressi Lab has just published a new paper on @EmboMolMed
📕Combinatorial activation of the WNT-dependent fibrogenic program by distinct complement subunits in dystrophic muscle
ℹ️www.embopress.org/doi/full/10.15252/emmm.202317405
#musculardystrophy -
EMBO Mol. Medicine
@EmboMolMed
Paired box 6 gene delivery preserves #betacells and improves #islettransplantation efficacy.
By Wing Yan So, Weiping Han & colleagues @ASTARsg
Read 🗞️openaccess: doi.org/10.15252/emmm.202317928 -
EMBO Mol. Medicine
@EmboMolMed
Online today ➡️Combinatorial activation of the WNT-dependent fibrogenic program by distinct complement subunits in dystrophic muscle.
By F. Florio, S. Biressi & colleagues @CIBIO_UniTrento
#musculardystrophy
🗞️👉doi.org/10.15252/emmm.202317405 -
EMBO Mol. Medicine reposted
Mammary Cell News
@MammaryCell
In this @EmboMolMed study, scientists led by @Stefan_Prekovic provide a comprehensive assessment of glucocorticoid receptor action in cancer biology and its impact on tumor cell proliferation capacity, particularly in ER-positive breast cancer.
📑 idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine
@EmboMolMed
Online today! Luminal #breastcancer identity is determined by loss of #glucocorticoidreceptor activity
By @Stefan_Prekovic @zwartlab & colleagues @NKI_nl @UMCU_CMM
🗞️#openaccess: doi.org/10.15252/emmm.202317737 -
EMBO Mol. Medicine reposted
Immunology of Infectious Disease News
@infdisease_news
🦟 #malaria infection elicits both protective and pathogenic #immune responses, and IL-27 is a critical cytokine that regulates effector responses during #infection.
💡 Learn all about the role of IL-27 in modulating CD4+ T cell memory!
@EmboMolMed | bitly.ws/YCVH -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess: Allelic effects on #uromodulin aggregates drive autosomal dominant tubulointerstitial #kidneydisease
By G. Schiano, O. Devuyst & colleagues @UZH_en @IREC_UCLouvain
👉doi.org/10.15252/emmm.202318242 -
EMBO Mol. Medicine
@EmboMolMed
Oregon State researchers uncover mechanism for treating dangerous liver condition
🗞️doi.org/10.15252/emmm.202318367
today.oregonstate.edu/news/oregon-state-researchers-uncov… -
EMBO Mol. Medicine reposted
Lab of Michael Sieweke - LoMiS
@SiewekeLab
Exciting news! 📢 Our latest paper is now live in @EmboMolMed. 📚🔬 We explore how M-CSF triggers coordinated myeloid and NK cell differentiation, providing protection against CMV following hematopoietic cell transplantation. 🦠💉 Check it out!👇🏻 👇🏻 👇🏻
www.embopress.org/doi/full/10.15252/emmm.202317694 -
EMBO Mol. Medicine reposted
Sandrine Sarrazin
@SarrazinSand
Teamwork works !!🙌🏻
Our 2 site-lab @SiewekeLab at @CIML_Immunology and @CRTDpress just released a groundbreaking paper in @EmboMolMed.
🧪🔬Dive into the study revealing how M-CSF protects against CMV infection after hematopoietic stem cell transplantation.🧫🥼
Lab of Michael Sieweke - LoMiS
@SiewekeLab
Exciting news! 📢 Our latest paper is now live in @EmboMolMed. 📚🔬 We explore how M-CSF triggers coordinated myeloid and NK cell differentiation, providing protection against CMV following hematopoietic cell transplantation. 🦠💉 Check it out!👇🏻 👇🏻 👇🏻
www.embopress.org/doi/full/10.15252/emmm.202317694 -
EMBO Mol. Medicine
@EmboMolMed
Do not miss! IL-27 produced during acute #malaria infection regulates Plasmodium-specific memory #cd4 #tcells
By @mmaloum_, K. Yui & colleagues at Nagasaki University, Japan
🗞️doi.org/10.15252/emmm.202317713 -
EMBO Mol. Medicine
@EmboMolMed
Senescent #schwanncells induced by aging and chronic denervation impair axonal regeneration following #peripheralnerveinjury
By A. Fuentes-Flores, F. Court & colleagues @DiarioMayor @gerochile @BuckInstitute
👉doi.org/10.15252/emmm.202317907 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Multi-omic network analysis identified #betacellulin as a novel target of omega-3 fatty acid attenuation of western diet-induced #nonalcoholicsteatohepatitis
By N. Shulzhenko, D. Jump, A. Morgun & colleagues @OregonState
🗞️doi.org/10.15252/emmm.202318367 -
EMBO Mol. Medicine reposted
Malou Macalinao, PhD
@mmaloum_
Our paper's now online @EmboMolMed:
IL‐27 produced during acute malaria infection regulates Plasmodium‐specific memory CD4+ T cells ✨
We showed that while IL-27 regulates #malaria pathology, it also affects the maintenance of protective memory responses.
doi.org/10.15252/emmm.202317713 -
EMBO Mol. Medicine
@EmboMolMed
Avatars to help tailor glioblastoma therapies | Max Delbrück Center www.mdc-berlin.de/news/press/avatars-help-tailor-glioblas…
-
EMBO Mol. Medicine
@EmboMolMed
Online today! Proteome profiling of early gestational plasma reveals novel #biomarkers of #congenitalheartdisease
By R. Zhao, K. Sun, C. Ding, JY Zhao & colleagues, Shanghai, China
🗞️Full #openaccess: doi.org/10.15252/emmm.202317745
Highlighted by P. Madeddu 👉 doi.org/10.15252/emmm.202318680 -
EMBO Mol. Medicine reposted
Federico Rossari
@f_rossari
Congrats to @da_magliulo for this intriguing work shedding light on #hif2a contribution to #aml biology and paving the way to new putative therapeutic strategies! Really positive collab 🤝
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess: The transcription factor #hif2a partakes in the differentiation block of #acutemyeloidleukemia
By D. Magliulo, R. Bernardi & colleagues @SanRaffaeleMI
🗞️👉doi.org/10.15252/emmm.202317810 -
EMBO Mol. Medicine
@EmboMolMed
Downregulation of stromal #syntenin sustains #acutemyeloidleukemia development
By R. Leblanc & colleagues @LabZimmermann @CNRS @KU_Leuven
🗞️➡️doi.org/10.15252/emmm.202317570 -
EMBO Mol. Medicine
@EmboMolMed
📢Check our new issue online today!
Articles on #norriedisease (highlighted on our cover), #lyssavirus, #arthritis, #idiopathicinflammatorymyopathies, #hcc, #papillomavirus, & more!
👉Fully #openaccess: www.embopress.org/toc/17574684/2023/15/10 -
EMBO Mol. Medicine reposted
Dermal Cell News
@DermalCell
Experiments revealed that NRF3 transcription factor suppresses squamous carcinogenesis. #squamouscell
Learn more about the mechanisms uncovered in @EmboMolMed:
🔍 shorturl.at/lFN27 -
EMBO Mol. Medicine reposted
Immune Regulation News
@Immune_News
Recent experiments highlighted that interactions between glioblastoma and its associated #macrophages can be studied in a clinically relevant way using co-cultures and avatar models. 🐟
@EmboMolMed | 🗝️ idp.springer.com/authorize?response_type=cookie&client_id… -
EMBO Mol. Medicine
@EmboMolMed
Online today ➡️ NRF3 suppresses #squamouscarcinoma tumorigenesis, involving the unfolded protein response regulator #hspa5
By S. Gurri, S. Werner & colleagues @ETH
🗞️👉doi.org/10.15252/emmm.202317761 -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess: The transcription factor #hif2a partakes in the differentiation block of #acutemyeloidleukemia
By D. Magliulo, R. Bernardi & colleagues @SanRaffaeleMI
🗞️👉doi.org/10.15252/emmm.202317810 -
EMBO Mol. Medicine reposted
News Medical
@NewsMedical
Researchers explore immunomodulating targets for improving glioblastoma therapies www.news-medical.net/news/20231008/Researchers-explore-im… 🧠🔬🐟 #glioblastoma #genomics #zebrafish #tumor #rnaseq #immunosuppression #braincancer #therapeutics #personalizedmedicine @EMBOPress @EmboMolMed
-
EMBO Mol. Medicine reposted
MolecularGenetics@ErasmusMC
@MolecularGenet3
Exciting new work from Arjan Theil/Wim Vermeulen in @EmboMolMed: mutations in TTDN1/MPLKIP that cause #trichothiodystrophy lead to instability of lariat debranching protein DBR1 and, consequently, splicing defects and impaired keratinocyte differentiation and skin development.
EMBO Mol. Medicine
@EmboMolMed
Online today! #trichothiodystrophy -associated MPLKIP maintains DBR1 levels for proper lariat debranching and ectodermal differentiation.
By A. Theil, W. Vermeulen & colleagues @erasmusmcintl
Read #openaccess: doi.org/10.15252/emmm.202317973 -
EMBO Mol. Medicine reposted
Immunology of Infectious Disease News
@infdisease_news
This study out of @USUhealthsci shows that a single dose of F11, an anti-lyssavirus human monoclonal #antibody, limited viral load in the 🧠 brain and reversed disease signs following #infection with a lethal dose of #lyssavirus!
@EmboMolMed | bitly.ws/WAqL -
EMBO Mol. Medicine
@EmboMolMed
A Sharma & C Wolfrum @ETH_en report that DGAT1/2 pharmacological inhibition at post-absorptive phase in mice leads to increased #fattyacidoxidation and reduced plasma #fattyacid levels, which could open new therapeutic avenues to avoid GI complications
👇doi.org/10.15252/emmm.202318209 -
EMBO Mol. Medicine
@EmboMolMed
📢Round table discussion on challenges and opportunities in #malaria research with @e_levashina, @SoldatiLabToxo, @AndrewPWater, @FrischknechtLab
, and @rayner_julian.
🗞️➡️doi.org/10.15252/emmm.202318727 -
EMBO Mol. Medicine
@EmboMolMed
Online today! #trichothiodystrophy -associated MPLKIP maintains DBR1 levels for proper lariat debranching and ectodermal differentiation.
By A. Theil, W. Vermeulen & colleagues @erasmusmcintl
Read #openaccess: doi.org/10.15252/emmm.202317973 -
EMBO Mol. Medicine
@EmboMolMed
Avatars Aid in Customizing Glioblastoma Therapies / Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according www.miragenews.com/avatars-aid-in-customizing-glioblastom…
-
EMBO Mol. Medicine
@EmboMolMed
Scientists Develop New Zebrafish Platform for Screening Novel Glioblastoma Treatments www.expresshealthcaremgmt.com/news2/new-zebrafish-xenogra…
🗞️doi.org/10.15252/emmm.202318144 -
EMBO Mol. Medicine reposted
Pulmonary Cell News
@pulmonary_news
🥼 A team of researchers with Dr. Paolo Ceppi at @bmbSDU used an EMT-focused integrative functional 🧬 #genomic approach and identified an inverse association between short-chain fatty acids and EMT in #nsclc patients.
@EmboMolMed | idp.springer.com/transit?redirect_uri=https%3A%2F%2Flink.… -
EMBO Mol. Medicine reposted
Max Delbrück Center
@MDC_Berlin
#glioblastoma patients need new therapies, says #mdcberlin scientist @holger_gerhardt. With De Smet Lab @KU_Leuven & Lise Finotto @vib_ccb, @VIBLifeSciences, his lab created zebrafish avatars that could help identify treatments & drug targets. @EmboMolMed
www.mdc-berlin.de/news/press/avatars-help-tailor-glioblas… -
EMBO Mol. Medicine reposted
Freddy Frischknecht
@FrischknechtLab
Discussion with fellow @EMBO members @AndrewPWaters @e_levashina @SoldatiLabToxo and @rayner_julian reflects on progress made and what is still needed to control #malaria "moving beyond the search for magic bullets" @EmboMolMed www.embopress.org/doi/full/10.15252/emmm.202318727. Feedback appreciated.
-
EMBO Mol. Medicine
@EmboMolMed
Intratumoral co-injection of #nkcells and #nkg2a -neutralizing monoclonal antibodies
By I. Melero, M. Alvarez & colleagues @idisnanavarra
👉Read #openaccess: doi.org/10.15252/emmm.202317804 -
EMBO Mol. Medicine reposted
Noseda_lab
@NosedaLab
Excited to share our editorial on #scrnaseq in idiopathic inflammatory myopathies, out today in @EmboMolMed Congrats to Argyriou et al on their study, advancing our understanding of this complex disease!
@NosedaMichela @momina_yazdani @Mach_MD
www.embopress.org/doi/full/10.15252/emmm.202318190 -
EMBO Mol. Medicine
@EmboMolMed
Today is #worldrabiesday! Read #openaccess new article by K. Mastraccio, C. Huaman, C. Broder, B. Schaefer & colleagues @USUhealthsci
➡️mAb therapy controls CNS-resident #lyssavirus infection via a CD4 T cell-dependent mechanism
🗞️doi.org/10.15252/emmm.202216394 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Propionate reinforces epithelial identity and reduces aggressiveness of #lungcarcinoma
By V. Ramesh, P. Ceppi & colleagues @SyddanskUni & Uniklinikum Erlangen
🗞️👉doi.org/10.15252/emmm.202317836 -
EMBO Mol. Medicine
@EmboMolMed
Read commentary online today ➡️ L. D'Adamio discusses the challenges associated with #animalmodels of #alzheimersdisease and related #dementias that heavily rely on random insertion of presumed disease-inducing factors.
🗞️ doi.org/10.15252/emmm.202318479 -
EMBO Mol. Medicine reposted
Carlo Rinaldi
@rinaldi_ca
🔊New finding alert! The future of treatments for #sma is combined treatments 🙌🏻 🙌🏽 Big congratulations to @AnnaKordala for her first first author paper!🌟 @OxPaediatrics @IdrmOxford @OxNeuro @MDUK_News @EmboMolMed @CureSMA
www.embopress.org/doi/full/10.15252/emmm.202317683 -
EMBO Mol. Medicine
@EmboMolMed
Online today! PRMT inhibitor promotes SMN2exon 7 inclusion and synergizes with #nusinersen to rescue #spinalmuscularatrophy mice.
By A. Kordala, C. Rinaldi & colleagues @UniofOxford @IdrmOxford
🗞️doi.org/10.15252/emmm.202317683 -
EMBO Mol. Medicine reposted
Dominic Smiraglia
@SmiragliaLab
Really important work here. Congratulations @tmurraystewart @hopkinskimmel
EMBO Mol. Medicine
@EmboMolMed
Read!📢#difluoromethylornithine rebalances aberrant #polyamine ratios in #snyderrobinsonsyndrome
By @tmurraystewart, R. Casero & colleagues @hopkinskimmel
🗞️ #openaccess: doi.org/10.15252/emmm.202317833 -
EMBO Mol. Medicine
@EmboMolMed
S. Gilmour discusses the study by @tmurraystewart et al. that proposes the use of #difluoromethylornithine to rebalance the relative levels of spermidine & spermine in order to treat #snyderrobinsonsyndrome patients
doi.org/10.15252/emmm.202318506
Full article: doi.org/10.15252/emmm.202317833 -
EMBO Mol. Medicine reposted
Hematopoiesis News
@Hema_News
🌡️ Chronic inflammatory diseases are associated with #hematopoietic lineage bias.
Investigators reported that 🧬 genetic inhibition of Nlrp1 resulted in a reduced number of #neutrophils and increased #erythrocyte counts in zebrafish larvae.
@EmboMolMed | link.springer.com/article/10.15252/emmm.202318142 -
EMBO Mol. Medicine
@EmboMolMed
Read!📢#difluoromethylornithine rebalances aberrant #polyamine ratios in #snyderrobinsonsyndrome
By @tmurraystewart, R. Casero & colleagues @hopkinskimmel
🗞️ #openaccess: doi.org/10.15252/emmm.202317833 -
EMBO Mol. Medicine
@EmboMolMed
E. Solary discusses potential therapeutic use of macrophage colony-stimulating factor against #cytomegalovirus in immunocompromised individuals as reported by M. Sieweke & colleagues
➡️doi.org/10.15252/emmm.202318319
Full related article: doi.org/10.15252/emmm.202317694 -
EMBO Mol. Medicine
@EmboMolMed
Cingulin regulates #haircell cuticular plate morphology and is required for hearing in human and mouse 👂
By Z. Xu, J. Chen, X. Gao, G. Wan & colleagues at Nanjing University
Read #openaccess: doi.org/10.15252/emmm.202317611 -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess 👉 Sterile triggers drive joint #inflammation in TNF- and IL-1β-dependent mouse #arthritis models
By @ThiranAlexandra, D. Elewaut, @LarsVereecke & colleagues @ugent @VIBLifeSciences
🗞️doi.org/10.15252/emmm.202317691 -
EMBO Mol. Medicine reposted
Immune Regulation News
@Immune_News
🏫 Led by @ThiranAlexandra & @LarsVereecke, a team at @VIBLifeSciences revealed distinct triggers for gut and joint inflammation using germ-free mouse technology.
📗 @EmboMolMed: link.springer.com/article/10.15252/emmm.202317691
📰 press.vib.be/untangling-gut-and-joint-inflammation-in-art… -
EMBO Mol. Medicine reposted
Anushree Bharadwaj
@AnushreeBharad5
Happy to share cover image featured in the current issue of @EmboMolMed
Sam Mathew
@SamMathew_RCB
Thank you @EmboMolMed for featuring our work on the journal cover. Congratulations @AnushreeBharad5 @Jaydeep_Sharma_ @MahimaK2104 @TanushriDargar @bhargab76 Thanks to @unescorcb @DBTIndia @India_Alliance @rajesh_gokhale
-
EMBO Mol. Medicine reposted
Lars Vereecke
@LarsVereecke
Great to see our study on the gut-joint axis online in EMBO Molecular Medicine! The microbiota and gut inflammation are dispensable for TNF and IL1b dependent arthritis. Congratulation @ThiranAlexandra
and collaborators! @EmboMolMed
www.embopress.org/doi/full/10.15252/emmm.202317691 -
EMBO Mol. Medicine
@EmboMolMed
📢Our September issue is online!
Review on the functions of double-negative #bcells, articles on musculoskeletal defects (on the cover), #covid19, #endometrialfibrosis, #cancer, #barthsyndrome, #parkinsonsdisease and more!
🗞️Fully #openaccess: www.embopress.org/toc/17574684/2023/15/9 -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess: Full eradication of pre-clinical #humanpapillomavirus -induced tumors by a lentiviral vaccine
By L. Majlessi, P. Charneau & colleagues @institutpasteur
👉doi.org/10.15252/emmm.202317723 -
EMBO Mol. Medicine
@EmboMolMed
Online today! ZAKα/P38 kinase signaling pathway regulates #hematopoiesis by activating the #nlrp1 #inflammasome
By S D Tyrkalska, A B Pérez-Oliva, V Mulero & colleagues @IIC_UMU_IMIB
@UMU @CIBERER @IMIB_RMurcia
Read 🗞️doi.org/10.15252/emmm.202318142 -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess: Systemic #genetherapy rescues #retinaldysfunction and #hearingloss in a model of #norriedisease
By V. Pauzuolyte, J. C, Sowden & colleagues @ucl @GreatOrmondSt
👉doi.org/10.15252/emmm.202317393 -
EMBO Mol. Medicine
@EmboMolMed
M-CSF directs myeloid and #nkcell differentiation to protect from CMV after hematopoietic #celltransplantation
By M. Dalod, M.H. Sieweke & colleagues @Inserm @CNRS @tudresden_de
#cytomegalovirus
🗞️Read #openaccess: doi.org/10.15252/emmm.202317694 -
EMBO Mol. Medicine
@EmboMolMed
#metformin rescues migratory deficits of cells derived from patients with #periventricularheterotopia
By C. Bressan, A. Saghatelyan & colleagues @uOttawa @universitelaval
➡️doi.org/10.15252/emmm.202216908 -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess 👉 Discovery of oncogenic #ros1 missense mutations with sensitivity to #tyrosinekinaseinhibitors
By @DavareLab @OHSUNews
🗞️doi.org/10.15252/emmm.202217367 -
EMBO Mol. Medicine
@EmboMolMed
L. Mayo discusses the study by M. Brown, D. Church et al. that uses GEMMs to determine the functional consequences of missense & loss of function mutations in #fbxw7, #pten, & #tp53 in high-risk #endometrialcancers
doi.org/10.15252/emmm.202318166
full article: doi.org/10.15252/emmm.202217094 -
EMBO Mol. Medicine reposted
Davare Lab
@DavareLab
In press!
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors | EMBO Molecular Medicine www.embopress.org/doi/full/10.15252/emmm.202217367
#ros1 @EmboMolMed -
EMBO Mol. Medicine reposted
Science Advancement and Outreach
@SAOscience
Check out this interesting commentary from Alessio Butera, @ivanoamelio, @ToxmasHartung, & colleagues on the need to include #epigenetics in the study of how genetics and environmental factors interact to affect human disease risk. Published earlier this month in @EmboMolMed 👇
Ivano Amelio
@ivanoamelio
Happy to share our speculative article @embomolmed discussing #epigenetics in Gene-Environment interactions
Analogously to the epigenetic clock to estimate biological age, we provocatively propose the an "epigenetic scoremeter" to estimate disease risk
rb.gy/z9pu6 -
EMBO Mol. Medicine reposted
8Eevert ✨
@8Eevert
Clinical grade #ace2 as a universal agent to block SARS-CoV-2 variants
recombinant human soluble ACE2 (#apn01):
—neutralized infection by [Alpha, Beta, Gamma, Delta, & Omicron #covid] strains
—confirmed in two independent laboratories
EMBO Mol Med 2022
www.ncbi.nlm.nih.gov/pmc/articles/PMC9350269/
EMBO Mol. Medicine
@EmboMolMed
📢Clinical grade #ace2 as a universal agent to block #sarscov2 variants
By G. Wirnsberger, J. Penninger & colleagues @karolinskainst @invIOs_com @IMBA_Vienna @ubclifesciences
👉Fully #openaccess: doi.org/10.15252/emmm.202115230 -
EMBO Mol. Medicine
@EmboMolMed
Read online ➡️ Involvement of Csnk1e/d in the pathogenesis of familial #parkinsonsdisease caused by #chchd2
By S. Torii, S. Shimizu & colleagues @TMDUniversity
🗞️#openaccess: doi.org/10.15252/emmm.202317451 -
EMBO Mol. Medicine reposted
Karolinska Institutet
@karolinskainst
T cells in the muscle tissue of patients with idiopathic inflammatory myopathies was characterized by @KarineChem65601 et al in a study in @EmboMolMed. The results show that the same T cells persist in the muscle despite immunosuppressive treatment.
news.ki.se/persistent-t-cells-identified-in-the-muscle-of… -
EMBO Mol. Medicine
@EmboMolMed
Read online 👉 Spleen-targeted neoantigen #dnavaccine for personalized immunotherapy of #hepatocellularcarcinoma
By L. Wu, X. Liu & colleagues at Fujian Medical University
🗞️doi.org/10.15252/emmm.202216836 -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
Places are still available for our online scientific skills courses this autumn covering #researchintegrity, #research #communication, #peerreview and applying #design principles to figures. Find out more info + how to register here: lab-management.embo.org/dates @EMBO @EMBOpress
-
EMBO Mol. Medicine
@EmboMolMed
Our August issue is online!🌻
This month’s cover (@TeamSciStories) highlights the article by E Grant, @MDesai_Lab & colleagues on how maternal dietary #fiberintake & discrete changes in #gutmicrobiome shape the colonic #immunedevelopment of offspring
👉 www.embopress.org/toc/17574684/2023/15/8 -
EMBO Mol. Medicine reposted
Mahesh Desai Lab
@MDesai_Lab
Check out the latest @EmboMolMed cover featuring our work in an #earlylife model!
How does maternal #dietaryfiber deprivation impact establishment of mucin-degrader #akkermansia in offspring? Hint: it's not what you might expect! -
EMBO Mol. Medicine reposted
Pancreatic Cell News
@PancreaticCell
👀 Check it out in @EmboMolMed! #βcells #platelet
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess ➡️ #platelet -derived lipids promote #insulin secretion of #pancreaticβcells
By T. Karwen, K. Kolczynska-Matysiak, @StegnerLab, @NieswandtLab, @GrzegorzSumara & colleagues @Uni_WUE
🗞️doi.org/10.15252/emmm.202216858 -
EMBO Mol. Medicine reposted
EMBO
@EMBO
Increasing participation across Europe: @EMBOPress offers #oa publication at no cost for corresponding authors in #croatia #czechrepublic #estonia #greece #hungary #italy #lithuania #luxembourg #poland #slovenia #turkey and not covered by a PAR
www.embo.org/funding/increasing-participation-in-the-embo… -
EMBO Mol. Medicine reposted
Ivano Amelio
@ivanoamelio
Happy to share our speculative article @embomolmed discussing #epigenetics in Gene-Environment interactions
Analogously to the epigenetic clock to estimate biological age, we provocatively propose the an "epigenetic scoremeter" to estimate disease risk
rb.gy/z9pu6 -
EMBO Mol. Medicine
@EmboMolMed
Online today 👉 Graft conditioning with #fluticasonepropionate reduces #graftversushostdisease upon allogeneic #hematopoieticcell transplantation in mice
By E. Varady, LA Ayala, M. Inlay & colleagues @UCIrvine
🗞️ doi.org/10.15252/emmm.202317748 -
EMBO Mol. Medicine
@EmboMolMed
➡️New Commentary: Deconvoluting gene & environment interactions to develop an “epigenetic score meter” of disease
By @ivanoamelio & colleagues
🗞️doi.org/10.15252/emmm.202318208 -
EMBO Mol. Medicine reposted
EMBO Reports
@emboreports
The August issue is online!
www.embopress.org/toc/14693178/2023/24/8
The cover features work by Lei Wang and co-workers showing that reducing oxidative #protein folding alleviates #senescence by minimizing ER-to-nucleus H2O2 release.
-> www.embopress.org/doi/full/10.15252/embr.202256439 -
EMBO Mol. Medicine reposted
Endothelial Cell News
@endothelialnews
🥼🧪 Collaborators identified SMC5-SMC6 complex localization factor 2 as a DDR regulator and revealed co-targeting of the DDR and SUMOylation as a promising strategy for treating aggressive #lymphoma.
Get the full article in @EmboMolMed.
👉 link.springer.com/article/10.15252/emmm.202216431 -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess: Viral anti-inflammatory #serpin reduces immuno-coagulopathic pathology in #sarscov2 mouse models of infection
By L. Zhang, Y. Li, B. Hogue, A. Lucas & colleagues
@ASUBiodesign
👉doi.org/10.15252/emmm.202317376 -
EMBO Mol. Medicine
@EmboMolMed
Online today!
👉Metabolic switch from #fattyacidoxidation to #glycolysis in knock-in mouse model of #barthsyndrome
By A. Chowdhury, P. Rehling & colleagues @RehlingLab @mpi_nat
🗞️#openaccess: doi.org/10.15252/emmm.202317399 -
EMBO Mol. Medicine
@EmboMolMed
📢#singlecellprofiling of muscle-infiltrating #tcells in #idiopathicinflammatorymyopathies
By A. Argyriou, B. Horuluoglu, @LinMarDiaz, @KarineChem65601 & colleagues @karolinskainst
🗞️ #openaccess: doi.org/10.15252/emmm.202217240 -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess 👉 Quantitative multiorgan #proteomics of fatal #covid19 uncovers tissue-specific effects beyond #inflammation
By @LisaCSchweizer, R. Claus, M. Mann & colleagues @labs_mann @UKAugsburg
🗞️doi.org/10.15252/emmm.202317459 -
EMBO Mol. Medicine reposted
Lisa Schweizer
@LisaCSchweizer
MS-based proteomics and pathology create a synergy that provides new insights into complex disease mechanisms. You can read about our collaborative effort from @labs_mann and @ukaugsburg to uncover organ-specific effects in fatal COVID-19 beyond inflammation in @EmboMolMed
Matthias Mann Lab
@labs_mann
Curious about how SARS-CoV-2 affects organs beyond systemic inflammation? Check out our post-mortem tissue study that unmasks organ-specific effects in COVID-19, published today @EmboMolMed and supported by a great collaborative team @UKAugsburg: link.springer.com/article/10.15252/emmm.202317459
-
EMBO Mol. Medicine
@EmboMolMed
Targeting CD301+ macrophages inhibits #endometrialfibrosis and improves pregnancy outcome
By H. Lv, H. Sun, L. Wang, G. Zhao, Y. Lu & colleagues at Nanjing University
#intrauterineadhesion #endometrialfibrosis
👉Read #openaccess: doi.org/10.15252/emmm.202317601 -
EMBO Mol. Medicine reposted
Matthias Mann Lab
@labs_mann
Curious about how SARS-CoV-2 affects organs beyond systemic inflammation? Check out our post-mortem tissue study that unmasks organ-specific effects in COVID-19, published today @EmboMolMed and supported by a great collaborative team @UKAugsburg: link.springer.com/article/10.15252/emmm.202317459
-
EMBO Mol. Medicine reposted
Bruno Ramos-Molina, PhD
@Brunorm84
Platelet-derived lipids promote insulin secretion of pancreatic β cells #diabetes @EmboMolMed www.embopress.org/doi/full/10.15252/emmm.202216858
-
EMBO Mol. Medicine reposted
Jaydeep Sharma
@Jaydeep_Sharma_
Super Excited to share my 1st, First author paper published @EmboMolMed with @AnushreeBharad5. All thanks to my super cool boss @SamMathew_RCB for giving me the opportunity and support.
Special thanks to @AnushreeBharad5 for her support. congratulations to all the authors.
Sam Mathew
@SamMathew_RCB
Latest work from our lab @unescorcb published in EMBO Molecular Medicine @EmboMolMed
www.embopress.org/doi/full/10.15252/emmm.202217187
Superb, innovative & sustained efforts by @AnushreeBharad5, @Jaydeep_Sharma_, @Jagriti_Singh5, @MahimaK2104, @TanushriDargar, @bhargab76 -
EMBO Mol. Medicine reposted
Matthew S. Alexander
@Matt_Muscle_Guy
New @EmboMolMed paper: Musculoskeletal defects associated with myosin heavy chain-embryonic loss of function are mediated by the YAP signaling pathway. link.springer.com/article/10.15252/emmm.202217187
-
EMBO Mol. Medicine
@EmboMolMed
Online today! Musculoskeletal defects associated with #myosinheavychain -embryonic loss of function are mediated by the YAP signaling pathway
By A. Bharadwaj, J. Sharma, S. Mathew & colleagues @unescorcb
🗞️#openaccess: doi.org/10.15252/emmm.202217187 -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess ➡️ #platelet -derived lipids promote #insulin secretion of #pancreaticβcells
By T. Karwen, K. Kolczynska-Matysiak, @StegnerLab, @NieswandtLab, @GrzegorzSumara & colleagues @Uni_WUE
🗞️doi.org/10.15252/emmm.202216858 -
EMBO Mol. Medicine reposted
Fusion Conferences
@Fusion_Conf
Huge thank you to our long-standing partner @EMBOPress for supporting #recombination23, #mito23 & #amc23 in Portugal. Especially to editors Lise Roth (@EmboMolMed) & Daniel Klimmeck (@embojournal) for attending and awarding our sponsored poster prizes!
-
EMBO Mol. Medicine reposted
Mohammed Hankir
@HankirMohammed
Congratulations on publishing this beautiful piece of work! It was such a pleasure to see Till present it for his PhD defence which was one of the best I've ever seen!
-
EMBO Mol. Medicine reposted
SumaraGLab
@GrzegorzSumara
Happy to share our collaborative study with @NieswandtLab and @StegnerLab on the role of #platelets in #insulin secretion, which is now online at @EmboMolMed doi.org/10.15252/emmm.202216858
Many thanks to all the authors, especially Till and Kasia.
@NenckiInstitute and @RVZ_Wuerzburg -
EMBO Mol. Medicine reposted
Centre Leon Berard
@CLCCLeonBerard
🔎Une équipe de recherche du @crcl co-dirigée par le Dr Olivier Tredan, oncologue au @CLCCLeonBerard, vient de montrer qu'un biomarqueur permettant de prédire la réponse des patientes au tamoxifène existe. #cancerdusein
En savoir plus sur cette étude 👇www.centreleonberard.fr/institution/actualites/cancer-du-…
EMBO Mol. Medicine
@EmboMolMed
Online today! Nuclear #prmt5 is a biomarker of sensitivity to #tamoxifen in ERα+ #breastcancer
By C Poulard, TH Pham, O Trédan, M Le Romancer & colleagues @crcl
🗞️#openaccess: doi.org/10.15252/emmm.202217248 -
EMBO Mol. Medicine
@EmboMolMed
📢Online today! Actionable loss of SLF2 drives B-cell #lymphomagenesis & impairs the #dnadamageresponse
By L. Zhang, U. Keller, M. Schick & colleagues @ChariteBerlin @DKFZ @MDC_Berlin
🗞️Read #openaccess: doi.org/10.15252/emmm.202216431 -
EMBO Mol. Medicine reposted
Guido Primiano
@primiano_guido
New insights into the metabolic remodeling in mitochondrial myopathies. #mitochondria, #mitochondrialdiseases, #merrf, #metabolism, @Unicatt, @WCM_BMRI, @EmboMolMed.
www.embopress.org/doi/full/10.15252/emmm.202216951 -
EMBO Mol. Medicine reposted
Fusion Conferences
@Fusion_Conf
What a group! Some fantastic research shared so far, and even more to come, including our Poster Session, Gala Dinner and a Wine Tour at a local vineyard🐭🍷 #amc23
-
EMBO Mol. Medicine reposted
Fusion Conferences
@Fusion_Conf
Congratulations to our #amc23 poster prize winners: Alberto Diaz (DKFZ), Catarina Rodrigues (IPO-Porto), Owen Crump (Sick Kids) & Alyssa Shepard (Moffitt Cancer Center)! Very well deserved!
-
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
We offer scientific skills training on #researchintegrity, #research #communication, #peerreview and applying #design principles to figures. Places still available for the autumn courses: lab-management.embo.org/dates @emboreports @embojournal @MolSystBiol @EmboMolMed @EMBO @EMBOpress
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
We are pleased to sponsor @Fusion_Conf Animal Models of Cancer this week in Lisbon. Our @EmboMolMed editor Lise Roth is attending and will present a poster prize - talk to her about publishing your latest data! #amc23
-
EMBO Mol. Medicine reposted
Cancer Research Center of Lyon
@crcl
Latest study from M Le Romancer & O Trédan Lab @crcl. Great work with potential clinical application!
👏👏 #breastcancer #research
EMBO Mol. Medicine
@EmboMolMed
Online today! Nuclear #prmt5 is a biomarker of sensitivity to #tamoxifen in ERα+ #breastcancer
By C Poulard, TH Pham, O Trédan, M Le Romancer & colleagues @crcl
🗞️#openaccess: doi.org/10.15252/emmm.202217248 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Nuclear #prmt5 is a biomarker of sensitivity to #tamoxifen in ERα+ #breastcancer
By C Poulard, TH Pham, O Trédan, M Le Romancer & colleagues @crcl
🗞️#openaccess: doi.org/10.15252/emmm.202217248 -
EMBO Mol. Medicine reposted
Espinet Lab
@ElisaEspinet
Congrats to all! And a special mention to @HamedAlborzy. I am always impressed by your commitment. Thanks for letting me have a small contribution to this story 👨🏼🔬🙂🐁
EMBO Mol. Medicine
@EmboMolMed
Online today! #lrp8 -mediated #selenocysteine uptake is a targetable vulnerability in MYCN-amplified #neuroblastoma
#ferroptosis #cancer
By @HamedAlborzy @AngeliFriedmann @hi_stem_lab & colleagues
🗞️Read #openaccess: doi.org/10.15252/emmm.202318014 -
EMBO Mol. Medicine
@EmboMolMed
Online today! #lrp8 -mediated #selenocysteine uptake is a targetable vulnerability in MYCN-amplified #neuroblastoma
#ferroptosis #cancer
By @HamedAlborzy @AngeliFriedmann @hi_stem_lab & colleagues
🗞️Read #openaccess: doi.org/10.15252/emmm.202318014 -
EMBO Mol. Medicine reposted
James Olzmann
@OlzmannLab
Awesome to see this work out in @EmboMolMed highlighting LRP8 and #selenium metabolism as a specific #ferroptosis vulnerability in MYCN-amplified neuroblastoma. Important therapeutic implications. Congrats @AngeliFriedmann @HamedAlborzy @hi_stem_lab! www.embopress.org/doi/full/10.15252/emmm.202318014
-
EMBO Mol. Medicine reposted
José Pedro Friedmann Angeli
@AngeliFriedmann
Now online in @EmboMolMed, a joint effort between our group and @hi_stem_lab. Work spearheaded @HamedAlborzy #zhiyichen and #umutydiz
Only possible due to the great support offered by @Ferroptosis2306 www.embopress.org/doi/full/10.15252/emmm.202318014
Congrats to al co-aurhors!!! -
EMBO Mol. Medicine
@EmboMolMed
📢@EmboMolMed editor Zeljko Durdevic will be attending #emig2023, get in touch!
👉emig2023.ch -
EMBO Mol. Medicine
@EmboMolMed
🌞Our July issue is online!
The cover highlights the study by @LeaLescouzeres @PascaleBomont et al. that used the #zebrafish as model of neuromuscular disease & identified small molecules restoring physiological/cellular deficits in #giantaxonalneuropathy
www.embopress.org/toc/17574684/2023/15/7 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Early reg deadline is Aug 1st for @KeystoneSymp #immunity and #aging, and @EmboMolMed editor Kelly Anderson is attending. See scholarship, abstract and discount reg dates: www.keystonesymposia.org/conferences/conference-listing/m…
#ksaging24 #immunology #senescence #inflammaging -
EMBO Mol. Medicine reposted
Bomont Pascale
@PascaleBomont
Presently in beautiful Krakow-Poland for the @EZM2023, I am so happy to see our work featured in the cover of the last issue of @EmboMolMed. I will present our fresh results (from @LeaLescouzeres and co-authors) Thursday at the meeting!! @ZebrafishRock @eu_fish !Dziękuję bardzo!
Bomont Pascale
@PascaleBomont
So excited to see this online🌈🌈🌈On top of amazing authors (@LeaLescouzeres from my lab) & the great scientific adventure, this was one of my my best experience with a top editorial office & helpful reviewers 🌈🌈🌈 @ZebrafishRock
-
EMBO Mol. Medicine reposted
Léa Lescouzères
@LeaLescouzeres
🎉What could be more satisfying than seeing our work on the cover of @EmboMolMed 's last issue ? 🗞️Thanks again to everyone involved in this exciting project @BaudotAnais @MRI_Montpellier ! And a huge thank to @PascaleBomont who will present our results this Thursday @EZM2023 ☀️
-
EMBO Mol. Medicine reposted
Hepatic Cell News
@hepaticcellnews
.@LUMC_Leiden researchers and collaborators show that inhibition of DHCR24 decreases liver #collagen content and plasma alanine transaminase levels in an established #nafld model.
🔓 #openaccess at @EmboMolMed
link.springer.com/article/10.15252/emmm.202216845 -
EMBO Mol. Medicine
@EmboMolMed
New review online & #openaccess ➡️ Targeting shared molecular etiologies to accelerate #drugdevelopment for #raredisease
By G. Zanello, M. Garrido-Estepa, P. J. Brooks & colleagues @NIH@Inserm @SaludISCIII
🗞️doi.org/10.15252/emmm.202217159 -
EMBO Mol. Medicine reposted
Enchen
@Enchen__Zhou
I am so happy to share my last unpublished PhD project @Rensen_Lab which is just published online @EmboMolMed now! And many thanks to our great collaborators!🤓🤓
EMBO Mol. Medicine
@EmboMolMed
Online today! Inhibition of DHCR24 activates LXRα to ameliorate #hepaticsteatosis and #inflammation
By E. Zhou, Y. Wang & colleagues at Xi'an Jiaotong University and Leiden University
#nash #nafld
🗞️Read #openaccess: doi.org/10.15252/emmm.202216845 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Inhibition of DHCR24 activates LXRα to ameliorate #hepaticsteatosis and #inflammation
By E. Zhou, Y. Wang & colleagues at Xi'an Jiaotong University and Leiden University
#nash #nafld
🗞️Read #openaccess: doi.org/10.15252/emmm.202216845 -
EMBO Mol. Medicine reposted
Oroboros Instruments
@OroborosI
Today we present this #mitobesity article from Axelrod et al:
wiki.oroboros.at/index.php/Axelrod_2021_EMBO_Mol_Med
Want to learn more or give a presentation about mitObestiy and healthy aging? Join us at #mip2023:
www.mitophysiology.org/index.php/MiP2023_Obergurgl_AT
@DrJohnKirwan @EmboMolMed @PBRCNews @CCLRI @cwru @UNSW @LSU -
EMBO Mol. Medicine reposted
DFG_FOR2722
@DFG_FOR2722
Congratulations to J. Etich, M. Rehberg and colleagues on their recent contribution to @EmboMolMed @DFG_FOR2722 "TAPT1—at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta" @UniCologne @UKKoeln
EMBO Mol. Medicine
@EmboMolMed
➡️New study that expands the spectrum of #osteogenesisimperfecta -causing TAPT1 mutations & links extracellular matrix changes to signaling regulation.
By J. Etich, M. Rehrberg & colleagues @UniCologne @goetheuni
🗞️Read #openaccess: doi.org/10.15252/emmm.202317528 -
EMBO Mol. Medicine reposted
DrawImpacts
@DrawImpacts
1/3 🎉 Exciting news! Our illustration graces the cover of @EmboMolMed 's June issue! 📖 Take a look at the captivating artwork on "PM2.5 promotes lung cancer progression through activation of the AhR-TMPRSS2-IL18 pathway" by PC Yang, CY Chen &al. 🚗🌫️
-
EMBO Mol. Medicine reposted
Hepatic Cell News
@hepaticcellnews
Is environmental 🌲 or therapeutic 💉 AAV infection a critical risk factor for #livercancer in individuals with #obesity and #diabetes?
🔎 Find out why this question is important in @EmboMolMed!
link.springer.com/article/10.15252/emmm.202217230 -
EMBO Mol. Medicine reposted
Bruno Ramos-Molina, PhD
@Brunorm84
AAV induces hepatic necroptosis and carcinoma in diabetic and obese mice dependent on Pebp1 pathway #obesity #diabetes @EmboMolMed www.embopress.org/doi/full/10.15252/emmm.202217230
-
EMBO Mol. Medicine reposted
Mahesh Desai Lab
@MDesai_Lab
Very excited to share this article by our lab!
EMBO Mol. Medicine
@EmboMolMed
#maternaldiet and #gutmicrobiome composition modulate early-life immune development
By E. Grant, M. Desai & colleagues @LIH_Luxembourg
👉doi.org/10.15252/emmm.202217241 -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
It's not too late to join this online “How to review a scientific paper” workshop on 27-28 June! Don't miss the deadline on 19 June - sign up now: lab-management.embo.org/dates/review #peerreview @EMBOPress @EMBO
EMBO Lab Leadership
@LifeSciLearn
Learn more about the principles + practicalities of #peerreview amongst other topics in an interactive setting with Martina Rembold, Senior #editor @emboreports @embopress. Sign up now for the “How to review a scientific paper” workshop on 27-28 June 2023 lab-management.embo.org/dates/review
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
out today: PRO-MaP open method + protocol recommendations for Researchers, Research institutions, Publishers & Funders, which will enhance #reproducibility. Glad @EMBOPress could contribute policies eg. structured methods with no text limit & text reuse. osf.io/x85gh
-
EMBO Mol. Medicine reposted
Immunology of Infectious Disease News
@infdisease_news
Scientists found that the spleen tyrosine kinase-coupled C-type lectin member 2, which was highly expressed in platelets and alveolar macrophages, interacted with the receptor-binding domain of #sarscov2 spike protein directly. @EmboMolMed
📝 link.springer.com/article/10.15252/emmm.202216351 -
EMBO Mol. Medicine reposted
Frank Zaucke
@FZaucke
Our latest contribution to the field of #osteogenesisimperfecta research has been published in @EmboMolMed
@DFG_FOR2722 @Matrixbiologie @IntSocMatBio
it is open acces and can be found here 👇www.embopress.org/doi/full/10.15252/emmm.202317528 -
EMBO Mol. Medicine reposted
Frank Zaucke
@FZaucke
The latest @FOR2722 publication now online...amazing collaborative effort with @aforlino @David_S_Bristol and many others🥂🍻🍾
EMBO Mol. Medicine
@EmboMolMed
➡️New study that expands the spectrum of #osteogenesisimperfecta -causing TAPT1 mutations & links extracellular matrix changes to signaling regulation.
By J. Etich, M. Rehrberg & colleagues @UniCologne @goetheuni
🗞️Read #openaccess: doi.org/10.15252/emmm.202317528 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
reformatting for biomed jnls costs ~US$230 million + delays & frustration. Why not chose format free submission @embojournal @emboreports @EmboMolMed @MolSystBiol @LSAjournal? light formatting & data checklists are sorted in final revision at acceptance www.nature.com/articles/d41586-023-01846-9
-
EMBO Mol. Medicine
@EmboMolMed
➡️New study that expands the spectrum of #osteogenesisimperfecta -causing TAPT1 mutations & links extracellular matrix changes to signaling regulation.
By J. Etich, M. Rehrberg & colleagues @UniCologne @goetheuni
🗞️Read #openaccess: doi.org/10.15252/emmm.202317528 -
EMBO Mol. Medicine
@EmboMolMed
☀️Our June issue is online!
On the cover, the work by PC Yang, CY Chen & al. that links #airpollution & #lungcancer -> possible explanation for increased lung cancer in non-smokers🫁
Check also our editorial on EMM scope expansion!
#environmentalhealth
www.embopress.org/toc/17574684/2023/15/6 -
EMBO Mol. Medicine reposted
Michael Chung
@Avastin_33
Finally got my first publication as a scientist in @EmboMolMed!! It’s a review surrounding IgD-CD27- Double-Negative B cells and their roles in different diseases, including #sle, #covid19 and #nsclc!!
Read here: www.embopress.org/doi/full/10.15252/emmm.202217341 -
EMBO Mol. Medicine
@EmboMolMed
#maternaldiet and #gutmicrobiome composition modulate early-life immune development
By E. Grant, M. Desai & colleagues @LIH_Luxembourg
👉doi.org/10.15252/emmm.202217241 -
EMBO Mol. Medicine
@EmboMolMed
#aav induces hepatic necroptosis and carcinoma in #diabetic and #obese mice dependent on Pebp1 pathway
By Y. Cheng, Z. Zhang, Q. Zhai & colleagues at University of Chinese Academy of Sciences
🗞️doi.org/10.15252/emmm.202217230 -
EMBO Mol. Medicine
@EmboMolMed
New review on the functions of double-negative #bcells in #autoimmunediseases, #infections, and #cancers!
By N-W Kam, W Dai & colleagues at University of Hong Kong
Read #openaccess: doi.org/10.15252/emmm.202217341 -
EMBO Mol. Medicine reposted
Dermal Cell News
@DermalCell
👀 New #psoriasis research in @EmboMolMed — check it out!
EMBO Mol. Medicine
@EmboMolMed
FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice
By B. Malik, A. Csiszar & colleagues @MedUni_Wien
#psoriasis #keratinocyte #skinlesions
Read #openaccess: doi.org/10.15252/emmm.202216758 -
EMBO Mol. Medicine
@EmboMolMed
Read new #openaccess commentary on the development & potential clinical translation of the #cas13 -based #antiviraltherapies.
By S. Sharma & C. Myhrvold @Princeton
👉doi.org/10.15252/emmm.202217146 -
EMBO Mol. Medicine
@EmboMolMed
FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice
By B. Malik, A. Csiszar & colleagues @MedUni_Wien
#psoriasis #keratinocyte #skinlesions
Read #openaccess: doi.org/10.15252/emmm.202216758 -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
Learn more about the principles + practicalities of #peerreview amongst other topics in an interactive setting with Martina Rembold, Senior #editor @emboreports @embopress. Sign up now for the “How to review a scientific paper” workshop on 27-28 June 2023 lab-management.embo.org/dates/review
-
EMBO Mol. Medicine reposted
Irene Liparulo
@IreLiparulo
📚 Excited to have contributed to this paper during my visiting research period @WeillCornell 🔬doi.org/10.15252/emmm.202216951 @EmboMolMed @Mito_News
-
EMBO Mol. Medicine
@EmboMolMed
Online today! A coordinated multiorgan #metabolicresponse contributes to human #mitochondrialmyopathy
By N. Southwell, G. Primiano, Q. Chen, M. D’aurelio & colleagues @WeillCornell @Unicatt
🗞️Read #openaccess: doi.org/10.15252/emmm.202216951 -
EMBO Mol. Medicine
@EmboMolMed
Inhibition of #sarscov2 -mediated #thromboinflammation by CLEC2.Fc 🫁
By P-S Sung, C-P Sun, M-H Tao & S-L Hsieh at Academia Sinica
#openaccess👉doi.org/10.15252/emmm.202216351 -
EMBO Mol. Medicine
@EmboMolMed
Online! Control of #fibrosis with enhanced safety via asymmetric inhibition of prolyl-tRNA synthetase 1
By I. Yoon, S. Kim, K. Y. Hwang, S. Kim & colleagues at Yonsei University and Korea University
🗞️Read #openaccess: doi.org/10.15252/emmm.202216940 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
We're excited for #emblmalaria to begin this morning in Heidelberg! Our @EmboMolMed editor Zeljko Durdevic is attending and interested in meeting with participants both in-person and virtually. @EMBLEvents
www.embl.org/about/info/course-and-conference-office/even… -
EMBO Mol. Medicine
@EmboMolMed
📢EMBO Molecular Medicine is expending its scope!
#environmentalhealth #clinicalstudies #biomedicaltechnologies
Read all about it in new editorial online today👇
doi.org/10.15252/emmm.202317921 -
EMBO Mol. Medicine reposted
Phenomics
@Phenomics_J
Tumor-informed and tumor-naïve assays were developed to compare detection of circulating #tumor #dna in serial plasma samples from patients with stage I–IV #breastcancer!
@EmboMolMed #phenomics
Read more here:
www.embopress.org/doi/full/10.15252/emmm.202216505 -
EMBO Mol. Medicine
@EmboMolMed
Comparison of tumor-informed and tumor-naïve sequencing assays for #ctdna detection in #breastcancer
By A. Santonja, W.N. Cooper, J.E. Abraham, D. Gale & colleagues
#liquidbiopsies
👉Read #openaccess: doi.org/10.15252/emmm.202216505 -
EMBO Mol. Medicine
@EmboMolMed
#oxidativestress enhances the therapeutic action of a respiratory inhibitor in MYC-driven #lymphoma
By G. Donati, B. Amati & colleagues @IEOufficiale
🗞️doi.org/10.15252/emmm.202216910 -
EMBO Mol. Medicine reposted
Immunology of Infectious Disease News
@infdisease_news
This enhanced protection was mediated by ⬆️ increased neutrophilia in the lung, and was independent of trained circulating #monocytes.
#openaccess in @EmboMolMed 👇
EMBO Mol. Medicine
@EmboMolMed
➡️Subcutaneous #bcgvaccination protects against streptococcal #pneumonia via regulating innate immune responses in the lung 🫁
By A. King, Z. Xing & colleagues @McMasterU
Read #openaccess: doi.org/10.15252/emmm.202217084 -
EMBO Mol. Medicine
@EmboMolMed
➡️Subcutaneous #bcgvaccination protects against streptococcal #pneumonia via regulating innate immune responses in the lung 🫁
By A. King, Z. Xing & colleagues @McMasterU
Read #openaccess: doi.org/10.15252/emmm.202217084 -
EMBO Mol. Medicine
@EmboMolMed
Read this #openaccess commentary in which A. Lucas & colleagues @ASU discuss the biological functions of serine protease inhibitors (#serpins) and their therapeutic potential for the treatment of various diseases.
👉doi.org/10.15252/emmm.202217144 -
EMBO Mol. Medicine reposted
Synapse Biology Group | NCBio ERA Chair @i3S_Porto
@AstrocytesRus
Proud to have our work featured as main cover of @EmboMolMed , a successful collaboration with @ys_lidia and @LabListon! @i3S_UPorto @HorizonEU
EMBO Mol. Medicine
@EmboMolMed
💫Our May issue is online!
The beautiful cover highlights the work by @LabListon & colleagues using IL2 #genetherapy to partially reverse ageing-related cognitive decline in mice
Read also on #neurodegeneration, #sarscov2, #cancer, #retinopathy & more!
🗞️www.embopress.org/toc/17574684/2023/15/5 -
EMBO Mol. Medicine
@EmboMolMed
Read ➡️Microbial metabolites in #chronicheartfailure and its common comorbidities
#diabetes #chronickidneydisease #cardiometabolicdiseases
By Hao Wu, Wei Jin & colleagues, Shanghai, China
🗞️ doi.org/10.15252/emmm.202216928 -
EMBO Mol. Medicine
@EmboMolMed
#skeletalmuscle delimited #myopathy and verapamil toxicity in SUR2 mutant mouse models of AIMS
By C. McClenaghan, C. G. Nichols & colleagues @WUSTLmed
👉Read #openaccess: doi.org/10.15252/emmm.202216883 -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
We offer scientific skills training on #researchintegrity, #research #communication, #peerreview and applying #design principles to figures. New course dates are now available: lab-management.embo.org/dates @emboreports @embojournal @MolSystBiol @EmboMolMed @EMBO @EMBOpress
-
EMBO Mol. Medicine
@EmboMolMed
💫Our May issue is online!
The beautiful cover highlights the work by @LabListon & colleagues using IL2 #genetherapy to partially reverse ageing-related cognitive decline in mice
Read also on #neurodegeneration, #sarscov2, #cancer, #retinopathy & more!
🗞️www.embopress.org/toc/17574684/2023/15/5 -
EMBO Mol. Medicine reposted
Adrian Liston
@LabListon
Our paper on using #genedelivery of #il2 to the #ageing #brain now has the cover image at @EmboMolMed!
Take a look at the paper here - a new therapeutic option to halt cognitive decline with #age.
www.embopress.org/doi/full/10.15252/emmm.202216805 -
EMBO Mol. Medicine reposted
Bomont Pascale
@PascaleBomont
So excited to see this online🌈🌈🌈On top of amazing authors (@LeaLescouzeres from my lab) & the great scientific adventure, this was one of my my best experience with a top editorial office & helpful reviewers 🌈🌈🌈 @ZebrafishRock
-
EMBO Mol. Medicine reposted
Léa Lescouzères
@LeaLescouzeres
It is a GREAT joy to announce that our last paper in @EmboMolMed is out today! 🔬
👉“A multilevel screening pipeline in #zebrafish identifies therapeutic drugs for #giantaxonalneuropathy”
🗞️ doi.org/10.15252/emmm.202216267 -
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉A multilevel screening pipeline in #zebrafish identifies therapeutic drugs for GAN
#giantaxonalneuropathy
By L. Lescouzères, @PascaleBomont & colleagues @Inserm @CNRS
🗞️Read #openaccess: doi.org/10.15252/emmm.202216267 -
EMBO Mol. Medicine reposted
CNRS Biologie
@CNRSbiologie
#resultatscientifique🔎| Cancer de la prostate : une nouvelle piste thérapeutique
🤝 @CNRS @CNRS_Alsace @Inserm @unistra
✍️ Daniel Metzger
📕 @EmboMolMed | idp.springer.com/transit?redirect_uri=https%3A%2F%2Flink.…
www.insb.cnrs.fr/fr/cnrsinfo/cancer-de-la-prostate-une-no… -
EMBO Mol. Medicine reposted
North East & Yorkshire Genomics
@NEYGenomics
Researchers have identified a link between harmful variants of the #gene #top3a, and the severity of #mitochondrial disease, which could lead to more accurate diagnoses and care for patients.
You can read more about this research here: ney-genomics.org.uk/new-research-could-help-to-diagnose-p… -
EMBO Mol. Medicine reposted
Ine Koeken
@KoekenIne
What an honour to win the poster prize at EMBO workshop on ferroptosis!
All with the support of @TomVBerghe and the VandenBerghe Lab 💪🏻
@EMBO #ferroptosis
Caroline
@CaroMedChem
Congratulations to @KoekenIne for the best poster award at the EMBo workshop on ferroptosis 👏👏👏👏
Cc @TomVBerghe -
EMBO Mol. Medicine reposted
Caroline
@CaroMedChem
Congratulations to @KoekenIne for the best poster award at the EMBo workshop on ferroptosis 👏👏👏👏
Cc @TomVBerghe -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Submit your application by April 30th for the position of Scientific Editor at @embojournal! Backgrounds in #neuroscience and #immunology particularly encouraged.
www.embo.org/about-embo/work-for-us/ -
EMBO Mol. Medicine reposted
Phenomics Australia
@phenomics
Kudos @FilipovskaLab @DanielleRudler @TheRackhamLab @Es_Marcellin @kara_perks31 et al 👏😀
Another great use of #phenomicsaustralia #researchinfrastructure
#rna #ncrna #prostatecancer #ncrisimpact
@telethonkids @nhmrc @UWAresearch @PerkinsComms @ARC_CoESB @EmboMolMed
Aleksandra Filipovska
@FilipovskaLab
Defects in noncoding RNA processing activate tumorigenic pathways and identify an ELAC2 variant as a predisposing factor for prostate cancer.
Multi-omic profiling reveals changes that underly prostate tumorigenesis. #rna #ncrna
www.embopress.org/doi/10.15252/emmm.202317463 -
EMBO Mol. Medicine reposted
Oliver Rackham
@TheRackhamLab
Variation in a protein that orchestrates mitochondrial and nuclear tRNA processing predisposes to prostate cancer:
doi.org/10.15252/emmm.202317463
#mitochondria #cancer -
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉Multi-omic profiling reveals an #rnaprocessing rheostat that predisposes to #prostatecancer
By M. Stentenbach, A. Filipovska & colleagues @FilipovskaLab @PerkinsComms
🗞️Read #openaccess: doi.org/10.15252/emmm.202317463 -
EMBO Mol. Medicine reposted
Prostate Cell News
@ProstateCell
Resistance development to #androgen deprivation therapy in #prostatecancer patients is a major clinical issue.
New study has found a promising target 🎯 for treatment - HIF1A signaling.
Learn more at @EmboMolMed:
📑 link.springer.com/article/10.15252/emmm.202217209 -
EMBO Mol. Medicine
@EmboMolMed
Molecular & functional properties of human #plasmodiumfalciparum CSP C-terminus antibodies
By JP Julien, E Levashina, H Wardemann & labs @DKFZ @maxplanckpress @SickKidsNews @UofT
🗞️: doi.org/10.15252/emmm.202317454
👉Read also commentary by J Murdoch & J Baum: doi.org/10.15252/emmm.202317556 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
We announced recently that @SpringerNature will publish our journals from 2024. If you have experience in scientific publishing and great project management skills, consider applying to onboard and manage @embojournal @emboreports @MolSystBiol @EmboMolMed!
careers.springernature.com/job/Heidelberg-Project-Manager… -
EMBO Mol. Medicine
@EmboMolMed
Online today! #axin2 coupled excessive Wnt-glycolysis signaling mediates social defect in #autismspectrumdisorders
By Y. Wang, S. Wu & colleagues at Xi’an, China
👉 #openaccess: doi.org/10.15252/emmm.202217101 -
EMBO Mol. Medicine
@EmboMolMed
Join @EmboMolMed editor Lise Roth @KeystoneSymp
#pulmonary #hypertension: State of the Art and Therapeutic Opportunities #kspulmonary23
Get in touch!
EMBO Press
@EMBOPress
Scholarship and abstract deadline is today @KeystoneSymp #pulmonary #hypertension: State of the Art and Therapeutic Opportunities. Register & info 👉 keysym.us/KSPulmonary23
#kspulmonary23 #pulmonarydisease #hypertension -
EMBO Mol. Medicine
@EmboMolMed
J. Schimenti & X. Ding discuss the study by Weijie Wang et al that reports novel pathogenic variants in PABPC1L that cause #oocytematuration arrest and #femaleinfertility.
👉#openaccess: doi.org/10.15252/emmm.202317729
Full article: doi.org/10.15252/emmm.202217177 -
EMBO Mol. Medicine
@EmboMolMed
Read 🗞️ #openaccess: doi.org/10.15252/emmm.202115352
H1 Connect
@H1Connect
Coughs and sneezes: Markus Engstler and Brooke Morriswood @ZEB_UniWue recommend this commentary by Gabriele Neumann & Yoshihiro Kawaoka @UWMadison in @EmboMolMed on what causes the seasonality of respiratory #viruses, e.g., #influenza and #sarscov2
facultyopinions.com/article/742014250 -
EMBO Mol. Medicine reposted
IGBMC
@IGBMC
👨🔬👩🔬 New article from @lab_metzger on a new potential therapeutic approach to prostate cancer : inhibiting Hif1a to allow tumors to regress and fight against resistance to treatments.
📕 @EmboMolMed
📰 www.igbmc.fr/igbmc/article/cancer-de-la-prostate-une-nouv…
✏ @JulieTerzic
EMBO Mol. Medicine
@EmboMolMed
#hif1a inhibition overcomes castration resistance of prostate tumors
By J. Terzic, M. el Maaty, D. Metzger & colleagues @IGBMC
#prostatecancer
👉doi.org/10.15252/emmm.202217209 -
EMBO Mol. Medicine
@EmboMolMed
#hif1a inhibition overcomes castration resistance of prostate tumors
By J. Terzic, M. el Maaty, D. Metzger & colleagues @IGBMC
#prostatecancer
👉doi.org/10.15252/emmm.202217209 -
EMBO Mol. Medicine
@EmboMolMed
📢#raf1 deficiency causes a lethal syndrome that underscores RTK signaling during #embryogenesis
By H. Kayserili, N. Escande-Beillard, B. Reversade & colleagues @ASTARsg @kocuniversity
🗞️Read #openaccess: doi.org/10.15252/emmm.202217078 -
EMBO Mol. Medicine reposted
AnnemiekeAartsma-Rus
@oligogirl
#apaperaday Neurodegenerative themed again because yesterday I visited @DZNE_de Today's pick is a cool (pun intended) paper on temperature and splicing controlled RBM3 expression as a neuroprotective mechanism published in @EmboMolMed . DOI: 10.15252/emmm.202217157
-
EMBO Mol. Medicine
@EmboMolMed
Bi-allelic pathogenic variants in PABPC1L cause #oocyte maturation arrest and #femaleinfertility
By Ge Lin, Lei Wang & colleagues, Shanghai, China
🗞️Read #openaccess: doi.org/10.15252/emmm.202217177 -
EMBO Mol. Medicine
@EmboMolMed
🌷Our April issue is online!
This month's cover highlights an article on #shearstress control of vascular leaks & #atheromas
Read also: articles on #breastcancer, #neuralstemcells, #prematureovarianinsufficiency, #psoriasis, #cln1 & more!
🗞️#openaccess: www.embopress.org/toc/17574684/2023/15/4 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Come work with us! @embojournal is recruiting a scientific editor with a background in #immunology or #neuroscience. Apply by April 30th => www.embl.org/jobs/position/EMBO00143
-
EMBO Mol. Medicine reposted
StrickerLab
@StrickerLab
Great work from our @fubcp colleagues!
EMBO Mol. Medicine
@EmboMolMed
Gene therapy approach to boost 'cold shock protein' in the brain without cooling protects mice against neurodegenerative disease shar.es/afIZjj
-
EMBO Mol. Medicine
@EmboMolMed
Online today! Pathological variants in TOP3A cause distinct disorders of mitochondrial & nuclear genome stability
By D. Erdinc, A. Rodríguez-Luis, T.J. Nicholls & colleagues @StudentsNCL @goteborgsuni
#mitochondrialdisease #top3a
🗞️👉doi.org/10.15252/emmm.202216775 -
EMBO Mol. Medicine reposted
Marco Preußner
@pre_mRCO
Hypothermia in a syringe: Manipulation of RBM3 alternative splicing using antisense RNA therapeutics prevents neurodegeneration at normal temperature. Check our article with @MallucciLab and @OmiqaBio in @EmboMolMed Link: doi.org/10.15252/emmm.202217157
-
EMBO Mol. Medicine reposted
Geneva Centre for Inflammation Research
@GCIR_Unige
Read in @EmboMolMed about the role of #brain-specific IL-2 as a #neuroprotective agent!
Adrian Liston
@LabListon
Paper time! We have a new #aging #neuroimmunology study out at @EmboMolMed!
Fantastic work from Pierre Lemaitre, @SamarTareen
and @EmanuelaPasciu1, collaborating with the labs of @ys_lidia and Matthew Holt, at @KU_Leuven, @i3S_UPorto, @VIBLifeSciences and @BabrahamInst. 1/5 -
EMBO Mol. Medicine
@EmboMolMed
Brain p3-Alcβ peptide restores neuronal viability impaired by Alzheimer's #amyloidβ -peptide.
#alzheimersdisease 🧠
By Y. Ouchi, T. Suzuki & colleagues @HokkaidoUni & University School of Medicine, Hamamatsu, Japan
🗞️Read #openaccess: doi.org/10.15252/emmm.202217052 -
EMBO Mol. Medicine reposted
Synapse Biology Group | NCBio ERA Chair @i3S_Porto
@AstrocytesRus
Ever heard about #inflammaging?Have a 👀at our freshly published paper at @EmboMolMed where immune modulation may be a path to preserving cognitive function for healthy aging. Thanks to our collaborators @LabListon @ys_lidia🤝
📌bit.ly/3TSJDGb -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Starting in 2024, @EMBO and @SpringerNature will cooperate to publish EMBO’s scientific publications: @embojournal @emboreports @MolSystBiol @EmboMolMed.
Read the press release: www.embo.org/press-releases/springer-nature-and-embo-coop…
#openaccess #openscience #sourcedata #publishing -
EMBO Mol. Medicine
@EmboMolMed
👉#tfeb and #tfe3 drive #kidney #cystogenesis and #tumorigenesis
By W.M. Linehan, A. Ballabio & colleagues @Tigem_Telethon @NIH @bcmhouston
🗞️Read #openaccess: doi.org/10.15252/emmm.202216877 -
EMBO Mol. Medicine reposted
Adrian Liston
@LabListon
Paper time! We have a new #aging #neuroimmunology study out at @EmboMolMed!
Fantastic work from Pierre Lemaitre, @SamarTareen
and @EmanuelaPasciu1, collaborating with the labs of @ys_lidia and Matthew Holt, at @KU_Leuven, @i3S_UPorto, @VIBLifeSciences and @BabrahamInst. 1/5 -
EMBO Mol. Medicine
@EmboMolMed
Gene therapy approach to boost 'cold shock protein' in the brain without cooling protects mice against neurodegenerative disease shar.es/afIZjj
-
EMBO Mol. Medicine
@EmboMolMed
Molecular and cognitive signatures of #ageing partially restored through synthetic delivery of #il2 to the brain
By M.G. Holt, L. Yshii, A. Liston @LabListon & colleagues @CBD_VIB
👉Read #openaccess: doi.org/10.15252/emmm.202216805 -
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉 PM2.5 promotes #lungcancer progression through activation of the AhR-TMPRSS2-IL18 pathway
By PC Yang, CY Chen & colleagues at Academia Sinica & Taiwan University, Taiwan
#particulatematter2.5
🗞️Read #openaccess: doi.org/10.15252/emmm.202217014 -
EMBO Mol. Medicine reposted
Anna Obenauf
@obenaufa
Super proud of #lukasleiendecker for a beautiful PhD thesis #defense, presenting his 2 first-author papers on virus-driven cancers MCC @EmboMolMed and HPV42 @CD_AACR and for winning two major #awards pubmed.ncbi.nlm.nih.gov/36213965/ www.imp.ac.at/news/article/egon-macher-award-for-lukas-le… he will be greatly missed!
-
EMBO Mol. Medicine
@EmboMolMed
L Iruela-Arispe @ArispeLab discusses the study by Niaudet et al @hlatim: #s1pr1 activation blocks abnormal permeability, neovascular tuft development & resolves pathological #vascularlesions due to hypoxia-driven #retinopathy
👉doi.org/10.15252/emmm.202317520
🗞️ doi.org/10.15252/emmm.202216645 -
EMBO Mol. Medicine reposted
Hepatic Cell News
@hepaticcellnews
🚨 New research published in @EmboMolMed uncovers a crucial role of the WD-repeat family in #hcc progression, affecting the immune microenvironment by targeting UVRAG and promoting tumor growth.
Learn more:
➡️ link.springer.com/article/10.15252/emmm.202215924 -
EMBO Mol. Medicine
@EmboMolMed
Targeting WDxR motif reprograms #immunemicroenvironment and inhibits #hepatocellularcarcinoma progression
By Z. Zhang, Q. Li, X. Fan & colleagues
🗞️doi.org/10.15252/emmm.202215924 -
EMBO Mol. Medicine
@EmboMolMed
Online today👉 Nirmatrelvir treatment of #sarscov2 -infected mice blunts antiviral adaptive immune responses
By V. Fumagalli, L. Guidotti, M. Iannacone & colleagues @iannaconelab @SanRaffaeleMI
🗞️Read #openaccess: doi.org/10.15252/emmm.202317580 -
EMBO Mol. Medicine reposted
Iannacone Lab
@iannaconelab
Happy to share our latest paper (www.embopress.org/doi/full/10.15252/emmm.202317580), spearheaded by star postdoc @ValeFuma91, where we show that nirmatrelvir blunts antiviral adaptive immune responses in SARS-CoV-2 infected mice. A thread 🧵👇1/12
-
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
We're hiring! If you want to join our great #embolablead team as a 1. trainer or 2. a strategist/project manager, do apply 🙏. We'd love to talk about how you could contribute to our work with life scientists: Trainer: www.linkedin.com/jobs/view/3533289022/ Strategist: www.linkedin.com/jobs/view/3533285956/
-
EMBO Mol. Medicine reposted
Ralser Lab
@RalserLab
Protein biomarker panels offer a more comprehensive view of human physiology, but integrating them into clinical practice has been limited. Please read our contribution @EmboMolMed , discussing some reasons and solutions #precisionmedicine #proteomics doi.org/10.15252/emmm.202216061
-
EMBO Mol. Medicine reposted
EMBO
@EMBO
The EMBO Journal and EMBO Reports will switch from encouraging to applying #openaccess to all published papers. Papers published in @EMBOPress journals will include source data and data availability sections. Data and #preprint-citation will be encouraged.
www.embo.org/press-releases/embo-press-to-be-fully-open-a… -
EMBO Mol. Medicine
@EmboMolMed
New Commentary by M. Ralser (@RalserLab) & collaborators on the importance of quantitative protein biomarker panels in clinical medicine & challenges that must be addressed
#proteomics #proteinbiomarkers
Read 🗞️#openaccess: doi.org/10.15252/emmm.202216061 -
EMBO Mol. Medicine
@EmboMolMed
D. Slade & J. Loizou discuss the study by L. Planas-Paz et al. that identifies HRDness in #sarcoma subtypes & shows the benefit of combining #dnadamagingagents & inhibitors of #dnarepairpathways in these subtypes
👉 doi.org/10.15252/emmm.202317453
👉Full 🗞️: doi.org/10.15252/emmm.202216863 -
EMBO Mol. Medicine reposted
Pavel Tomancak
@PavelTomancak
@EMBOPress is the unsung hero of reform in scientific publishing. Look at the track record! Taken from PR announcing move towards #openaccess for all journals.
www.embo.org/press-releases/embo-press-to-be-fully-open-a…
Open consultative #peerreview, #sourcedata, @ReviewCommons Looking forward to what comes next -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
📢All @EMBOPress journals to be fully #openaccess from 1 January 2024 and include the #sourcedata that were used to generate figures in published papers.
www.embo.org/press-releases/embo-press-to-be-fully-open-a… -
EMBO Mol. Medicine
@EmboMolMed
Bi-allelic mutation in SEC16B alters #collagen trafficking and increases #erstress
By A. El-Gazzar, W. Högler & colleagues @jkulinz @unibirmingham
👉Read #openaccess: doi.org/10.15252/emmm.202216834 -
EMBO Mol. Medicine reposted
DrawImpacts
@DrawImpacts
🆕 New @EmboMolMed cover from the studio!
"Gut microbiota dysfunctions in myopathies"🦠 #sciart #drawimpacts
Learn more 👉www.embopress.org/toc/17574684/2023/15/3
EMBO Mol. Medicine
@EmboMolMed
📢March issue online!
The cover highlights 2 articles on #gutmicrobiota dysfunctions in #myopathies
Read a review on peritoneal #metastases & articles on #melanoma, #alcoholicliverinjury, #diabetes, #multiplesulfatasedeficiency, #braintumors & more!
🗞️www.embopress.org/toc/17574684/2023/15/3 -
EMBO Mol. Medicine
@EmboMolMed
👁️Therapeutic activation of endothelial sphingosine-1-phosphate receptor 1 by chaperone-bound S1P suppresses proliferative #retinalneovascularization
By C. Niaudet, T. Hla @hlatim & colleagues @BostonChildrens @harvardmed
🗞️#openaccess: doi.org/10.15252/emmm.202216645 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Specific associations between #plasmabiomarkers and postmortem #amyloidplaque and tau tangle loads 🧠
By G. Salvado, O. Hansson & colleagues @lunduniversity
➡️Read #openaccess: doi.org/10.15252/emmm.202217123 -
EMBO Mol. Medicine
@EmboMolMed
Macrophage #dclk1 promotes #atherosclerosis via binding to IKKβ and inducing #inflammatoryresponses
By Z. Huang, G. Liang & colleagues at Wenzhou Medical University
🗞️Read #openaccess: doi.org/10.15252/emmm.202217198 -
EMBO Mol. Medicine
@EmboMolMed
F. Wang & D. Pei discuss the study by Carvajal Ibanez et al @EmboMolMed that investigates the connection between #interferon signaling and neural #stemcell functions.
👉Read #openaccess: doi.org/10.15252/emmm.202217307
👉Full research article: doi.org/10.15252/emmm.202216434 -
EMBO Mol. Medicine
@EmboMolMed
📢March issue online!
The cover highlights 2 articles on #gutmicrobiota dysfunctions in #myopathies
Read a review on peritoneal #metastases & articles on #melanoma, #alcoholicliverinjury, #diabetes, #multiplesulfatasedeficiency, #braintumors & more!
🗞️www.embopress.org/toc/17574684/2023/15/3 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Our @EmboMolMed editor Lise Roth is participating in this week's @KeystoneSymp #cancerimmunotherapy: Mechanisms of Response versus Resistance. Visit our virtual booth via the conference app to make an appointment to discuss your research!
#kscancerimmuno23 -
EMBO Mol. Medicine reposted
CNIO Stop Cancer
@CNIOStopCancer
‼️ New paper
@EmboMolMed by @EGlezSuarezlab
@CNIOStopCancer @idibell_cat
The study supports the therapeutic benefit of denosumab in postmenopausal patients with hormone-receptor negative breast tumours and RANK protein expression.
👇
www.cnio.es/en/news/cnio-news/cnio-researchers-propose-bi… -
EMBO Mol. Medicine
@EmboMolMed
#rank is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal #breastcancer.
By M. Ciscar, E.M. Trinidad, E. Gonzalez-Suarez & colleagues @CNIOStopCancer
🗞️doi.org/10.15252/emmm.202216715
Read also www.cnio.es/en/news/cnio-news/cnio-researchers-propose-bi… -
EMBO Mol. Medicine
@EmboMolMed
CNIO researchers propose #biomarkers to select #breastcancer patients who could benefit from #denosumab treatment
@CNIOStopCancer
➡️www.cnio.es/en/news/cnio-news/cnio-researchers-propose-bi…
🗞️Read full #openaccess article: doi.org/10.15252/emmm.202216715 -
EMBO Mol. Medicine
@EmboMolMed
Online today! An innovative #hematopoieticstemcell #genetherapy approach benefits #cln1 disease in the mouse model
By M. Peviani, A. Biffi & colleagues @DanaFarber @BostonChildrens @UniPadova
➡️#openaccess: doi.org/10.15252/emmm.202215968 -
EMBO Mol. Medicine
@EmboMolMed
From #netrin1 -targeted SPECT/CT to internal #radiotherapy for management of advanced #solidtumors
By D. Kryza, P. Mehlen, D. Sarrut, B. Gibert & colleagues @UnivLyon1 @CLCCLeonBerard @Inserm @CNRS
🗞️#openaccess: doi.org/10.15252/emmm.202216732 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
In the latest newsletter: @EMBO pays APCs for qualifying authors, a call for more creativity in research, reviewed preprints for @EMBOPress papers, outreach to Chinese scientists, 40 years of @embojournal papers and a collection of fresh #podcasts.
www.embopress.org/newsletter -
EMBO Mol. Medicine
@EmboMolMed
➡️Metabolic rewiring in keratinocytes by miR-31-5p identifies therapeutic intervention for #psoriasis
By RY Huang, CJ Lu, B. Burgering & colleagues @oncodeinstitute & Guangzhou University of Chinese Medicine
🗞️#openaccess: doi.org/10.15252/emmm.202215674 -
EMBO Mol. Medicine
@EmboMolMed
P Gissen and B Şeker Yilmaz discuss novel liver-directed #genetherapy for #gyrateatrophy of the choroid and retina due to ornithine aminotransferase deficiency, as reported by @brunetti_pierri & colleagues.
👉doi.org/10.15252/emmm.202217285
🗞️Related article: doi.org/10.15252/emmm.202217033 -
EMBO Mol. Medicine
@EmboMolMed
A Jayaraman and S Pettersson discuss the studies by Farini et al & Kalkan et al that independently reported the role of #gutmicrobiota in pathogenesis of #duchennemusculardystrophy
🗞️doi.org/10.15252/emmm.202217324
Full articles 👇
doi.org/10.15252/emmm.202216225
doi.org/10.15252/emmm.202216244 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Early registration deadline is March 7 for @KeystoneSymp The Resistant #tumormicroenvironment. Join @EmboMolMed's Lise Roth at this meeting in Vancouver!
For info & to register 👉 www.keystonesymposia.org/conferences/conference-listing/m… #kstumorresist23 #tumorresistance #microenvironment -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
Scientific editors from @EMBOpress help develop + deliver scientific skills training on #peerreview, writing & presenting research and #researchintegrity. Places still available on upcoming courses: lab-management.embo.org/dates @emboreports @embojournal @MolSystBiol @EmboMolMed @EMBO
-
EMBO Mol. Medicine
@EmboMolMed
➡️#nanobody -mediated complement activation to kill #hiv -infected cells
By M.L. Pedersen, M. Tolstrup & colleagues @AarhusUni_int
🗞️Read #openaccess: doi.org/10.15252/emmm.202216422 -
EMBO Mol. Medicine reposted
Eva Gonzalez-Suarez lab
@EGlezSuarezlab
Yes! Manuscript accepted in @EmboMolMed! Thanks to the persistence of Marina Ciscar, Eva Trinidad, Gema Perez Chacon and many others. Team work.
-
EMBO Mol. Medicine
@EmboMolMed
#drugscreening identifies #tazarotene and #bexarotene as therapeutic agents in #multiplesulfatasedeficiency
By L. Schlotawa, J. Gärtner & colleagues @uniGoettingen
🗞️#openaccess: doi.org/10.15252/emmm.202114837 -
EMBO Mol. Medicine
@EmboMolMed
📢Our February issue is online !
Review on #panethcells, articles on #alzheimersdisease, #stroke, #cadasil, #leukemia, #qfever, #chronickidneydisease, #diabeticwoundhealing (our cover) & more!
👉Read 🗞️fully #openaccess: embopress.org/toc/17574684/2 -
EMBO Mol. Medicine reposted
Louis-Jeantet Foundation / Fondation Louis-Jeantet
@LouisJeantetFDN
IVAN ĐIKIĆ @iDikic2 @goetheuni @IBC2_GU and BRENDA SCHULMAN @MPI_Biochem will share the 2023 Louis-Jeantet Prize for Medicine for their contributions to our understanding of the functions of ubiquitin and the mechanisms of ubiquitination.
👉www.jeantet.ch/en/prix-louis-jeantet/laureats/2023-en/dik… -
EMBO Mol. Medicine reposted
Louis-Jeantet Foundation / Fondation Louis-Jeantet
@LouisJeantetFDN
DARIO ALESSI @mrcppu is awarded the 2023 Jeantet-Collen Prize for Translational Medicine for elucidating molecular bases of neurodegenerative disorders and developing novel approaches to therapeutic intervention in Parkinson’s disease.
👉 www.jeantet.ch/en/prix-louis-jeantet/laureats/2023-en/dar… -
EMBO Mol. Medicine reposted
Louis-Jeantet Foundation / Fondation Louis-Jeantet
@LouisJeantetFDN
📢 The Louis-Jeantet Foundation is happy to announce the 2023 #louisjeantetprizes, awarded to DARIO ALESSI @mrcppu and jointly to IVAN ĐIKIĆ @iDikic2 @goetheuni @IBC2_GU and BRENDA SCHULMAN @MPI_Biochem
CONGRATULATIONS!
👉 www.jeantet.ch/en
👇 follow thread -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
Places are still available for the online "How to review a scientific paper" course next month. Register now to avoid disappointment: lab-management.embo.org/dates/review @EMBO @EmboMolMed @EMBOPress
EMBO Lab Leadership
@LifeSciLearn
Learn more about the principles + practicalities of #peerreview amongst other topics in an interactive setting with Lise Roth, Senior Editor @EmboMolMed @embopress. Sign up for the “How to review a scientific paper” workshop on 14-15 March 2023 lab-management.embo.org/dates/review @EMBO
-
EMBO Mol. Medicine
@EmboMolMed
Online today ➡️ Unravelling #homologousrecombinationrepair deficiency & therapeutic opportunities in soft tissue and bone #sarcoma
By L. Planas-Paz, A. Pliego-Mendieta, C. Pauli & colleagues @Unispital_USZ @UZH_en
🗞️Read #openaccess: doi.org/10.15252/emmm.202216863 -
EMBO Mol. Medicine reposted
Hao Yin
@HaoYin20
#laminarshear pushes VE-PTP (How?🤓) to downstream pole of #endothelialcell, followed by endocytosis->⏫p-Tie2
Potentially explain how #disturbedflow⏫#vascularpermeability & #atherosclerosis
Dr. Donald McDonald & Dietmar Vestweber labs @EmboMolMed 2023
www.embopress.org/doi/full/10.15252/emmm.202216128 -
EMBO Mol. Medicine reposted
Dra. Alba Tristán-Noguero
@AlbaAlbot
Happy to anounce that our work is finally out in @EmboMolMed!🥳🥳
We have generated the first iPSC THD model that recapitulates disease phenotype and replicates patients response to treatment. @ConsiglioLab @idibell_cat @AGarciaCazorla @IRSJD_info @la_marato @AsocDeNeu
EMBO Mol. Medicine
@EmboMolMed
#ipsc-based modeling of Tyrosine hydroxylase deficiency (THD) recapitulates disease phenotypes and reveals neuronal malformation
By À. García-Cazorla, A. Consiglio & colleagues @IBUB_UB @idibell_cat @IRSJD_info
Read #openaccess: doi.org/10.15252/emmm.202215847 -
EMBO Mol. Medicine reposted
MedUni Wien
@MedUni_Wien
Therapy for human #braintumours 🧠➜ Find out how a whole-genome scan for #artemisinin cytotoxicity reveals the novel therapy option. #openaccess in @EmboMolMed! ➡️ link.springer.com/article/10.15252/emmm.202216959
#medunivienna, @LisaGblr, @andreaspeyrl, @IMBA_Vienna, @UBC, @viennabiocenter
Johannes Gojo
@gojojohannes
Happy to share our latest study on novel therapies against high-risk brain tumors led by JM Penninger @IMBA_Vienna.
Fantastic use of our patient-derived tumor models @MedUni_Wien to prove preclinical activity of novel therapeutic approaches! 🔬👇
EMBO Mol. Medicine
@EmboMolMed
Happy Monday! 🙂
Online today: A whole-genome scan for #artemisinin cytotoxicity reveals a novel therapy for human #braintumors
By J. Taubenschmid-Stowers, JM Penninger & colleagues
@IMBA_Vienna @UBC
🗞️Read #openaccess: doi.org/10.15252/emmm.202216959 -
EMBO Mol. Medicine reposted
Johannes Gojo
@gojojohannes
Happy to share our latest study on novel therapies against high-risk brain tumors led by JM Penninger @IMBA_Vienna.
Fantastic use of our patient-derived tumor models @MedUni_Wien to prove preclinical activity of novel therapeutic approaches! 🔬👇
EMBO Mol. Medicine
@EmboMolMed
Happy Monday! 🙂
Online today: A whole-genome scan for #artemisinin cytotoxicity reveals a novel therapy for human #braintumors
By J. Taubenschmid-Stowers, JM Penninger & colleagues
@IMBA_Vienna @UBC
🗞️Read #openaccess: doi.org/10.15252/emmm.202216959 -
EMBO Mol. Medicine
@EmboMolMed
📢Our February issue is online today!
Review on #panethcells, articles on #alzheimersdisease, #stroke, #cadasil, #leukemia, #qfever, #chronickidneydisease, #diabeticwoundhealing (our cover) & more!
👉Read fully #openaccess: www.embopress.org/toc/17574684/2023/15/2 -
EMBO Mol. Medicine reposted
The Knoblich Lab
@Knoblich_lab
Exciting new study on Artemisinin and its potential use as a novel therapy against brain tumors, demonstrated on our unguided neural organoids amongst other models. Great collaborative work, including Knoblich lab alumnus Shan Bian and Christian Krauditsch.
EMBO Mol. Medicine
@EmboMolMed
Happy Monday! 🙂
Online today: A whole-genome scan for #artemisinin cytotoxicity reveals a novel therapy for human #braintumors
By J. Taubenschmid-Stowers, JM Penninger & colleagues
@IMBA_Vienna @UBC
🗞️Read #openaccess: doi.org/10.15252/emmm.202216959 -
EMBO Mol. Medicine reposted
Dra A. García-Cazorla
@AGarciaCazorla
THD leads to #dopamine depletion, pediatric #parkinsonism and neuronal morphology changes that can be prevented with early L-Dopa treatment. New results from IPSC model. @idibell_cat @ConsiglioLab @SJDbarcelona_es @IRSJD_info
Early treatment is crucial in #neurodevelopment
EMBO Mol. Medicine
@EmboMolMed
#ipsc-based modeling of Tyrosine hydroxylase deficiency (THD) recapitulates disease phenotypes and reveals neuronal malformation
By À. García-Cazorla, A. Consiglio & colleagues @IBUB_UB @idibell_cat @IRSJD_info
Read #openaccess: doi.org/10.15252/emmm.202215847 -
EMBO Mol. Medicine reposted
Antonella Consiglio
@ConsiglioLab
Happy to share our last article in @EmboMolMed
We generated the first iPSCmodel of THD that recapitulates pathological features. The study highlights the importance of prenatal treatment with L-Dopa in cases of THDB.
@AGarciaCazorla @AlbaAlbot @idibell_cat @la_marato @IBUB_UB
EMBO Mol. Medicine
@EmboMolMed
#ipsc-based modeling of Tyrosine hydroxylase deficiency (THD) recapitulates disease phenotypes and reveals neuronal malformation
By À. García-Cazorla, A. Consiglio & colleagues @IBUB_UB @idibell_cat @IRSJD_info
Read #openaccess: doi.org/10.15252/emmm.202215847 -
EMBO Mol. Medicine reposted
JasminSTowers
@JTaubenschmid
A long time in the making – but I am very happy to see our collaborative effort with @penningerlab @IMBA_Vienna finally published in @EMBOMolMed “A whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors” doi.org/10.15252/emmm.202216959
EMBO Mol. Medicine
@EmboMolMed
Happy Monday! 🙂
Online today: A whole-genome scan for #artemisinin cytotoxicity reveals a novel therapy for human #braintumors
By J. Taubenschmid-Stowers, JM Penninger & colleagues
@IMBA_Vienna @UBC
🗞️Read #openaccess: doi.org/10.15252/emmm.202216959 -
EMBO Mol. Medicine reposted
UBC Life Sciences Institute
@ubclifesciences
📢LSI Paper of the day ☀️
From a whole-genome screen of an anti-malarial #artemisinin cytotoxicity to novel therapy for #braintumors By J. Taubenschmid-Stowers, JM Penninger (@penningerlab) & colleagues
@UBC @UBCmedicine @IMBA_Vienna
EMBO Mol. Medicine
@EmboMolMed
Happy Monday! 🙂
Online today: A whole-genome scan for #artemisinin cytotoxicity reveals a novel therapy for human #braintumors
By J. Taubenschmid-Stowers, JM Penninger & colleagues
@IMBA_Vienna @UBC
🗞️Read #openaccess: doi.org/10.15252/emmm.202216959 -
EMBO Mol. Medicine reposted
IMBA imbavienna.bsky.social
@IMBA_Vienna
#justpublished
#artemisinin, the most widely used drug against #malaria, uncovers a critical molecular pathway and a novel therapy for various #brain tumors 🧠
#braincancer #braintumor #glioblastoma
@penningerlab @ubclifesciences
EMBO Mol. Medicine
@EmboMolMed
Happy Monday! 🙂
Online today: A whole-genome scan for #artemisinin cytotoxicity reveals a novel therapy for human #braintumors
By J. Taubenschmid-Stowers, JM Penninger & colleagues
@IMBA_Vienna @UBC
🗞️Read #openaccess: doi.org/10.15252/emmm.202216959 -
EMBO Mol. Medicine
@EmboMolMed
#ipsc-based modeling of Tyrosine hydroxylase deficiency (THD) recapitulates disease phenotypes and reveals neuronal malformation
By À. García-Cazorla, A. Consiglio & colleagues @IBUB_UB @idibell_cat @IRSJD_info
Read #openaccess: doi.org/10.15252/emmm.202215847 -
EMBO Mol. Medicine
@EmboMolMed
#shearstress control of vascular leaks and #atheromas through #tie2 activation by VE-PTP sequestration.
By D. McDonald, D. Vestweber & colleagues at MPI for molecular biomedicine / @UCSFCancer
👉#openaccess: doi.org/10.15252/emmm.202216128 -
EMBO Mol. Medicine
@EmboMolMed
Happy Monday! 🙂
Online today: A whole-genome scan for #artemisinin cytotoxicity reveals a novel therapy for human #braintumors
By J. Taubenschmid-Stowers, JM Penninger & colleagues
@IMBA_Vienna @UBC
🗞️Read #openaccess: doi.org/10.15252/emmm.202216959 -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
Learn more about the principles + practicalities of #peerreview amongst other topics in an interactive setting with Lise Roth, Senior Editor @EmboMolMed @embopress. Sign up for the “How to review a scientific paper” workshop on 14-15 March 2023 lab-management.embo.org/dates/review @EMBO
-
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉Mutated #axonguidance gene #plxnb2 sustains growth and invasiveness of stem cells isolated from #cancerofunknownprimary
By @GiraudoEnrico, L. Tamagnone & colleagues
@fpoirccs @unito @Unicatt
🗞️Read #openaccess: doi.org/10.15252/emmm.202216104 -
EMBO Mol. Medicine
@EmboMolMed
Targetable Brg1-CXCL14 axis contributes to alcoholic #liverinjury by driving #neutrophil trafficking
By Z. Li, Z. Fan, Y. Xu & colleagues at Nanjing University
👉Read #openaccess: doi.org/10.15252/emmm.202216592 -
EMBO Mol. Medicine
@EmboMolMed
JA Sahel & B Rosin discuss the recent study by Kong et al: inhibiting #hif2α & protecting mitochondrial function via #αKetoglutarate supplementation may delay the progression of retinal degeneration in the clinic
👉doi.org/10.15252/emmm.202217259
Full 🗞️: doi.org/10.15252/emmm.202216525 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Register today to join @EmboMolMed editor Lise Roth at the @Fusion_Conf Animal Models of Cancer Confernce this July! We are pleased to sponsor #amc23 with a poster prize.
Fusion Conferences
@Fusion_Conf
1 week left to submit an abstract for #amc23! Remaining talk slots will be filled from abstract submissions, so don't miss out on joining our incredible line up of speakers in Portugal!
📆Talk submission: 06 Feb 2023
🌐www.fusion-conferences.com/conference/147 @SageJulien @KevinHaigisLab -
EMBO Mol. Medicine reposted
DiseaseGenes
@DiseaseGenes
RT @JamesFasham: #morbidgene - CFID is an AR cause of infancy-onset diabetes & developmental delay
Super work @DrElisaDeFranco @Exeter_Diabetes @UniofExeterNews
EMBO Mol. Medicine
@EmboMolMed
Infancy-onset #diabetes caused by de-regulated AMPylation of the human #endoplasmicreticulum chaperone BiP
By D. Ron, E. De Franco & colleagues @Cambridge_Uni @UniofExeter
🗞️Read #openaccess: doi.org/10.15252/emmm.202216491 -
EMBO Mol. Medicine reposted
Hematopoiesis News
@Hema_News
Drs. Slim Azouzi and Thierry Peyrard showed that SLC44A2 underlies a novel human blood group system and confirmed the function of SLC44A2 in hearing 👂 preservation.
💡 Learn more in @EmboMolMed | ✔️ link.springer.com/article/10.15252/emmm.202216320 -
EMBO Mol. Medicine
@EmboMolMed
Infancy-onset #diabetes caused by de-regulated AMPylation of the human #endoplasmicreticulum chaperone BiP
By D. Ron, E. De Franco & colleagues @Cambridge_Uni @UniofExeter
🗞️Read #openaccess: doi.org/10.15252/emmm.202216491 -
EMBO Mol. Medicine
@EmboMolMed
Review by S. Bootsma (@SanneBootsma), M. Bijlsma, and L. Vermeulen (@vermeulenlouis1) 👉 overview of the histopathological, genomic, and transcriptomic features of #peritoneal metastases.
@oncodeinstitute
🗞️Fully #openaccess: doi.org/10.15252/emmm.202215914 -
EMBO Mol. Medicine
@EmboMolMed
Lack of the human choline transporter-like protein #slc44a2 causes #hearingimpairment and a rare red #blood phenotype
By B. Koehl. C. Vrignaud, S. Azouzi, T. Peyrard & colleagues
🗞️Read #openaccess: doi.org/10.15252/emmm.202216320 -
EMBO Mol. Medicine
@EmboMolMed
Online today! An in vivo #avianmodel of human #melanoma to perform rapid and robust preclinical studies 🐔
By @CastellaniLab, J. Caramel, C. Delloye-Bourgeois & colleagues @CLCCLeonBerard @Inserm @CNRS
👉Read #openaccess: doi.org/10.15252/emmm.202216629 -
EMBO Mol. Medicine
@EmboMolMed
Thioparib inhibits #homologousrecombinationrepair, activates the #typeiifn response, and overcomes #olaparib resistance.
By JY lang, ZH Miao, A Zhang, JX He & colleagues, Shanghai & Beijing, China
#parpi #cancertherapy
👉doi.org/10.15252/emmm.202216235 -
EMBO Mol. Medicine
@EmboMolMed
Online! A progeroid syndrome caused by a deep intronic variant in TAPT1 is revealed by RNA/SI-NET sequencing.
#progeroid_syndrome
By A. Mayer, B. Reversade & colleagues @ReversadeLab @mayer_lab
🗞️#openaccess: doi.org/10.15252/emmm.202216478 -
EMBO Mol. Medicine reposted
Tigem Telethon
@Tigem_Telethon
Check out our last publication by @brunetti_pierri & al on Liver-directed #genetherpay for ornithine aminotransferase deficiency
www.embopress.org/doi/full/10.15252/emmm.202217033 -
EMBO Mol. Medicine reposted
Bio-Techne Spatial
@bt_spatial
Chang et. al. @EMBOMolMed (2022) demonstrated the use of #mirnascope ISH assay to visualize siRNA targets in SARS-CoV-2 positive mice and determine that the novel siRNA therapeutic reaches different regions of the respiratory tract. #advancingyourrnaish
link.springer.com/10.15252/emmm.202115298 -
EMBO Mol. Medicine
@EmboMolMed
➡️Liver-directed #genetherapy for ornithine aminotransferase deficiency
By I. Boffa, @brunetti_pierri & colleagues @Tigem_Telethon @UninaIT
🗞️doi.org/10.15252/emmm.202217033 -
EMBO Mol. Medicine reposted
Peter M.J. Quinn
@PeterMJQuinn
Happy to have contributed this project! DFO stabilizes HIF2α and disrupts mitochondrial oxphos, leading to RPE atrophy. Inhibiting HIF2α and preserving mitochondrial oxidative phosphorylation by AKG mitigate RPE cell death and ameliorate visual impairment in the clinic.
EMBO Mol. Medicine
@EmboMolMed
Online today 👉#hif2α activation and mitochondrial deficit due to #ironchelation cause #retinalatrophy 👁️
#retinalpigmentepithelium #deferoxamine #αKetoglutarate
By S. Tsang & colleagues @Columbia
🗞️#openaccess: doi.org/10.15252/emmm.202216525 -
EMBO Mol. Medicine
@EmboMolMed
Online today 👉#hif2α activation and mitochondrial deficit due to #ironchelation cause #retinalatrophy 👁️
#retinalpigmentepithelium #deferoxamine #αKetoglutarate
By S. Tsang & colleagues @Columbia
🗞️#openaccess: doi.org/10.15252/emmm.202216525 -
EMBO Mol. Medicine
@EmboMolMed
If you missed it ➡️ Review on the biological functions of #panethcells and their importance for intestinal homeostasis and organismal health
By C. Wallaeys, N. Garcia-Gonzalez & C. Libert @ugent @VIBLifeSciences
#panethcells
🗞️Fully #openaccess: doi.org/10.15252/emmm.202216427 -
EMBO Mol. Medicine
@EmboMolMed
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate #chronickidneydisease
By Z. Jia, A. Zhang & colleagues at Nanjing Medical University, China
👉doi.org/10.15252/emmm.202216581 -
EMBO Mol. Medicine
@EmboMolMed
Online today! #interferon regulates #neuralstemcell function at all ages by orchestrating #mtor and #cellcycle 🧠
By A. Marciniak-Czochra, A. Martin-Villalba & colleagues @DKFZ @UniHeidelberg
🗞️#openaccess: doi.org/10.15252/emmm.202216434 -
EMBO Mol. Medicine
@EmboMolMed
Our first issue of 2023 is out!💫
Review on #highthroughput #massspec in #drugdiscovery, articles on #depressivedisorders (our cover), #alzheimersdisease, #retinalangiogenesis, #cancer, #multidrugresistance, #creactiveprotein & more!
👉Fully #openaccess: www.embopress.org/toc/17574684/2023/15/1 -
EMBO Mol. Medicine reposted
Davina Biel
@davinabiel
Excited to share our new work in @EmboMolMed🧠🧪 We show that earliest Abeta abnormalities are associated with sTREM2-related microglial responses, which may drive p-tau elevations. Many thanks to @nfranzme, @matbrendel, @M_SuarezCalvet and many others!
doi.org/10.15252/emmm.202216987 -
EMBO Mol. Medicine reposted
Nico Franzmeier
@nfranzme
Happy to share @davinabiel's newest in @EmboMolMed: Earliest Abeta aggregation triggers an sTREM2-related microglial response ensuing p-tau increases and glucose hypermetabolism (e.g. neuroinflammation?). Huge thanks to @matbrendel, @M_SuarezCalvet et al!
doi.org/10.15252/emmm.202216987 -
EMBO Mol. Medicine reposted
Intestinal Cell News
@Intestinal_Cell
Dr. Claude Liberts' team at @InflamResCen provides valuable knowledge 💡 of the multiple functions of #panethcells, and the mechanisms and consequences of Paneth cell dysfunction associated with intestinal health.
🔂 Read and share!
@EmboMolMed | link.springer.com/article/10.15252/emmm.202216427 -
EMBO Mol. Medicine reposted
Maite Marcantoni
@MaiteMarcantoni
@AlmirAljovic @BareyreLab @anne_jac83 I can’t express how much I am happy that FGF22 paper is out!!!
- my first real science project
-my first real job in science
-my first real salary
-my first job experience abroad
- amazing PI!
Congrats to the entire Bareyre’s Lab -
EMBO Mol. Medicine reposted
Almir Aljović
@AlmirAljovic
I'm very excited today!🥳🎉
Our study on using gene therapy with FGF22 to enhance neural rewiring and recovery after spinal cord injury has been published in @EmboMolMed
@BareyreLab @anne_jac83 @MaiteMarcantoni @Valerie_VSBN @KasiaPlesniar @arekken
doi.org/10.15252/emmm.202216111 -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
.@EMBOpress scientific editors help develop and deliver scientific skills training on #researchintegrity, writing & presenting research and #peerreview. 2023 course dates are now available: lab-management.embo.org/dates @emboreports @embojournal @MolSystBiol @EmboMolMed @EMBO
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Did you miss our round-up of #ecology & #evolution content published in our journals this year? Browse the collection and consider submitting your work today! 👇
www.embopress.org/page/collections/evolution-ecology-2022
@embojournal @emboreports @MolSystBiol @EmboMolMed Illustration @TeamSciStories -
EMBO Mol. Medicine reposted
Karolinska Institutet
@karolinskainst
KI researchers have developed a #vaccine for the hereditary small vessel disease #cadasil that appears to be both effective and safe. A study on mice published in @EmboMolMed shows that it reduces NOTCH3 aggregates in brain capillaries and in the blood. doi.org/10.15252/emmm.202216556
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
New cross-journal article collection on #aging & #senescence - why not add a new browser tab to your holiday reading list? Illustration @TeamSciStories.
@embojournal @emboreports @EmboMolMed @MolSystBiol
👉 www.embopress.org/page/collections/aging-senescence-2022 -
EMBO Mol. Medicine reposted
Matthew S. Alexander
@Matt_Muscle_Guy
New @EmboMolMed paper: Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice. link.springer.com/article/10.15252/emmm.202216244
-
EMBO Mol. Medicine reposted
Daniel V. Oliveira
@dfvoliveira
I am happy to finally share my main PhD first-author paper from Helena Karlström lab ( (twitterless), where we show that active immunization with a small mutated NOTCH3 peptide led to the reduction of NOTCH3 aggregation surrounding the brain capillaries!
EMBO Mol. Medicine
@EmboMolMed
Online today! Active immunotherapy reduces #notch3 deposition in brain capillaries in a #cadasil mouse model
By U Lendahl, H Karlström & colleagues @karolinskainst
🗞️doi.org/10.15252/emmm.202216556 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Active immunotherapy reduces #notch3 deposition in brain capillaries in a #cadasil mouse model
By U Lendahl, H Karlström & colleagues @karolinskainst
🗞️doi.org/10.15252/emmm.202216556 -
EMBO Mol. Medicine
@EmboMolMed
Review on Advances in #highthroughput #massspectrometry in #drugdiscovery
By ME Dueñas, M Trost & colleagues @StudentsNCL
👉Read #openaccess: doi.org/10.15252/emmm.202114850 -
EMBO Mol. Medicine reposted
Endothelial Cell News
@endothelialnews
Scientists show that activation of the PGF2α/PTGFR axis accelerates experimental proliferative #retinopathy and propose that the axis may represent a therapeutic target 🎯 for pathological retinal #angiogenesis. 👁️
Check out the article in @EmboMolMed | link.springer.com/article/10.15252/emmm.202216373 -
EMBO Mol. Medicine reposted
Matthias Trost 🇪🇺
@TrostLab
We - led by @mariemiliad - wrote a nice review with colleagues from @GSK and @Boehringer on the use of #massspec in #drugdiscovery in @EmboMolMed
have a read!
www.embopress.org/doi/full/10.15252/emmm.202114850 -
EMBO Mol. Medicine
@EmboMolMed
PGF2α facilitates pathological #retinalangiogenesis by modulating endothelial FOS-driven ELR+ CXC chemokine expression
By Hua Yan, Ying Yu & colleagues by Tianjin Medical University, China
🗞️doi.org/10.15252/emmm.202216373 -
EMBO Mol. Medicine
@EmboMolMed
Disease modification and symptom relief in #osteoarthritis using a mutated GCP-2/CXCL6 chemokine
By J. Sherwood, A. Day, F. Dell’Accio & colleagues @QMUL @OfficialUoM @UK_Muenster
👉doi.org/10.15252/emmm.202216218 -
EMBO Mol. Medicine
@EmboMolMed
📢A human monoclonal antibody bivalently binding 2 different epitopes in #streptococcal M protein mediates #immunefunction
By W. Bahnan, P. Nordenfelt (@Pnordenfelt) & colleagues @Lundsuni
Full #openaccess 🗞️: doi.org/10.15252/emmm.202216208
See also 👉 www.lunduniversity.lu.se/article/antibody-discovery-paves… -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Come work @EMBO! We're hiring two scientific editors for @embojournal and @EmboMolMed/@MolSystBiol.
Apply by 2 January 2023 => www.embo.org/about-embo/work-for-us/ -
EMBO Mol. Medicine reposted
Lund University
@lunduniversity
Antibody discovery paves way for new therapies against group A streptococcal infections: www.lunduniversity.lu.se/article/antibody-discovery-paves… @EmboMolMed #strepa #groupastrep
-
EMBO Mol. Medicine
@EmboMolMed
This Commentary by D. McKenna & R. Perlingeiro discusses the production process of an #inducedpluripotentstemcell -derived clinical grade therapeutic – from bench to bedside.
👉doi.org/10.15252/emmm.202115315 -
EMBO Mol. Medicine
@EmboMolMed
The genetic regulation of protein expression in #cerebrospinalfluid
By O. Hansson, N. Mattsson-Carlgren & colleagues @lunduniversity
#braindisease #pqtls
🗞️#openaccess: doi.org/10.15252/emmm.202216359 -
EMBO Mol. Medicine
@EmboMolMed
Online today 👉 #macrophages inhibit #coxiellaburnetii by the ACOD1-itaconate pathway for containment of #qfever
By L. Kohl, R. Lang & colleagues @UniFAU
🗞️ #openaccess: doi.org/10.15252/emmm.202215931 -
EMBO Mol. Medicine reposted
The EMBO Journal
@embojournal
Job openings for #postdocs interested in becoming #editors - 4 more days to apply!!!
#molecularbiology, #cellbiology, #biochemistry, #structuralbiology, etc. - working at @embojournal lets you stay close to fascinating research & #openscience!
EMBO Press
@EMBOPress
Join our team! We have openings for two scientific editor positions @embojournal @MolSystBiol @EmboMolMed.
Apply by December 11th 👉 www.embo.org/about-embo/work-for-us/ -
EMBO Mol. Medicine
@EmboMolMed
🎄Our December issue is out!⛄️
Review on #tuberculosis #biomarkers, articles on #alagillesyndrome (our cover), #gbm, colorectal, liver & skin #cancer, #lymphoma, #hemophagocyticlymphistiocytosis, #septicarthritis, #pneumoniae & #coffinsirissyndrome!
👉www.embopress.org/toc/17574684/2022/14/12 -
EMBO Mol. Medicine reposted
Vid Nukala, PhD. MA.
@VidNukala
EMBO Mol. Medicine
@EmboMolMed
📢One week left to apply!
2 open positions @EMBOPress (one for @EmboMolMed - @MolSystBiol & one for @embojournal)
Apply by Dec 11 👉 www.embo.org/about-embo/work-for-us/ -
EMBO Mol. Medicine reposted
EMBO Lab Leadership
@LifeSciLearn
How do you start writing a #researcharticle? How do you assemble figures? What's the best way to structure your #abstract? Find the answers and more from an
@EMBOPress #journaleditor at @EMBO course on 25-26 January 2023 - Sign up now: lab-management.embo.org/dates/comm-research -
EMBO Mol. Medicine
@EmboMolMed
A novel phosphocholine-mimetic inhibits pro-inflammatory conformational change in #creactiveprotein
By M Parker, K Peter, S Eisenhardt & colleagues @UniFreiburg @UniMelb
🗞️ #openaccess: doi.org/10.15252/emmm.202216236
👉Accompanying N&V by J Filep: doi.org/10.15252/emmm.202217003 -
EMBO Mol. Medicine
@EmboMolMed
📢One week left to apply!
2 open positions @EMBOPress (one for @EmboMolMed - @MolSystBiol & one for @embojournal)
Apply by Dec 11 👉 www.embo.org/about-embo/work-for-us/ -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
The @EMBOPress team is at #cellbio2022 and wants to meet you! Visit booth #1433 to discuss your latest research. Daily meet-the-editor sessions from 2-3PM.
@embojournal @emboreports @MolSystBiol @EmboMolMed @LSAjournal @ReviewCommons -
EMBO Mol. Medicine reposted
Review Commons
@ReviewCommons
We're looking forward to meeting you at #cellbio2022. Review Commons Managing Editor Sara Monaco and Project Lead Thomas Lemberger will be at this year's @ASCBiology and @EMBO meeting in Washington DC - come and talk with us about Review Commons!
-
EMBO Mol. Medicine
@EmboMolMed
IMPDH inhibition activates TLR-VCAM1 pathway & suppresses the development of MLL-fusion #leukemia
By X. Liu, S. Goyama & colleagues @UTokyo_News_en
👉Read 🗞️#openaccess: doi.org/10.15252/emmm.202115631
👉Discussed in News & Views: doi.org/10.15252/emmm.202217042 -
EMBO Mol. Medicine
@EmboMolMed
G. Huang & M. Sezaki discuss repurposing of #immunosuppressants targeting IMPDH for treatment of #acutemyeloidleukemia as reported by S. Goyama et al, in this issue of @EmboMolMed.
👉doi.org/10.15252/emmm.202217042
🗞️Full related article: doi.org/10.15252/emmm.202115631 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Congratulations to the winners of the #msbj2022 Science Pitch prizes from @embojournal @emboreports @EmboMolMed @MolSystBiol for best short talks selected from 600 talks! Yuka Koga, Mariko Tsuruta, Akihirio Tanaka, Nagisa Matusda, Tsuji Lee, Risa Takada,Kikuchi Arrika,Suda Kajiro
-
EMBO Mol. Medicine reposted
UAB Pulmonary
@UABPulmonary
@jacepeabody and @stevenmrowe collaborated with an international team to research a high-resolution 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions, published in @EmboMolMed link.springer.com/article/10.15252/emmm.202216283
-
EMBO Mol. Medicine
@EmboMolMed
Online today 👉 Commentary that provides a brief overview & new perspectives for more systematic efforts to explore the functions of the #elongator in health & disease.
By M. Gaik, M. Kojic, B. Wainwright & S. Glatt
🗞️doi.org/10.15252/emmm.202216418 -
EMBO Mol. Medicine
@EmboMolMed
You can now follow us on #mastodon 👉
@EmboMolMed@sciencemastodon.com
We will be posting on both platforms (for now), looking forward to finding many of you over at #sciencemastodon -
EMBO Mol. Medicine reposted
Steyn Lab
@SteynTBLab
Our recent research article on the high-resolution 3D imaging of #tuberculosis and #covid19 lungs got featured in @UABNews and a special editorial in @EmboMolMed
Link to the @UABNews article:
uab.edu/news/research/item/13278-tuberculosis-and-covid-1…
Link to the @EmboMolMed article:
www.embopress.org/doi/full/10.15252/emmm.202216876
Steyn Lab
@SteynTBLab
New from the Steyn Lab: "A high‐resolution #3d atlas of the spectrum of #tuberculous and #covid19 lung lesions" www.embopress.org/doi/full/10.15252/emmm.202216283
-
EMBO Mol. Medicine reposted
ImmunoSensation
@ImmunoSens
Here we go again with #spotonscience 🧪🔦
Watch Episode #2 now youtu.be/18fZXVe8gyE
Dr. Damien Bertheloot of @IIIBonn @UniklinikBonn @UniBonn introduces his work on disassembling #inflammasome(s) using #nanobodies published in @EmboMolMed.
#immunology #science #research -
EMBO Mol. Medicine reposted
Mol Syst Biol
@MolSystBiol
Interested in working as a scientific editor? There are two open positions @EMBOPress (one for @MolSystBiol - @EmboMolMed & one for @embojournal
Apply by Dec 11, more info below ⬇️
EMBO Press
@EMBOPress
Join our team! We have openings for two scientific editor positions @embojournal @MolSystBiol @EmboMolMed.
Apply by December 11th 👉 www.embo.org/about-embo/work-for-us/ -
EMBO Mol. Medicine
@EmboMolMed
Online! 👉Commentary by Prof. N. Li & colleagues, who discuss the challenges related to rare tumors definition, clinical trials, and therapies with a focus on China.
#raretumors #clinicaltrials
🗞️Read #openaccess: doi.org/10.15252/emmm.202216415 -
EMBO Mol. Medicine
@EmboMolMed
👉MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative #breastcancer
By R. Dinami, L. Pompili, E. Petti, A. Biroccio & colleagues @AlleConCancro
#tnbc
🗞️Read #openaccess: doi.org/10.15252/emmm.202216033 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Join our team! We have openings for two scientific editor positions @embojournal @MolSystBiol @EmboMolMed.
Apply by December 11th 👉 www.embo.org/about-embo/work-for-us/ -
EMBO Mol. Medicine reposted
PioneerCampus @HelmholtzMunich
@PioneerCampus
@Jeremias_lab @HelmholtzMunich uncovers promising therapeutic target for relapse/resistance ALL, the most frequent childhood malignancy!
Great effort with tangible therapeutic impact👏🏻👏🏻👏🏻 @EmboMolMed -
EMBO Mol. Medicine
@EmboMolMed
New #openaccess 🗞️: X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL
By P. Hundsdoerfer, I. Jeremias & colleagues @HelmholtzMunich @ChariteBerlin @DKTK_ @LMU_Uniklinikum
#leukemia
👉doi.org/10.15252/emmm.202114557 -
EMBO Mol. Medicine reposted
Jeremias Lab
@Jeremias_lab
Happy to announce that our latest research got published @EmboMolMed. Congratulations to our talented first authors @CarletMichela, @karin_Charite and @JennyVergalli
-
EMBO Mol. Medicine reposted
Australasian Virology Society
@AusVirologySoc
Did you know @PhageAustralia clinicians and @Iredell_Lab scientists @WestmeadInst saved a little girl’s leg from amputation using #phagetherapy?
@EmboMolMed featured #phagetherapy on the cover for our effort to treat #criticalinfection and prevent amputation in a child! -
EMBO Mol. Medicine
@EmboMolMed
#artificialsweeteners inhibit #multidrug -resistant #pathogen growth and potentiate #antibiotic activity
By R. de Dios, R. McCarthy (@McCarthy_Ronan) @Bruneluni
🗞️#openaccess: doi.org/10.15252/emmm.202216397
Read also: Artificial sweeteners smash superbugs www.brunel.ac.uk/news-and-events/news/articles/Artificial… -
EMBO Mol. Medicine reposted
Ronan McCarthy
@McCarthy_Ronan
Delighted to share this work on the antimicrobial and antibiotic potentiating activity of artificial sweeteners against MDR pathogens in @EmboMolMed www.embopress.org/doi/full/10.15252/emmm.202216397 #waaw2022 (1/4)
-
EMBO Mol. Medicine reposted
The EMBO Journal
@embojournal
3 more weeks to APPLY for joining our team of editors!
Especially if you have expertise related to #rna, #chromatin, #transcription or protein synthesis, @embojournal is looking for you! -
EMBO Mol. Medicine reposted
Neural Cell News
@NeuralCell
🏁 New methods of studying major #depressivedisorder with suicide behaviour!
Scientists generated patient-derived #ipsc and differentiated them into interneurons and #organoids to study molecular mechanisms and drug 💊 discoveries.
@EmboMolMed | link.springer.com/article/10.15252/emmm.202216364 -
EMBO Mol. Medicine
@EmboMolMed
Acetate supplementation restores cognitive deficits caused by ARID1A haploinsufficiency in excitatory #neurons
By Y Tang, ZQ Teng, CM Liu & colleagues at Chinese Academy of Sciences, Beijing
#coffinsirissyndrome
👉Read #openaccess: doi.org/10.15252/emmm.202215795 -
EMBO Mol. Medicine reposted
Fabian F. Voigt
@voigtvision
📢New paper alert @EmboMolMed! #mesospim #lightsheet #microscopy to quantifies the effect of antibodies & polythiophenes against Aβ plaques at scale! Work led by @D_Birschenkaum @AdrianoAguzzi & Co! www.embopress.org/doi/epdf/10.15252/emmm.202216789
-
EMBO Mol. Medicine
@EmboMolMed
🧠Online today! Whole-brain microscopy reveals distinct temporal and spatial efficacy of anti- #aβ therapies
By JH Lee, A Aguzzi (@AdrianoAguzzi) & colleagues @Unispital_USZ @Stanford @UZH_en
#alzheimersdisease #amyloid #brainatlas
Read 🗞️doi.org/10.15252/emmm.202216789 -
EMBO Mol. Medicine reposted
Organoid News
@organoidscience
😔 #majordepressivedisorder with suicide behavior (sMDD) can bring tremendous burden to family and society. In this study, scientists provide a human cellular model for studying the molecular mechanisms and drug discoveries for sMDD.
📖 @EmboMolMed | link.springer.com/article/10.15252/emmm.202216364 -
EMBO Mol. Medicine
@EmboMolMed
👉In this Commentary, M. Mittelbrunn (@Mmittelbrunn), E Gabandé-Rodríguez (@EnriqueGab) & M. Pffeifer discuss T cell-based #immunotherapy for age-related diseases.
@UAM_Madrid
#tcell #immunotherapy #aging
#openaccess🗞️: doi.org/10.15252/emmm.202216301 -
EMBO Mol. Medicine
@EmboMolMed
Depressive patient-derived #gaba interneurons reveal abnormal neural activity associated with HTR2C
By X. Guo, Y. Liu & colleagues at Nanjing Medical University, China
#mooddisorder #depression #gaba
🗞️Read #openaccess: doi.org/10.15252/emmm.202216364 -
EMBO Mol. Medicine reposted
Rare Disease Advisor
@RareDisease_Adv
A new study has found significant sex differences in #bleedingevents in patients with #alagillesyndrome (#algs), with females having more #spontaneousbleeds than males. @EmboMolMed @EMBOPress www.rarediseaseadvisor.com/news/sex-differences-vascular-… #liverdisease #livertwitter #retinography #raredisease
-
EMBO Mol. Medicine reposted
Mol Syst Biol
@MolSystBiol
Pls RT: we are hiring an editor for @MolSystBiol & @EmboMolMed (deadline Dec 11, more info below)
➡️www.embl.org/jobs/position/EMBO00131 -
EMBO Mol. Medicine
@EmboMolMed
Concurrent targeting of #glycolysis in #bacteria and host cell #inflammation in #septicarthritis
By H-K K, F Lee & colleagues @Yale
👉Read #openaccess: doi.org/10.15252/emmm.202115284 -
EMBO Mol. Medicine reposted
Review Commons
@ReviewCommons
With our revision plan, authors have the option to explain how they plan to address the points raised by the reviewers before embarking on new experimentations & analyses.
#refereedpreprint
www.reviewcommons.org/blog/streamlining-the-journal-submi… -
EMBO Mol. Medicine reposted
Hepatic Cell News
@hepaticcellnews
📖 #openaccess in @EmboMolMed!
Investigators found that long-term #metformin exposure led to metabolic adaptation of #hepatocellularcarcinoma cells, characterized by an EMT phenotype and compensatory elevation ⬆️ of oxidative phosphorylation.
🔍 link.springer.com/article/10.15252/emmm.202216082 -
EMBO Mol. Medicine reposted
Peter Wolf's Lab
@WolfDermGraz
Incredibly excited to share our new paper in @EmboMolMed with the support from @FWF_at & @FWFOpenAccess.
EMBO Mol. Medicine
@EmboMolMed
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous #tcelllymphoma
#stat3 #leukemia
By P. Gunning, L. Kenner, R. Moriggl, P. Wolf & colleagues @VetmeduniVienna @MedUniGraz @MedUni_Wien @UTM
👉doi.org/10.15252/emmm.202115200 -
EMBO Mol. Medicine reposted
Emma Andersson
@EmmaRAndersson
Why do children with the liver disease Alagille syndrome (ALGS) bleed spontaneously?
What exacerbates bleeding risk?
Can blood vessel anomalies be detected in patients non-invasively?
Our work addressing these questions is out now:
doi.org/10.15252/emmm.202215809 -
EMBO Mol. Medicine
@EmboMolMed
Online today!🧠Sex differences and #riskfactors for bleeding in #alagillesyndrome
By S. Hankeova, E. Andersson (@EmmaRAndersson) & colleagues @karolinskainst
Read 🗞️full #openaccess: doi.org/10.15252/emmm.202215809 -
EMBO Mol. Medicine reposted
Metabolomics Papers
@Metabbot
Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis. EMBO Mol Med #metabolomics onlinelibrary.wiley.com/doi/10.15252/emmm.202115343
-
EMBO Mol. Medicine reposted
Krishna C.
@Krishna4Science
🚨New Pub from @SteynTBLab. A stunning #3d reconstruction of #tuberculosis and #covid19 lungs showing the novel #immunopathological features in the whole diseased #lungs 🫁. On the #coverpage @EmboMolMed Congratulations👏🍾 @gordonwells @hayden_pacl @UABMicrobiology @AHRI_News
Steyn Lab
@SteynTBLab
New from the Steyn Lab: "A high‐resolution #3d atlas of the spectrum of #tuberculous and #covid19 lung lesions" www.embopress.org/doi/full/10.15252/emmm.202216283
-
EMBO Mol. Medicine reposted
Gunning Group
@GunningLabUofT
Thanks @EmboMolMed for providing us with a wonderful venue to share this story! The collaborative spirit between our lab, @richard_moriggl @VetmeduniVienna, @LukasKenner @MedUni_Wien, and @WolfDermGraz @MedUniGraz is as strong as ever!
EMBO Mol. Medicine
@EmboMolMed
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous #tcelllymphoma
#stat3 #leukemia
By P. Gunning, L. Kenner, R. Moriggl, P. Wolf & colleagues @VetmeduniVienna @MedUniGraz @MedUni_Wien @UTM
👉doi.org/10.15252/emmm.202115200 -
EMBO Mol. Medicine
@EmboMolMed
📢Our November issue is out!
Articles on #monkeypox, #salmonella, #sarscov2, #tuberculosis (our stunning cover), #ewingsarcoma, #osteoporosis, #inheritedretinaldisease, & review on #hipsc as model to study the toxic effects of environmental exposure
🗞️👉www.embopress.org/toc/17574684/2022/14/11 -
EMBO Mol. Medicine reposted
Gunning Group
@GunningLabUofT
Incredibly excited to share our new paper with the @jakstattarget consortium out in @EmboMolMed!! We integrated genomic and pharmacologic studies to identify the PAK-STAT3/5 axis as a novel therapeutic node in leukemic cutaneous T-cell lymphoma (L-CTCL)!
www.embopress.org/doi/full/10.15252/emmm.202115200 -
EMBO Mol. Medicine
@EmboMolMed
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous #tcelllymphoma
#stat3 #leukemia
By P. Gunning, L. Kenner, R. Moriggl, P. Wolf & colleagues @VetmeduniVienna @MedUniGraz @MedUni_Wien @UTM
👉doi.org/10.15252/emmm.202115200 -
EMBO Mol. Medicine
@EmboMolMed
Online today! In vivo #singlecelltranscriptomics reveal #klebsiella pneumoniae skews #lung #macrophages to promote infection
By A. Dumigan (@DumiganAmy), J. Bengoechea (@josebengoechea) & colleagues @QUBelfast
Read 🗞️ #openaccess: doi.org/10.15252/emmm.202216888 -
EMBO Mol. Medicine reposted
Josebengoechea
@josebengoechea
Proud of our last work led by super scientist @DumiganAmy showing how Klebsiella skews lung macrophages to a new state to overcome host restriction by hijacking iL10, type I IFN and STAT6. From in vivo to in vitro to human cells www.embopress.org/doi/full/10.15252/emmm.202216888 hats off @EmboMolMed
-
EMBO Mol. Medicine reposted
BRIC-inStem
@DBT_inStem
📣India-@EMBO Lecture Course on 𝗠𝗼𝗱𝗲𝗹𝗶𝗻𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝘄𝗶𝘁𝗵 𝗵𝘂𝗺𝗮𝗻 𝘁𝗶𝘀𝘀𝘂𝗲 𝗼𝗿𝗴𝗮𝗻𝗼𝗶𝗱𝘀 from 6-9 Feb 2023
Travel and childcare grants are available!
Register by 10 Dec🔗instem.res.in/events/embo-1
@EMBOPress #emboorganoids2023 -
EMBO Mol. Medicine reposted
James Clement
@jamesclementjnc
The short talk 1st prize winner @HannahB77100208 (Hannah Bruce), and 1st prize poster prize winner Priyadharishini Veeraraghavan at the EMBO conference #emboneurodev @EMBOevents @EMBOPress @TedAbelneuro @NCBS_Bangalore @UIowaNeuro @DBT_NBRC
-
EMBO Mol. Medicine
@EmboMolMed
Online now: Disrupting #metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis
By P. Jin, J. Jiang, C. Huang & colleagues at Sichuan University, Chengdu, China
#livercancer #metformin
Read 🗞️#openaccess: doi.org/10.15252/emmm.202216082 -
EMBO Mol. Medicine reposted
Cancer Research Center of Lyon
@crcl
The organizing committee was honored to welcome you during these event marked by the quality of the conferences and discussions!👏
Many thanks to all speakers, exhibitors, participants and sponsors who made this #crclsymposium a real success
See you soon for the next edition✨ -
EMBO Mol. Medicine
@EmboMolMed
📢Online! Intestinal Apc-inactivation induces HSP25 dependency
By S. van Neerven (@SvanNeerven), L. Vermeulen (@vermeulenlouis1) & colleagues
@oncodeinstitute @amsterdamumc
#colorectalcancer #intestinaltumor
🗞️#openaccess: doi.org/10.15252/emmm.202216194 -
EMBO Mol. Medicine
@EmboMolMed
IQCN disruption causes #fertilization failure and male #infertility due to manchette assembly defect
By W. Zheng, G. Lin & colleagues at Central South University, ChangSha, China
Read #openaccess: doi.org/10.15252/emmm.202216501 -
EMBO Mol. Medicine reposted
Intestinal Cell News
@Intestinal_Cell
🤔 What drives #colorectalcancer initiation?
Researchers find a crucial role of HSP25 in facilitating Apc-driven intestinal transformation using #organoids!
More from Dr. Louis Vermeulen (@vermeulenlouis1) & team at @ScienceLab_MCBI.
@EmboMolMed | 🔗 link.springer.com/article/10.15252/emmm.202216194 -
EMBO Mol. Medicine
@EmboMolMed
A Agrawal & D Agrawal discuss the study by A Steyn et al @EmboMolMed: high-resolution 3D atlas tuberculous and COVID-19 lung lesions established via micro-X-ray computed tomography
#tuberculosis #covid19
👉doi.org/10.15252/emmm.202216876
👉Full related article: doi.org/10.15252/emmm.202216283 -
EMBO Mol. Medicine
@EmboMolMed
📢Don’t miss this comprehensive review by B. Andrade & colleagues on #diagnosticbiomarkers for active #tuberculosis!
🗞️Full #openaccess: doi.org/10.15252/emmm.202114088 -
EMBO Mol. Medicine reposted
jpedrokessner
@KessnerJp
Biomarkers for Active Tuberculosis: a Review.
doi.org/10.15252/emmm.202114088
🫁😮💨🧫🔬🧪🧬📚
@EmboMolMed @HopkinsMedicine @VUmedicine @ufrj @ufba @UCT_news @accpchest @atscommunity @EuroRespSoc @ALATorax @SeparRespira @neumopararesis @SPLF_SocPneumo @NeumoMadrid -
EMBO Mol. Medicine reposted
Cancer Research Center of Lyon
@crcl
The symposium is also an opportunity to meet the editors ! 🗞️
We are delighted to welcome Lise Roth and Lisa Hoffmann-Haas, editors @EmboMolMed and @NatureCancer to discuss about scientific publishing ! -
EMBO Mol. Medicine reposted
EMBO YIP
@EMBO_YIP
As of yesterday, #openaccess publication at no cost in all @EMBOPress journals @embojournal, @emboreports, @MolSystBiol, and @EmboMolMed for corresponding authors based in one of the eleven countries mentioned below and not covered by a transformational agreement.
EMBO
@EMBO
OA publication at no cost in @EMBOPress @embojournal @emboreports @MolSystBiol @EmboMolMed for corresponding authors in #croatia #czechrepublic #estonia #greece #hungary #italy #lithuania #luxembourg #poland #slovenia #turkey not covered by PAR agreement.
www.embo.org/press-releases/increasing-participation-in-t… -
EMBO Mol. Medicine reposted
solid tumor cancer stem cell network
@SUNRiSE_cancer
Do not miss this fantastic work! Well done @Thomas_Daubon 👏🏼
EMBO Mol. Medicine
@EmboMolMed
Online today! #lactatedehydrogenase promote #glioblastoma growth and invasion via a metabolic symbiosis
By J. Guyon, @AndreasBikfalvi, @Thomas_Daubon & colleagues @Inserm @CNRS
@univbordeaux_EN
🗞️doi.org/10.15252/emmm.202115343 -
EMBO Mol. Medicine reposted
ESC & iPSC News
@ESC_iPSC_News
😮 Did you know that #ipscs can be used to study the effects of environmental toxins in the body? Drs. @mjkchandy, @DetlefObal, and @Joseph_C_Wu from @StanfordCVI tell us how.
Read more about their recent work in @EmboMolMed. 👇
📖 link.springer.com/article/10.15252/emmm.202013260 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
On behalf of @EmboMolMed, we are pleased to support this exciting workshop with a poster prize award. Great line-up of talks! #emboneurodev
James Clement
@jamesclementjnc
All set for the EMBO workshop to discuss recent discoveries on neurodevelopmental disorders @EMBOevents @EMBO @EMBOPress @jncasr #embo #conference #neuroscience #autismawareness #autismnews @Syngap1Fnd @TedAbelneuro @DBT_NBRC
-
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉 AhR/SRC axis constitutes a therapeutic vulnerability in BRAFi-resistant #melanoma
By A. Paris, N. Tardif, MD. Galibert, S. Corre & colleagues @UnivRennes1 @Inserm @CNRS
#melanoma #chemoresistance #ahr
🗞️doi.org/10.15252/emmm.202215677 -
EMBO Mol. Medicine reposted
EMBO
@EMBO
OA publication at no cost in @EMBOPress @embojournal @emboreports @MolSystBiol @EmboMolMed for corresponding authors in #croatia #czechrepublic #estonia #greece #hungary #italy #lithuania #luxembourg #poland #slovenia #turkey not covered by PAR agreement.
www.embo.org/press-releases/increasing-participation-in-t… -
EMBO Mol. Medicine
@EmboMolMed
Read this review by M. Chandy, D. Obal & J. Wu @StanfordMed who discuss the potential of human #ipsc as a modeling system to investigate the toxic effects of environmental exposure on human health
#ipsc #environmentalhealth
👉#openaccess: doi.org/10.15252/emmm.202013260 -
EMBO Mol. Medicine
@EmboMolMed
📢Online today! A high-resolution 3D atlas of the spectrum of #tuberculous and #covid19 lung lesions
By G. Wells, A. Steyn & colleagues @UKZN @UABNews
🗞️Fully #openaccess: doi.org/10.15252/emmm.202216283 -
EMBO Mol. Medicine
@EmboMolMed
Online today! #lactatedehydrogenase promote #glioblastoma growth and invasion via a metabolic symbiosis
By J. Guyon, @AndreasBikfalvi, @Thomas_Daubon & colleagues @Inserm @CNRS
@univbordeaux_EN
🗞️doi.org/10.15252/emmm.202115343 -
EMBO Mol. Medicine reposted
Review Commons
@ReviewCommons
RC project leader @tlemberger & @AdrianoAguzzi discussed the process & the role of preprints and journals on the #embopodcast last year
🎧👇
www.embo.org/podcasts/from-prions-to-preprints/ -
EMBO Mol. Medicine
@EmboMolMed
#adoptivetcelltherapy cures mice from active #hemophagocyticlymphohistiocytosis (HLH)
By K. Weißert, P. Aichele & colleagues @UniFreiburg
🗞️Read #openaccess: doi.org/10.15252/emmm.202216085 -
EMBO Mol. Medicine reposted
Gunning Group
@GunningLabUofT
Our visiting scholar Helena Sorger from the Moriggl lab @VetmeduniVienna was featured in The Cancer Researcher @EACRnews on her experience in our lab @UofT as an EACR Travel Fellow! Can't wait to read her first-author paper just submitted to @EmboMolMed!
magazine.eacr.org/a-personal-highlight-of-my-trip-was-sub… -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
EMBO will cover all #openaccess charges @embojournal @emboreports @EmboMolMed & @MolSystBiol for corresp. authors in #italy #croatia #czechrepublic #estonia #greece #hungary #lithuania #luxembourg #poland #slovenia #turkey. Make use of this time limited initiative (excludes TAs)
-
EMBO Mol. Medicine
@EmboMolMed
Using host receptor as a decoy to treat #covid19: a solution for immune escape?
👉PC Yang, MS Lin, & KY Huang discuss how engineered soluble ACE2 can be used against #sarscov2 infection as reported by E. Procko et al in
👉doi.org/10.15252/emmm.202216818
🗞️doi.org/10.15252/emmm.202216109 -
EMBO Mol. Medicine reposted
COST DARTER
@AON_Delivery
🫣 Seems like the perfect excuse to have yet another look over our beloved #embomolmed review and the depiction we have there on the #delivery technologies used to improve the ADMET properties of #oligonucleotides. 🤫
Again: this is an 🆓#openaccess publication. Go check it ✅ -
EMBO Mol. Medicine reposted
Oncode Institute
@oncodeinstitute
The team of Oncode Investigator Jarno Drost (@prinsesmaximac) successfully cultured organoids from rhabdomyosarcoma, an aggressive soft tissue tumor, for the first time. The new study is featured on the cover of @EmboMolMed's October issue. Read more: www.oncodeinstitute.nl/news/first-step-towards-precision-…
-
EMBO Mol. Medicine
@EmboMolMed
🍂Our October issue is out!🍂
On the cover: #tumororganoid models of #rhabdomyosarcoma, @prinsesmaximac & @oncodeinstitute
but also articles on #tumorimmunity, #cancer, #sarscov2vaccine, #autoimmunediseases, and more!
👉Read fully #openaccess: www.embopress.org/toc/17574684/2022/14/10 -
EMBO Mol. Medicine
@EmboMolMed
💫Online #openaccess! miR-181a/b downregulation: a mutation-independent therapeutic approach for #inheritedretinaldiseases
by S. Carrella, S. Banfi & colleagues @BanfisLab @Tigem_Telethon
🗞️doi.org/10.15252/emmm.202215941 -
EMBO Mol. Medicine reposted
Tigem Telethon
@Tigem_Telethon
Congratulations to Sabrina Carrella @CarrellaSabrina from @BanfisLab for her recent publication in @EmboMolMed:
📰miR-181a/b downregulation: amutation-independent therapeutic approach for inherited retinal diseases
💻Read here: www.embopress.org/doi/epdf/10.15252/emmm.202215941 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Antagonizing microRNA-19a/b augments PTH anabolic action and restores bone mass in #osteoporosis in mice
By H. Taipaleenmäki, H. Saito, E. Hesse & colleagues @LMU_Muenchen @UKEHamburg
🗞️Read #openaccess: doi.org/10.15252/emmm.202013617 -
EMBO Mol. Medicine
@EmboMolMed
📢A nontyphoidal #salmonella serovar domestication accompanying enhanced niche adaptation
This study reveals 2 novel subclades of S. Livingstone linked to human infections & mainly emerged in China
By Y Li, M Yue & al. at Zhejiang University, China
🗞️doi.org/10.15252/emmm.202216366 -
EMBO Mol. Medicine reposted
Immunology of Infectious Disease News
@infdisease_news
A team led by Dr. Florian Kurth (@KurthGroup) at @ChariteBerlin has characterized the proteome of the #monkeypox 🐒 human host response.
📚: @EmboMolMed
🔗: link.springer.com/article/10.15252/emmm.202216643 -
EMBO Mol. Medicine
@EmboMolMed
📢Online today! Plasma proteome analysis of patients with #monkeypox (MPX) reveals key features of the host response to MPX infection.
Repurposing of a #covid19 -derived #biomarker panel.
By M Mülleder, M Ralser, F Kurth & colleagues @ChariteBerlin
🗞️doi.org/10.15252/emmm.202216643
EMBO Mol. Medicine
@EmboMolMed
Read also: www.embo.org/press-releases/monkeypox-study-reveals-poten…
-
EMBO Mol. Medicine reposted
Nationales Centrum für Tumorerkrankungen Dresden
@NCT_UCC_DD
Gastric cancer patients whose tumors show increased activation of the MAPK signaling pathway could benefit in future from a novel treatment with targeted drugs. ➡️ www.nct-dresden.de/en/about-nctucc-dresden/newsroom/press… @CNIOStopCancer #nctucc @dkfz @tudresden_de @viennabiocenter @Ikerbasque @EmboMolMed
-
EMBO Mol. Medicine
@EmboMolMed
📢Assessing and enhancing migration of human myogenic #progenitors using directed #inducedpluripotentstemcells differentiation & advanced #tissuemodelling
By SW Choi, G Ferrari & @lab_tedesco @TheCrick @ucl
🗞️doi.org/10.15252/emmm.202114526 -
EMBO Mol. Medicine
@EmboMolMed
An #ace2 decoy can be administered by inhalation and potently targets #omicronvariants of #sarscov2
By L. Zhang, L. Rong, J. Rehman, A. Malik, E. Procko & colleagues @uiccom
🗞️Read #openaccess: doi.org/10.15252/emmm.202216109 -
EMBO Mol. Medicine reposted
Matthew S. Alexander
@Matt_Muscle_Guy
New @EmboMolMed paper: Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling. link.springer.com/article/10.15252/emmm.202114526
-
EMBO Mol. Medicine reposted
EMBO Reports
@emboreports
Lessons of epidemics past and present:
embo.org/podcasts/lessons-of-epidemics-past-and-present/……
Eugene Koonin, Nash Rochman @evogenome @NCBI @NLM_NIH and Vincent Racaniello @profvrr tell what we have learned from the past seven major epidemics and discuss open questions.
See also:
www.embopress.org/doi/full/10.15252/embr.202255393 -
EMBO Mol. Medicine reposted
Review Commons
@ReviewCommons
"Another key enhancement is applying a scooping protection policy from the day of preprint posting or journal submission, which allows authors to undertake through revision without the constant fear of losing out on reporting priority."
www.embo.org/people/increasing-trust-in-research-with-tra… -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Did you know? @EMBOpress scientific editors helped develop & deliver scientific skills training on the themes of #researchintegrity, writing & presenting research and #peerreview. @LifeSciLearn
@emboreports @embojournal @MolSystBiol @EmboMolMed
Info: lab-management.embo.org/course-overview -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
We aim to add #ecr referees to our referee panels and initiated an early PI advisory panel earlier this year.
@LSAjournal @emboreports @MolSystBiol @embojournal @EmboMolMed
Editorial: embopress.org/doi/full/10.15252/embj.2021110330 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
EMBO Press encourages named co-reviewing so that younger researchers gain experience in evaluating the science of their peers and acquire skills to become expert referees in their area of expertise. #peerreviewweek22
@LSAjournal @emboreports @MolSystBiol @embojournal @EmboMolMed -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
.@EmboMolMed senior editor Lise Roth is attending next week's @AegeanConf 'Tumor Microenvironment and Cellular Stress' meeting in Rhodes. Contact her to discuss your latest research!
www.aegeanconferences.org/src/App/conferences/view/161 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Interview for #peerreviewweek2022 with @BerndPulverer discussing how @EMBOPress increases trust in published research with a special focus on the journals' #transparentpeerreview initiative.
@embojournal @emboreports @MolSystBiol @EmboMolMed @EMBOPress
www.embo.org/people/increasing-trust-in-research-with-tra… -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
offering choices to encourage #transparency in #peerreview promotes fairness and #researchintegrity. (2/2)
@MolSystBiol @LSAjournal @EmboMolMed @embojournal @emboreports #peerreviewweek22
www.embopress.org/transparent-process -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Authors may opt for double-blind peer review at our journals. We publish referee reports with our papers & encourage reviewers to sign reports. Independent scientific editors and referee panels balanced by gender, region & seniority reduce bias, and (1/2)
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Our pre-publication image screening service complements peer review to support reproducibility and #researchintegrity. We work with authors, referees and research institutions to contextualize & resolve mistakes before publication. #peerreviewweek @C0PE
doi.org/10.15252/embj.201570080 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Peer review at @emboreports @EmboMolMed @LSAjournal @embojournal @MolSystBiol is run by professional scientific editors who are trained to avoid bias, which in turn promotes fairness and #integrity in #peerreview. Contact an editor: forms.gle/V7GQiUWBWAcgh4wj8 #peerreviewweek22
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Key feature of #transparentpeerreview @EMBOPress: Referee Cross-Commenting (reviewers are invited to comment on one another’s reports prior to editorial decision) is now enhanced with Author Preconsultations to take into account the authors' response to referee suggestions. 1/2
-
EMBO Mol. Medicine reposted
Feske lab at NYU
@Feskelab
Excited to share our latest work in @EmboMolMed! We explore #storeoperatedcalciumentry (SOCE) in #ibd, highlighting therapeutic application for #cracchannel inhibitors. Led by Marilena Letizia, @Yinhu_Wang and @Uli_Kaufmann, in collaboration with C Weidinger lab @ChariteBerlin
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Our #transparentpeerreviewprocess launched more than a decade ago – publishing referee reports, author rebuttals and editorial correspondence alongside papers reveals all aspects of the editorial process and improves #researchintegrity. #peerreviewweek22 doi.org/10.1038/emboj.2010.307
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
#peerreviewweek22 will be taking place from 19-23 Sept, encouraging a global discussion about #researchintegrity in #peerreview. Follow along as we share our related policies and best practices.
@EmboMolMed @MolSystBiol @embojournal @LSAjournal @emboreports -
EMBO Mol. Medicine reposted
Carolin Sauer
@Carolinmsa
If you are interested in our other work, take a look at our
@EmboMolMed
paper on ctDNA analyses from dried blood spots in PDX mouse models (doi.org/10.15252/emmm.202215729) and our bioRxiv pre-print on copy number work (doi.org/10.1101/2021.07.19.452658) -
EMBO Mol. Medicine
@EmboMolMed
Neuropilin-1 (#nrp1) expression distinguishes self-reactive helper #tcells in systemic #autoimmunedisease.
By B. Raveney, S. Oki & colleagues at National Institute of Neuroscience, Tokyo
#systemiclupuserythematosus #nrp1
👉Read #openaccess: doi.org/10.15252/emmm.202215864 -
EMBO Mol. Medicine
@EmboMolMed
Read online #openacces 👉 Proteolytically generated soluble Tweak Receptor Fn14 is a #bloodbiomarker for #γsecretase activity.
By G. Güner, S. Lichtenthaler & colleagues @DZNE_en @TU_Muenchen
🗞️doi.org/10.15252/emmm.202216084 -
EMBO Mol. Medicine reposted
Basto_Lab
@basto_lab
We are very happy to see our study in epithelial ovarian cancers and centrosomes published today in EMBO Mol Med. An enormous THANK YOU to all the patients involved, medical teams, all the authors and their multiple contributions and funding: Inca, WWC, Institut Curie and CNRS.
-
EMBO Mol. Medicine reposted
Céline Carret
@carret_celine
Congratulations Renata, to you and your lab! Very pleased to see your article in @EmboMolMed 😍
Basto_Lab
@basto_lab
We are very happy to see our study in epithelial ovarian cancers and centrosomes published today in EMBO Mol Med. An enormous THANK YOU to all the patients involved, medical teams, all the authors and their multiple contributions and funding: Inca, WWC, Institut Curie and CNRS.
-
EMBO Mol. Medicine reposted
JP_M.
@jp_morretton
Very happy to share our study in centrosomes and epithelial ovarian cancers published in @EmboMolMed!
Congratulations and a big thanks at all authors specially @Anthony_inParis @Oumou_goundiam @BastoRenata and all @basto_lab!
www.embopress.org/doi/10.15252/emmm.202215670 -
EMBO Mol. Medicine reposted
Vanja Nagy Neuroscientist
@Lab_Nagy
We are incredibly proud to have our latest paper highlighted on the cover of @embomolmed where we describe a novel #ecm receptor in the brain and the causality of its variants in a rare #neurodevelopmentaldisorder. #raredisease #autism #glycosaminoglycans #neuroscience a🧵
-
EMBO Mol. Medicine
@EmboMolMed
📢Our September issue is online!
Beautiful cover on #fibcd1 & #neurological disorder
👉Articles on #cancer, #tuberculosis, #ibd, #lysosomalstoragedisorders, #steatohepatitis, & more!
👉Review on systemic inflammation after stroke
🗞️Fully #openaccess: www.embopress.org/toc/17574684/2022/14/9 -
EMBO Mol. Medicine
@EmboMolMed
In situ #msimaging reveals heterogeneous #glycogen stores in human normal and cancerous tissues
By M. Gentry, R. Sun (@RCSunlab) & colleagues @UF @universityofky
#ewingsarcoma #glycogen #msimaging
🗞️doi.org/10.15252/emmm.202216029 -
EMBO Mol. Medicine
@EmboMolMed
📢A universal SARS-CoV #dnavaccine inducing highly cross-reactive neutralizing antibodies and #tcells
By A. Mirazimi, M. Sällberg & colleagues @karolinskainst
#covid19 #vaccine
🗞️Read fully #openaccess: doi.org/10.15252/emmm.202215821 -
EMBO Mol. Medicine
@EmboMolMed
If you missed it 👉 sensitivity towards #hdac inhibition is associated with RTK/MAPK pathway activation in #gastriccancer
By J. Muñoz, D. Stange & colleagues
@NCT_UCC_DD @DKFZ @CNIOStopCancer @Ikerbasque
Read 🗞️#openaccess: doi.org/10.15252/emmm.202215705 -
EMBO Mol. Medicine reposted
Ramon Sun
@RCSunlab
Glad to finally see this exciting collaboration with the Gentry lab out in @EmboMolMed . We are "perfecting the wheel" in spatial glycogen quantitation and metabolism. #spatialbiology #msimaging #glycogen #glycotime @IMSSNews
www.embopress.org/doi/full/10.15252/emmm.202216029 -
EMBO Mol. Medicine reposted
CNRS Biologie
@CNRSbiologie
#resultatscientifique🔎 | TOP3A, un acteur majeur du maintien des télomères dans les ostéosarcomes pédiatriques
🤝 @CNRS @CNRS_dr12 @Inserm @univamu @paoli_calmettes @crcm_marseille
✍️ Vincent Géli
📕 @EmboMolMed | doi.org/10.15252/emmm.202215859
www.insb.cnrs.fr/fr/cnrsinfo/top3a-un-acteur-majeur-du-ma… -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Registration and scholarship deadlines extended to Aug 24 for @KeystoneSymp Interconnection between the #gutbrain and #microbiome for #metabolicdisease. Join @EmboMolMed's Zeljko Durdevic for this meeting in October => keysym.us/23J2EMBO #ksgutbrainmicro23 #gutbrainaxis
-
EMBO Mol. Medicine reposted
Vanja Tepavcevic
@TepavcevicVanja
@KKuhbandner at @preLights reviewed the 1st preprint version of our paper now published in
@EmboMolMed and highlighted several issues later raised by the reviewers. She now revisits our journey from preprint to published paper. @AchucarroGlia @Matutelab @InstitutCerveau
preLights
@preLights
As part of #prelights, we aim to explore the #journey of the #preprint to the #peerreviewedpaper.
prelights.biologists.com/highlights/genetically-modified-…
⬆️ @KKuhbandner revisits her #prelight on work from @TepavcevicVanja and colleagues
@MatuteLab now published in
@EmboMolMed - doi.org/10.15252/emmm.202114759 -
EMBO Mol. Medicine reposted
Karolinska Institutet
@karolinskainst
A new generation of #coronavirus #vaccine, designed to be less sensitive to mutations and equipped for future strains, shows promising results in a preclinical study published in @EmboMolMed by KI researcher Matti Sällberg and colleagues. #covid19 news.ki.se/new-generation-of-corona-vaccine-shows-promisi…
-
EMBO Mol. Medicine reposted
CNIO Stop Cancer
@CNIOStopCancer
A ‘weak spot’ discovered that potentially makes multi-drug resistant tumors vulnerable
💥 A paper by #cniostopcancer researchers @KP_twitt_llo and @LauSancBurgos
🗞️ @EmboMolMed July 2022
▶️ www.cnio.es/cancer/4y43 -
EMBO Mol. Medicine reposted
Review Commons
@ReviewCommons
Müller et al's pre-erythrocytic malaria vaccine preprint has been published as an article in @EmboMolMed
www.embopress.org/doi/full/10.15252/emmm.202013390
Review Commons
@ReviewCommons
"Low immunogenicity of #malaria pre-erythrocytic stages can be overcome by vaccination"
#refereedpreprint
Katja Müller, Julius Hafalla et al @LSHTM_malaria
eeb.embo.org/doi/10.1101/2020.09.03.281238 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
⏰Abstract deadline is today 1 Sept for @KeystoneSymp Human #microbiome conference taking place in December. @EmboMolMed will be there - more info and deadlines => keysym.us/22Q3EMBO #kshumanmicro22
-
EMBO Mol. Medicine reposted
Dominik Paquet
@PaquetLab
Press release for our recent study in @EmboMolMed
Universität München
@LMU_Muenchen
In certain neurodegenerative diseases, metabolic by-products build up in cells. The modulation of an ion channel could offer a new therapeutic approach.
www.lmu.de/en/newsroom/news-overview/news/ion-channel-as-… -
EMBO Mol. Medicine reposted
Alba Simats
@SimatsAlba
Check out our latest review on the indisputable importance of systemic immunity on stroke outcome and comorbidities!
@ArthurLiesz @EmboMolMed www.embopress.org/doi/full/10.15252/emmm.202216269 -
EMBO Mol. Medicine reposted
Arthur Liesz
@ArthurLiesz
Interested in the systemic immune response to stroke?
Check out our new review with @SimatsAlba in @EmboMolMed.
www.embopress.org/doi/full/10.15252/emmm.202216269 -
EMBO Mol. Medicine
@EmboMolMed
New review published online on the impact of #ischemicstroke on systemic immunity, its interaction with common comorbidities, and the underlying mechanisms of systemic brain-immune communication.
By A. Simats & A. Liesz @LMU_Muenchen
🗞️Fully #openaccess: doi.org/10.15252/emmm.202216269 -
EMBO Mol. Medicine
@EmboMolMed
S. Kappel & C. Peinelt discuss the study by S. Feske (@Feskelab), C. Weidinger & al. published in @EmboMolMed that reports that #storeoperatedcalciumentry controls immune cell function in #ibd.
👉doi.org/10.15252/emmm.202216489
🗞️Read related full article: doi.org/10.15252/emmm.202215687 -
EMBO Mol. Medicine
@EmboMolMed
Novel Nanotechnology That Combats Cancer Cells Developed at Bar-Ilan University themedialine.org/life-lines/novel-nanotechnology-that-com… via @TheMediaLine
-
EMBO Mol. Medicine
@EmboMolMed
Gene therapy using a modified form of the DGKk enzyme showed promise for behavioral symptoms in fragile X syndrome, a study in mice has found. fragilexnewstoday.com/news/gene-therapy-improve-behaviora…
Full #openaccess article: doi.org/10.15252/emmm.202114649 -
EMBO Mol. Medicine
@EmboMolMed
CalciMedica Announces Publication of Preclinical Data in EMBO Molecular Medicine Supporting the Development of CRA... www.prnewswire.com/news-releases/calcimedica-announces-pu…
full #openaccess article: doi.org/10.15252/emmm.202215687 -
EMBO Mol. Medicine
@EmboMolMed
📢Online today! In this #openaccess commentary, M. De Palma & A. Martinez-Usatorre define #dendriticcells cross-dressing and discuss how this phenomenon may be used to enhance #antitumorimmunity.
@EPFL_en
👉doi.org/10.15252/emmm.202216523 -
EMBO Mol. Medicine reposted
CalciMedica
@CalciMedicaInc
We are excited to announce the publication of preclinical data in @EmboMolMed supporting the potential development of CRAC channel inhibitors in inflammatory bowel disease (IBD). Read the press release: calcimedica.com/2022/08/09/calcimedica-announces-publicat…
-
EMBO Mol. Medicine reposted
Tigem Telethon
@Tigem_Telethon
Congrats to Prof Diego Medina @Tigem_Telethon PI & head of our @HCS_Tigem facility for his involvement in this new publication in @EmboMolMed. The authors explore the role of TPC2 in neurodegenerative diseases like mucolipidosis type IV & #batten disease
🗞️doi.org/10.15252/emmm.202115377 -
EMBO Mol. Medicine reposted
SFB_1403
@sfb_1403
What a nice cover from @EmboMolMed for their new issue illustrating the latest Rybniker Lab study (@UKKoeln) about tyrosine kinase mediated #immunecrosstalk in #sarscov2 #mrna #vaccination.
EMBO Mol. Medicine
@EmboMolMed
📢Our August issue is online!
Review on #hearingrestoration & articles on #tumourburden longitudinal monitoring, #cancer #immunotherapy, #radiodermatitis, #ibd, #myelinrepair and #covidvaccination (see our nice cover!)
🗞️Fully #openaccess👉 www.embopress.org/toc/17574684/2022/14/8 -
EMBO Mol. Medicine reposted
Iannis Aifantis
@iannisaifantis1
Another exciting addition in the area of Ion Channel signaling by the @Feskelab at @nyugrossman Pathology! www.embopress.org/doi/full/10.15252/emmm.202215687
-
EMBO Mol. Medicine
@EmboMolMed
📢Our August issue is online!
Review on #hearingrestoration & articles on #tumourburden longitudinal monitoring, #cancer #immunotherapy, #radiodermatitis, #ibd, #myelinrepair and #covidvaccination (see our nice cover!)
🗞️Fully #openaccess👉 www.embopress.org/toc/17574684/2022/14/8 -
EMBO Mol. Medicine reposted
Lucile Noyer
@NoyerLucile
Congrats to the team for this beautiful work highlighting the role of SOCE in IBD and potential application for CRAC channel inhibitors!
EMBO Mol. Medicine
@EmboMolMed
#storeoperatedcalciumentry controls innate and adaptive #immunecell function in #inflammatoryboweldisease
By C. Weidinger, S. Feske & colleagues @Feskelab @ChariteBerlin @nyugrossman
#ibd #storeoperatedcalciumentry
Read #openaccess: doi.org/10.15252/emmm.202215687 -
EMBO Mol. Medicine reposted
Elvira De Leonibus
@EDeLeonibus
Happy to have contributed to this super interesting, high translational, work for #lysosomal storage disorders. Thanks to @HCS_Tigem #diegomedina, #christiangrimm #sandromontefusco for the opportunity and to #mariateresapizzo 🔝🔝, for making our contribute feasible. @CNRsocial_
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉TPC2 rescues lysosomal storage in #mucolipidosis type IV, #niemannpick type C1, and #battendisease
By D. Medina, D. Paquet, C. Grimm & colleagues @LMU_Muenchen @Tigem_Telethon @UninaIT
🗞️Read #openaccess: doi.org/10.15252/emmm.202115377 -
EMBO Mol. Medicine reposted
EMBL Events
@EMBLEvents
Ready for another year full of groundbreaking science? Then check out our events line-up for 2023!🤩 We're excited for brand new conferences and courses as well as tried and true classics such as #emblmalaria and #eesimaging 🙌🏻
👩🏾💻 Have a look here️: www.embl.org/about/info/course-and-conference-office/wp-c… -
EMBO Mol. Medicine
@EmboMolMed
Online today! 👉TPC2 rescues lysosomal storage in #mucolipidosis type IV, #niemannpick type C1, and #battendisease
By D. Medina, D. Paquet, C. Grimm & colleagues @LMU_Muenchen @Tigem_Telethon @UninaIT
🗞️Read #openaccess: doi.org/10.15252/emmm.202115377 -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess 👉TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric #osteosarcomas using ALT
By D. Birnbaum, R. Reddel, V. Géli @crcm_marseille @Sydney_Uni
🗞️doi.org/10.15252/emmm.202215859 -
EMBO Mol. Medicine
@EmboMolMed
#storeoperatedcalciumentry controls innate and adaptive #immunecell function in #inflammatoryboweldisease
By C. Weidinger, S. Feske & colleagues @Feskelab @ChariteBerlin @nyugrossman
#ibd #storeoperatedcalciumentry
Read #openaccess: doi.org/10.15252/emmm.202215687 -
EMBO Mol. Medicine
@EmboMolMed
I Heidrich & K Pantel discuss the study by Sauer et al in @EmboMolMed that shows feasibility of longitudinal monitoring of disease burden & response using #ctdna from dried blood spots in xenografts
👉doi.org/10.15252/emmm.202216326
Related article #openaccess: doi.org/10.15252/emmm.202215729 -
EMBO Mol. Medicine
@EmboMolMed
📢Read #openacces! First collection of tumor organoid (tumoroid) models of pediatric #rhabdomyosarcomas (RMS) -> novel #preclinicalmodels for highly aggressive #pediatriccancer.
By M.T. Meister, J. Drost, F.C.P. Holstege & colleagues @prinsesmaximac
🗞️doi.org/10.15252/emmm.202216001 -
EMBO Mol. Medicine
@EmboMolMed
#fibcd1 is an endocytic GAG receptor associated with a novel #neurological disorder
By J.M. Penninger, V. Nagy & colleagues @Lab_Nagy @penningerlab @MedUni_Wien
@IMBA_Vienna @UBC @CeMM_News
🗞️Full #openaccess: doi.org/10.15252/emmm.202215829
Read also: cemm.at/news/detail/receptor-fibcd1-newly-identified-in-n… -
EMBO Mol. Medicine reposted
CeMM
@CeMM_News
For the first time, a research team led by Vanja Nagy (@Lab_Nagy) & Josef Penninger (@penningerlab) discovered a new function of the #fibcd1 gene in the brain & how its mutations could have a role in the development of #neurological disorders ➡️ cemm.at/news/detail/receptor-fibcd1-newly-identified-in-n…
-
EMBO Mol. Medicine reposted
IMBA imbavienna.bsky.social
@IMBA_Vienna
This study centers on the brain ECM and its associated neurological diseases. It might also help better understand the molecular paths leading to #autism, #adhd, #schizophrenia & #alzheimersdisease.
Link to the paper in @EmboMolMed ➡️ www.embopress.org/doi/10.15252/emmm.202215829
#neuroscience
2/2 -
EMBO Mol. Medicine reposted
IMBA imbavienna.bsky.social
@IMBA_Vienna
#justpublished‼️ Research led by @Lab_Nagy (@LBI_RUD @CeMM_News) & IMBA's @penningerlab links a new and rare #neurodevelopmental disorder to a sugar receptor in the #brain extracellular matrix ECM.
Read more ➡️ www.oeaw.ac.at/imba/research-highlights/news/receptor-fib…
@AHagelkruys @ChrisWFell #neuro @oeaw
1/2 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Our journals are now using a streamlined Author Checklist that incorporates the #mdar (material design analysis reporting) framework principles. www.cos.io/blog/the-mdar-framework-a-new-tool-for-life-sc…
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Listen to the latest #podcasts featuring @MolSystBiol & @embojournal authors as well as a conversation with @EMBO directors Fiona Watt and Maria Leptin. www.embo.org/category/podcasts/
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Browse a collection of @embojournal review articles on the theme of #tumor #biology. www.embopress.org/page/journal/14602075/focus/cancer-revi…
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
#refereedpreprints - like those created by @ReviewCommons and possible with all @EMBOPress journals - meet eligibility requirements for @EMBO postdoctoral fellowships. www.embo.org/features/refereed-preprints-recognized-as-el…
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Hear about the @EMBOPress Data Integrity Program in a conversation with our image-data analyst @ericawilfong and how we systematically screen image data in manuscripts submitted to our journals. www.embopress.org/newsletter-interview-boxheimer
-
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
An @emboreports editorial from @BerndPulverer and senior editor Esther Schnapp describe the journals scope expansion. doi.org/10.15252/embr.202255821
-
EMBO Mol. Medicine reposted
Review Commons
@ReviewCommons
We are seeking a scientist with broad & international research experience to join us as Scientific Editor here at Review Commons, @EMBO's preprint peer-reviewing platform.
Please RT.
www.embl.org/jobs/position/EMBO00125 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Don't miss the July edition of the @EMBOPress newsletter 👇
www.embopress.org/newsletter -
EMBO Mol. Medicine
@EmboMolMed
A 'weak spot' discovered that potentially makes multi-drug resistant tumors vulnerable www.cnio.es/en/news/a-weak-spot-discovered-that-makes-mul…
🗞️Read full article #openaccess: www.embopress.org/doi/full/10.15252/emmm.202215855 -
EMBO Mol. Medicine
@EmboMolMed
What role does a #trna modification complex, called Elongator, play in #braindevelopment?
mcb.uj.edu.pl/en_GB/glowna/aktualnosci/-/journal_content/…
🗞️ Read full article #openaccess: www.embopress.org/doi/full/10.15252/emmm.202115608 -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess 👉 #sarscov2 spike protein enhances MAP4K3/GLK-induced #ace2 stability in #covid19
By H-C Chuang, Y-H Chow, T-H Tan & colleagues at National Health Research Institutes Taiwan, & @bcmhouston
🗞️doi.org/10.15252/emmm.202215904 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Deadlines are approaching - join @EmboMolMed's Zeljko Durdevic for @KeystoneSymp #covid and Beyond, this October in Brussels! See scholarship, abstract and discount reg dates: keysym.us/23H5EMBO
#kscovid23 #infectiousdisease #globalhealth -
EMBO Mol. Medicine reposted
UBC Life Sciences Institute
@ubclifesciences
LSI Paper of the Day☀️
Evidence builds for #apn01, a soluble recombinant form of human #ace2 as a potentially universal treatment for #covid19.
This @EmboMolMed study led by Dr. Josef Penninger showed the drug neutralized infection in all tested #sarscov2 variants of concern. -
EMBO Mol. Medicine reposted
Marciniak Lab
@MarciniakLab
Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7‐deficient cells @EmboMolMed www.embopress.org/doi/full/10.15252/emmm.202215855
-
EMBO Mol. Medicine reposted
Kelsey Fisher-Wellman, PhD
@KFW_Lab
Latest findings covering #cancer #bioenergetics thanks to @BiomedNew biomed.news/bims-mibica/2022-07-24. Lab pick from @KP_twitt_llo in @EmboMolMed www.embopress.org/doi/full/10.15252/emmm.202215855
Great example of how expression data alone can mask functional deficiencies in mitochondria. Beautiful paper! -
EMBO Mol. Medicine reposted
EMBL Events
@EMBLEvents
👋 Meet 'Defining and defeating metastasis' poster prize winners! 🏆
🏅Benjamin Gordon
🏅María J. García-León
🏅Michael Brügger
🏅Maria Peiris-Pagès
🏅Sanne Bootsma
Visit our blog to find out more about their research and see the posters: blogs.embl.org/events/2022/07/13/poster-prizes-at-definin…
👏🏽 #eesmetastasis -
EMBO Mol. Medicine reposted
Diario Médico
@diariomedico
#oncología | 🔬 Descifran 'un punto débil' de la multiresistencia tumoral a fármacos
📌 Las mutaciones que inactivan el gen FBXW7 son las responsables, según un trabajo del @CNIOStopCancer que publica @EmboMolMed
✍ @alilo1920 dozz.es/bzjfg3 -
EMBO Mol. Medicine reposted
CIRI Lyon
@CIRI_Lyon
Découvrez dans la revue @EmboMolMed le dernier article du @GimapLab (@CIRI_Lyon, @Univ_St_Etienne, @ChuSaintEtienne) décrit certains des mécanismes immunologiques impliqués dans les maladies inflammatoires chroniques de l'intestin #mici
EMBO Mol. Medicine
@EmboMolMed
Online now! Alteration of #microbiota antibody-mediated immune selection contributes to dysbiosis in #inflammatoryboweldiseases.
By E. Michaud, S. Paul & colleagues @CIRI_Lyon
👉Read #openaccess: doi.org/10.15252/emmm.202115386 -
EMBO Mol. Medicine reposted
CNIO Stop Cancer
@CNIOStopCancer
🔎 A ‘weak spot’ discovered that makes multi-drug resistant tumors vulnerable by @KP_twitt_llo & @LauSancBurgos and with the help of @BU_CNIO & @falshahrour
🗞️ Published by @EmboMolMed, Great Job!!
www.cnio.es/en/news/a-weak-spot-discovered-that-makes-mul… -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Early registration, abstract and scholarship deadline is Aug. 9 for @KeystoneSymp 'Interconnection between the Gut, Brain and #microbiome for #metabolicdisease'. @EmboMolMed editor Zeljko Durdevic will attend and looks forward to connecting with you! keysym.us/23J2EMBO
-
EMBO Mol. Medicine reposted
APEIRON Biologics AG
@apeironbio
Congrats to R. Guggenberger, G. Wirnsberger and APEIRON Biologics founder Prof. Penninger. They report that all SARS-CoV-2 variants analyzed, including #voc such as #omicron, exhibit enhanced binding affinity to clinical grade #apn01.
EMBO Mol. Medicine
@EmboMolMed
📢Clinical grade #ace2 as a universal agent to block #sarscov2 variants
By G. Wirnsberger, J. Penninger & colleagues @karolinskainst @invIOs_com @IMBA_Vienna @ubclifesciences
👉Fully #openaccess: doi.org/10.15252/emmm.202115230 -
EMBO Mol. Medicine
@EmboMolMed
📢Online today! Activation of the #integratedstressresponse is a vulnerability for multidrug-resistant #fbxw7 -deficient cells
By @KP_twitt_llo, @LauSancBurgos & colleagues @CNIOStopCancer
#multidrugresistance #integratedstressresponse #fbxw7
🗞️doi.org/10.15252/emmm.202215855 -
EMBO Mol. Medicine reposted
SEMiPYP
@SEMiPYP
Alteration of microbiota antibody-mediated immune selection contributes to dysbiosis in inflammatory bowel diseases by Eva Michaud et al. ⤵️ idp.springer.com/authorize?response_type=cookie&client_id… Via @EmboMolMed #microbiota #ibd #dysbiosis
-
EMBO Mol. Medicine
@EmboMolMed
Online today! Review by D Keppeler, N Strenzke, T Moser et al. that summarizes the clinical translation of #genetherapy & #cochlearimplant innovations -> is there an unmet medical need for improving #hearing restoration?
@yourUMG @mpi_nat
🗞️ #openaccess: doi.org/10.15252/emmm.202215798 -
EMBO Mol. Medicine
@EmboMolMed
A type IV #autotaxin inhibitor ameliorates #acuteliverinjury and nonalcoholic #steatohepatitis.
By R. Booijink, A. Perrakis, R. Bansal & colleagues @utwenteEN @NKI_nl
👉Read #openaccess: doi.org/10.15252/emmm.202216333 -
EMBO Mol. Medicine reposted
Cell Therapy News
@celltherapynews
📢 New in @EmboMolMed!
A study led by Dr. Vanja Tepavčević (@TepavcevicVanja) provides proof of concept that #bloodcells can be used to deliver pro-remyelinating agents “at the right time and place”. ⏰
Read the paper: link.springer.com/article/10.15252/emmm.202114759 -
EMBO Mol. Medicine reposted
manic pixie dread boy
@redwinerascal
Instant top 5 graphics in any paper I've read
EMBO Mol. Medicine
@EmboMolMed
A novel platform for attenuating immune hyperactivity using the new #immunomodulator EXO-CD24 in #covid19 & beyond.
By S. Shapira, N. Arber & colleagues, Tel Aviv University
👉Read #openaccess: doi.org/10.15252/emmm.202215997 -
EMBO Mol. Medicine
@EmboMolMed
A novel platform for attenuating immune hyperactivity using the new #immunomodulator EXO-CD24 in #covid19 & beyond.
By S. Shapira, N. Arber & colleagues, Tel Aviv University
👉Read #openaccess: doi.org/10.15252/emmm.202215997 -
EMBO Mol. Medicine reposted
Vanja Tepavcevic
@TepavcevicVanja
Note: we recommend submitting to @EmboMolMed. Reviews were quick, and the editor was very clear on what should be the main focus of the revision. Although the revision took long (9 months+), the reviews were constructive and improved the paper.
-
EMBO Mol. Medicine reposted
Neurobiology Lab
@MatuteLab
Don't miss this fantastic work by @MatuteLab researcher @TepavcevicVanja on genetically modified macrophages as a tool to promote remyelination, published in @EmboMolMed #myelin #oligodendrocytes #genetherapy
Vanja Tepavcevic
@TepavcevicVanja
Our article on #genetherapy for #remyelination is published in @EmboMolMed !!tweetorial coming soon! Congrats to al authors @MatuteLab @NeuroSarah @MyelinIcm @nathaliecartie6 @InstitutCerveau @laubayoncordero @route135 @AchucarroGlia
EMBO Mol. Medicine
@EmboMolMed
Online today 👉 Genetically modified #macrophages accelerate #myelin repair.
By N. Cartier, C. Lubetzki, V. Tepavčević & colleagues @Inserm @Sorbonne_Univ_ @InstitutCerveau @AchucarroGlia
#genetherapy #sema3f #multiplesclerosis
🗞️#openaccess: doi.org/10.15252/emmm.202114759 -
EMBO Mol. Medicine reposted
Vanja Tepavcevic
@TepavcevicVanja
Our article on #genetherapy for #remyelination is published in @EmboMolMed !!tweetorial coming soon! Congrats to al authors @MatuteLab @NeuroSarah @MyelinIcm @nathaliecartie6 @InstitutCerveau @laubayoncordero @route135 @AchucarroGlia
EMBO Mol. Medicine
@EmboMolMed
Online today 👉 Genetically modified #macrophages accelerate #myelin repair.
By N. Cartier, C. Lubetzki, V. Tepavčević & colleagues @Inserm @Sorbonne_Univ_ @InstitutCerveau @AchucarroGlia
#genetherapy #sema3f #multiplesclerosis
🗞️#openaccess: doi.org/10.15252/emmm.202114759 -
EMBO Mol. Medicine
@EmboMolMed
Online today 👉 Genetically modified #macrophages accelerate #myelin repair.
By N. Cartier, C. Lubetzki, V. Tepavčević & colleagues @Inserm @Sorbonne_Univ_ @InstitutCerveau @AchucarroGlia
#genetherapy #sema3f #multiplesclerosis
🗞️#openaccess: doi.org/10.15252/emmm.202114759 -
EMBO Mol. Medicine reposted
CNIO Stop Cancer
@CNIOStopCancer
4⃣ February: Researchers design a drug screening platform compatible with patient biopsies to fight metastasis @EmboMolMed
by @valientelab
www.cnio.es/en/news/cnio-researchers-design-a-drug-screen… -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
'Fuse or die: A conversation with Orian Shirihai', the story behind an influential @embojournal paper on the mitochondrial life cycle.
Listen to the latest @EMBO podcast from @CyrilPedia with commentary from @winklhofer_lab.
Link => www.embo.org/podcasts/fuse-or-die-a-conversation-with-ori… -
EMBO Mol. Medicine
@EmboMolMed
Therapeutic application of PPE2 protein of #mycobacteriumtuberculosis in inhibiting #tissueinflammation
By R. Pal, M.B. Battu & S. Mukhopadhyay at CDFD, Hyderabad, India
#tuberculosis
👉Read #openaccess: doi.org/10.15252/emmm.202114891 -
EMBO Mol. Medicine
@EmboMolMed
📢Our July issue is online!
Read our articles on #vascularmalformations (our beautiful cover!), #acutemyeloidleukemia, #osteoporosis, #huntingtonsdisease, #neurodevelopmentaldisorders, & a review on #bacteriophagetherapy.
👉Fully #openaccess: www.embopress.org/toc/17574684/2022/14/7 -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Final days to apply for a 1-year position as @emboreports scientific editor!
EMBO Reports
@emboreports
We are looking for new colleague to join our team of scientific editors @EMBOPress in Heidelberg. Apply by 8th July here:
www.embl.org/jobs/position/EMBO00122 -
EMBO Mol. Medicine reposted
EMBO
@EMBO
EMBO announces its 67 new members and associate members from 22 countries. Congratulations and welcome!
Read more: www.embo.org/press-releases/embo-elects-67-new-members-an…
#embomembers #embo #lifesciences -
EMBO Mol. Medicine reposted
UBC Life Sciences Institute
@ubclifesciences
An @EmboMolMed study led by LSI Director Dr. Josef Penninger demonstrates proof of principle that APN01 - a clinical grade version of #ace2 - is effective as a pan-SARS-CoV-2 therapeutic.
#covid19 @UBCmedicine @ubcscience
EMBO Mol. Medicine
@EmboMolMed
📢Clinical grade #ace2 as a universal agent to block #sarscov2 variants
By G. Wirnsberger, J. Penninger & colleagues @karolinskainst @invIOs_com @IMBA_Vienna @ubclifesciences
👉Fully #openaccess: doi.org/10.15252/emmm.202115230 -
EMBO Mol. Medicine
@EmboMolMed
📢Clinical grade #ace2 as a universal agent to block #sarscov2 variants
By G. Wirnsberger, J. Penninger & colleagues @karolinskainst @invIOs_com @IMBA_Vienna @ubclifesciences
👉Fully #openaccess: doi.org/10.15252/emmm.202115230 -
EMBO Mol. Medicine
@EmboMolMed
Online now! Alteration of #microbiota antibody-mediated immune selection contributes to dysbiosis in #inflammatoryboweldiseases.
By E. Michaud, S. Paul & colleagues @CIRI_Lyon
👉Read #openaccess: doi.org/10.15252/emmm.202115386 -
EMBO Mol. Medicine
@EmboMolMed
#singlecelltranscriptomics reveals a #senescence -associated IL-6/CCR6 axis driving #radiodermatitis
By M. Paldor, E. Galun, J. Axelrod & colleagues @HebrewU The Goldyne-Savad Institute of Gene Therapy
👉Read #openaccess: doi.org/10.15252/emmm.202115653 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Spleen #tyrosinekinase mediates innate & adaptive #immunecrosstalk in #sarscov2 #mrna #vaccination
By S.J. Theobaldd, A. Simonis, J.M. Mudler, J. Rybniker & colleagues @UKKoeln
🗞️Read #openaccess: doi.org/10.15252/emmm.202215888
And (in german): www.uk-koeln.de/uniklinik-koeln/aktuelles/detailansicht/c… -
EMBO Mol. Medicine reposted
SFB_1403
@sfb_1403
📢New Paper! Together with the Walczak Lab, the Rybniker Lab at @UKKoeln found that Spleen tyrosine kinase mediates #immunecrosstalk in #sarscov2 #mrna #vaccination.
Congratualtions to all authors for this great publication in @EmboMolMed #sfb1403 ➡️ www.embopress.org/doi/full/10.15252/emmm.202215888 -
EMBO Mol. Medicine reposted
Uniklinik Köln
@UKKoeln
COVID-19-Impfung aktiviert langfristig das angeborene Immunsystem. Aktuelle Studie von Priv.-Doz. Dr. Dr. Jan Rybniker und Dr. Sebastian Theobald, #uniklinik #köln, zur Aktivierung von Abwehrzellen nach #covid19 #mrna-#impfung in @EmboMolMed publiziert.
www.uk-koeln.de/uniklinik-koeln/aktuelles/detailansicht/c… -
EMBO Mol. Medicine reposted
eriksahailab
@eriksahailab
Big congratulations to Alix Le Marois @CultureOfCells for winning an @EmboMolMed poster prize👍🍾. Very well deserved! Thanks also to @CR_UK @TheCrick @AstraZeneca for funding over the years.
-
EMBO Mol. Medicine
@EmboMolMed
Online today! Systemically targeted #cancer #immunotherapy and #genedelivery using transmorphic particles
By P. Asavarut, S. Waramit, K. Suwan, A. Hajitou & colleagues @ImperialMed @imperialcollege
👉Read #openaccess: doi.org/10.15252/emmm.202115418 -
EMBO Mol. Medicine
@EmboMolMed
📢In this #openaccess Commentary, A. Saied & colleagues discuss the current situation in Africa regarding #vaccine manufacturing & distribution, as well as challenges & perspectives to achieve a greater independence.
#vaccine #covid19
Read🗞️:doi.org/10.15252/emmm.202216287 -
EMBO Mol. Medicine reposted
Laurent Nguyen
@neuroliege
Cool work on Elongator from @GlattSebastian and Wainwright’s labs suggesting that its subcomplexes discriminate between distinct tRNA species www.embopress.org/doi/full/10.15252/emmm.202115608
-
EMBO Mol. Medicine reposted
Jacky GOETZ
@GoetzJacky
Yahi - awesome job 👍 from our post-doc Maria and thank you @embojournal @EmboMolMed for this prize
Massive efforts in the past years, in collaboration with P.Mangin @EFS_Sante (INSERMU1255) supported by @Institut_cancer @laliguecancer @InsermEst @unistra @CRBS_Strasbourg -
EMBO Mol. Medicine reposted
The EMBO Journal
@embojournal
At the end of #eesmetastasis, congratulations to @embojournal and @EmboMolMed poster prize winners Benjamin Gordon and Maria Garcia-Leon!
-
EMBO Mol. Medicine reposted
Sebastian Glatt
@GlattSebastian
Our latest work on #elongator is out in @EmboMolMed - after working on the complex for over 10 years, it still keeps surprising us - here a short summary 🧵@MCB_UJ @UJ @Struc_biol_PL @FNP_org_pl @ERC_Research
Malopolska Centre of Biotechnology UJ
@MCB_UJ
📰What role does a tRNA modification complex, called Elongator, play in brain development? Publication by @MCB_UJ scientists from @GlattSebastian @Struc_biol_PL @SOLARIS_science in @EmboMolMed
Details: mcb.uj.edu.pl/en_GB/glowna/aktualnosci/-/journal_content/…
Full text: www.embopress.org/doi/full/10.15252/emmm.202115608
EMBO Mol. Medicine
@EmboMolMed
Our June issue is online!
Beautiful review on #breastcancer #metastasis & #tumormicroenvironment, and articles on #inflammasome -dependent diseases targeting (our cover), #lymphoma, #inflammatoryboweldisease & #haemophiliaa.
👉Fully #openaccess: www.embopress.org/toc/17574684/2022/14/6 -
EMBO Mol. Medicine reposted
Malopolska Centre of Biotechnology UJ
@MCB_UJ
📰What role does a tRNA modification complex, called Elongator, play in brain development? Publication by @MCB_UJ scientists from @GlattSebastian @Struc_biol_PL @SOLARIS_science in @EmboMolMed
Details: mcb.uj.edu.pl/en_GB/glowna/aktualnosci/-/journal_content/…
Full text: www.embopress.org/doi/full/10.15252/emmm.202115608
EMBO Mol. Medicine
@EmboMolMed
Our June issue is online!
Beautiful review on #breastcancer #metastasis & #tumormicroenvironment, and articles on #inflammasome -dependent diseases targeting (our cover), #lymphoma, #inflammatoryboweldisease & #haemophiliaa.
👉Fully #openaccess: www.embopress.org/toc/17574684/2022/14/6 -
EMBO Mol. Medicine reposted
Agostinis Lab
@AgostinisLab
What a wonderful #immunooncology Conference we just had! Superb science, fantastic speakers, poster presenters and so efficient VIB organization! Thank you to all partecipants and sponsors!
-
EMBO Mol. Medicine reposted
VIB Training & Conferences
@VIBTrainConf
The @NatureRevCancer & @EmboMolMed poster prize winners for #immunoonco22 are Lucia Rodriguez Rogriguez of @UniversiteLiege & Federica Cappellesso of @vib_ccb, congratulations! 🎉🎉
We want to thank all participants, speakers and sponsors for making this a memorable conference! -
EMBO Mol. Medicine reposted
Mazzone Lab
@LabMazzone
Congrats to our PhD student Federica Cappellesso that won the EmboMolMed poster prize with her great story on SLC4A4 targeting as a way to overcome immunotherapy resistance in pancreatic cancer 🎉🎉 Good job!!! 👏
VIB Training & Conferences
@VIBTrainConf
The @NatureRevCancer & @EmboMolMed poster prize winners for #immunoonco22 are Lucia Rodriguez Rogriguez of @UniversiteLiege & Federica Cappellesso of @vib_ccb, congratulations! 🎉🎉
We want to thank all participants, speakers and sponsors for making this a memorable conference! -
EMBO Mol. Medicine reposted
CANCERPREV
@CANCERPREV1
Dr. Holger Breithaupt (Senior Features Editor) Responsible for #science & #society @emboreports giving his instructive lecture on "Science and Society" about #openscience
@EmboMolMed
@embojournal
@MolSystBiol
@ReviewCommons
@biorxivpreprint -
EMBO Mol. Medicine reposted
EMBO Press
@EMBOPress
Our @EmboMolMed scientific editor Lise Roth is pleased to attend @VIBConferences 'Recent insights into Immuno-Oncology' and looks forward to speaking with attendees about their latest research. #immunoonco22 #vibimmunoonco
VIB Training & Conferences
@VIBTrainConf
We're very proud to welcome 340 scientists to 2 days filled with #immunotherapy research @ #immunoonco22 in sunny #leuven. We hope to share new insights into the immune response to tumors and tackle unresolved questions. Want to know more? www.vibconferences.be/events/recent-insights-into-immuno-… #vibimmunoonco
-
EMBO Mol. Medicine reposted
Lev Kats
@LevKats
There’s a lot we still need to learn about pyrimidine synthesis in AML. Very nice succinct summary of our recent paper. Thanks @ElisaDonato17 and Andreas Trumpp.
EMBO Mol. Medicine
@EmboMolMed
E. Donato & A. Trumpp discuss the recent study by So et al that investigates the mechanism of action of a new potent inhibitor of de novo #pyrimidinesynthesis in the context of #acutemyeloidleukemia
👉 #openaccess: doi.org/10.15252/emmm.202216171
🗞️Full article: doi.org/10.15252/emmm.202115203 -
EMBO Mol. Medicine reposted
Angela An
@angie_anqier
Can one monitor disease burden and response using #ctdna from dried blood spots in pre-clinical models? 🩸🐁
Check out our latest paper published in @EmboMolMed. Delighted to have been involved in this work, and many thanks to @Carolinmsa & Katrin Heider for leading this effort!
Carolin Sauer
@Carolinmsa
Very excited to see our paper on the analysis of #ctdna from dried blood spots in PDX mice published @EmboMolMed yesterday! Many thanks to all the wonderful co-authors from the Rosenfeld & Brenton Labs @CRUK_CI!
Open access: doi.org/10.15252/emmm.202215729
🐁🩸🧬 Summary in thread... -
EMBO Mol. Medicine reposted
EMBO Reports
@emboreports
We are looking for new colleague to join our team of scientific editors @EMBOPress in Heidelberg. Apply by 8th July here:
www.embl.org/jobs/position/EMBO00122 -
EMBO Mol. Medicine reposted
Josep Carreras Leukaemia Research Institute (IJC)
@CarrerasIJC
"miransertib", an AKT inhibitor, could become the first molecular treatment effective against low-flow vascular malformations, according to the new study by @MarionaGraupera and @CastilloDSandra published on @EmboMolMed with @SJDbarcelona_ca.
Read more👇
www.carrerasresearch.org/en/miransertib-for-vascular-malf… -
EMBO Mol. Medicine
@EmboMolMed
Read #openaccess: Functional divergence of the two Elongator subcomplexes during #neurodevelopment
By M. Gaik, M. Kojic, S. Cingöz, B. Wainwright, S. Glatt & colleagues @MCB_UJ @UQ_News & Dokuz Eylül University
🗞️doi.org/10.15252/emmm.202115608 -
EMBO Mol. Medicine reposted
Carolin Sauer
@Carolinmsa
Very excited to see our paper on the analysis of #ctdna from dried blood spots in PDX mice published @EmboMolMed yesterday! Many thanks to all the wonderful co-authors from the Rosenfeld & Brenton Labs @CRUK_CI!
Open access: doi.org/10.15252/emmm.202215729
🐁🩸🧬 Summary in thread... -
EMBO Mol. Medicine reposted
Endothelial Cell News
@endothelialnews
💡 New research in @EmboMolMed shows that the onset of PI3K-related #vascularmalformations occurs during #angiogenesis and is prevented by the AKT inhibitor #miransertib.
Learn more: 🔎 link.springer.com/article/10.15252/emmm.202115619 -
EMBO Mol. Medicine
@EmboMolMed
📢Online today! The onset of #pi3k -related #vascularmalformations occurs during #angiogenesis and is prevented by the AKT inhibitor #miransertib
By P. Kobialka, H. Sabata, @MarionaGraupera, @CastilloDSandra & colleagues @CarrerasIJC
🗞️Read #openaccess: doi.org/10.15252/emmm.202115619 -
EMBO Mol. Medicine
@EmboMolMed
Longitudinal monitoring of disease burden and response using #ctdna from dried blood spots in #xenograft models
By C. Sauer, N. Rosenfeld, J. Brenton & colleagues
#cancer #patientderivedxenografts
🗞️Read #openaccess: doi.org/10.15252/emmm.202215729 -
EMBO Mol. Medicine
@EmboMolMed
E. Donato & A. Trumpp discuss the recent study by So et al that investigates the mechanism of action of a new potent inhibitor of de novo #pyrimidinesynthesis in the context of #acutemyeloidleukemia
👉 #openaccess: doi.org/10.15252/emmm.202216171
🗞️Full article: doi.org/10.15252/emmm.202115203 -
EMBO Mol. Medicine reposted
GrauperaLab
@MarionaGraupera
Very happy to see our last work on #pi3k and #vascularmalformations published today in @EmboMolMed
The onset of PI3K‐related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib | EMBO Molecular Medicine www.embopress.org/doi/full/10.15252/emmm.202115619 -
EMBO Mol. Medicine
@EmboMolMed
Our June issue is online!
Beautiful review on #breastcancer #metastasis & #tumormicroenvironment, and articles on #inflammasome -dependent diseases targeting (our cover), #lymphoma, #inflammatoryboweldisease & #haemophiliaa.
👉Fully #openaccess: www.embopress.org/toc/17574684/2022/14/6 -
EMBO Mol. Medicine
@EmboMolMed
Our March issue is online today!
Editorial from @EmboMolMed chief editor P. Sansonetti on #covid19 vaccination & correspondence on One-Health surveillance, but also articles on #psoriasis (our cover), #cancer and #metastasis, #otulin mutations, & more!
👉 www.embopress.org/toc/17574684/2022/14/3 -
EMBO Mol. Medicine
@EmboMolMed
Welcome to our new Advisory Editorial Board members!
We are looking forward to working with you, and are very grateful to all our board members for their continuous support! -
EMBO Mol. Medicine
@EmboMolMed
‘Publishing our paper on #genetherapy for #deafness at @EmboMolMed was a remarkable experience - reviews were constructive & next steps were smooth & professional. And the cover was a huge honor!’
@KarenAvraham @TAUMedFaculty
2022 @WomenScienceDay
Read: doi.org/10.15252/emmm.202013259 -
EMBO Mol. Medicine
@EmboMolMed
BET1 variants establish impaired #vesiculartransport as a cause for #musculardystrophy with #epilepsy
By C. Bönnemann, M. Schwake & colleagues @NIH @unibielefeld @NUFeinbergMed
-> Read #openaccess: doi.org/10.15252/emmm.202013787 -
EMBO Mol. Medicine
@EmboMolMed
Online today! Neonatal AAV #genetherapy rescues hearing in a mouse model of SYNE4 #deafness
By KB Avraham, JR Holt and colleagues @BostonChildrens and Tel Aviv University
-> Read #openaccess: doi.org/10.15252/emmm.202013259 -
Franck Courchamp
@franckcourchamp
If only (some) people learned to review, just as one learns to write papers... constructive and courteous reviews might be more common
Shane Liddelow 🍊
@LiddelowSA
Quick question to authors: do you find this reassuring?
Quick question to reviewers: does this make you change your tone/approach?
Quick question to journals: why doesn't every journal have such a statement?
Bravo @SciReports
EMBO Mol. Medicine
@EmboMolMed
@EMBOPress and @LifeSciLearn are working on a training course on how to review and write courteous and insightful reports! Stay tune...
-
EMBO Mol. Medicine
@EmboMolMed
“Autopsy registry can facilitate #covid19 research” S. von Stillfried, P. Boor @UniklinikAachen describe the 1st nation‐wide registry (DeRegCovid initiative) of #covid19 #autopsies as an essential tool for better understanding the disease.
www.embopress.org/doi/10.15252/emmm.202012885
































































































































































































































































































































































































































































































































































































































